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The human oral cavity is a complex polymicrobial environment, home to an array 
of microbes that play roles in health and disease. Oral bacteria have been shown to cause 
an array of systemic diseases and are particularly concerning to type II diabetics (T2D) 
with numerous predispositions that exacerbate bacterial infection. In this dissertation, 
we investigated the serum of healthy subjects and T2D subjects to determine whether 
we see greater translocation of oral bacteria into the bloodstream of T2D individuals. 
We didn’t observe any significant enrichment of oral taxa, however we detected the 
presence of an emerging pathogen, Acinetobacter baumannii that is also associated with 
impaired inflammation in T2D.    
While some are associated with disease, many oral taxa are important in the pre-
vention of disease. In this dissertation we investigated the interactions between two 
abundant health-associated commensal microbes, Haemophilus parainfluenzae and 
Streptococcus mitis. We demonstrated that H. parainfluenzae typically exists adjacent 
to Mitis group streptococci in vivo in healthy subjects. We revealed that this co-occur-
rence is density dependent and further influenced by H2O2 production. Additionally, 
Mitis group streptococci are likely the in vivo source of NAD for H. parainfluenzae 
further facilitating this co-occurrence. We also investigated H. parainfluenzae’s re-
sponse to H2O2, which is composed of a redundant OxyR-controlled system. Further-
more, we showed that H2O2 likely elicits the SOS response in H. parainfluenzae which 
may be a mechanism of generating genetic diversity within this species. These findings 
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CHAPTER 1: Introduction 
 
The human oral cavity is a complex environment, home to over 600 species of 
bacteria (1), most of whom are considered indigenous to this site (2). It is now well es-
tablished that the oral microbiota plays a vital role in the development of many dis-
eases. While intuitively, the oral microbiota plays a role in the development of oral 
diseases, oral microbes have also been associated with a range of systemic disorders 
beyond the oral cavity.  
One of the best-established associations is that of cardiovascular disease. Oral 
bacteria belonging to the HACEK (Haemophilus species, Aggregatibacter species, 
Cardiobacterium hominis, Eikenella corrodens and Kingella species) are known 
causes of infective endocarditis (IE) (3). Oral microbes, including Aggregatibacter ac-
tinomycetemcomitans and Porphyromonas gingivalis have also been detected in ather-
osclerotic plaques (4). Additionally, the development of oral diseases including perio-
dontitis has been shown to be an important risk factor for cardiovascular disease (5). 
The most common form of periodontal disease is gingivitis (6). Gingivitis is a reversi-
ble inflammatory disease caused by bacterial plaque that forms at the gingival margin 
(7). If left untreated, gingivitis may develop into periodontitis, which is a chronic, irre-
versible inflammatory disease that may result in destruction of connective tissue, vas-





An important patient population that is affected by periodontal disease are type II 
diabetics (T2D). The association between T2D and periodontitis can be considered to 
occur both ways as periodontitis is regarded as a potential complication of poorly con-
trolled diabetes and that periodontal pathogens can play a role in T2D (9). In fact dia-
betics have 3 times the risk of developing periodontitis compared to non-diabetics 
(10). Studies have shown differences in the composition of oral bacteria in T2D sub-
jects compared to non-diabetics, including elevated numbers of some periodontal path-
ogens (11,12). The abundance of some periodontal pathogens has also been shown to 
worsen glycemic control. Notably, the lipopolysaccharide (LPS) of the periodontal 
pathogen Porphyromonas gingivalis can stimulate inflammatory cytokines that impair 
insulin activity (13).  
Given the propensity of some oral bacteria to cause systemic disease, it is im-
portant to determine factors that can contribute to bacterial translocation into the 
bloodstream. This is particularly important among diabetics as they have multiple pre-
dispositions that can exacerbate bacterial infection. The presence of bacteria in the 
bloodstream outside of sepsis has been a contentious topic (14). While the advent of 
Next generation sequencing (NGS) has improved our ability to detect bacteria that are 
both unculturable and found in low abundance, the lack of appropriate controls in 
early studies investigating the “human blood microbiome” has hindered our under-
standing of this environment (14). It is now established that at least transient bacterial 
translocation occurs even after brushing teeth or mastication of food (15,16). Given 




ing and diminished bacterial uptake by phagocytosis (17–19), it is important to deter-
mine whether there is a greater translocation of oral bacteria into the blood of T2D. 
Similarly, given that diabetics are disproportionately affected by periodontitis, it is im-
portant to determine the effects of these conditions on bloodstream colonization.  
While the abundance of certain oral bacteria has been associated with both oral 
and systemic disease, the abundance and selection of commensal bacteria has been as-
sociated with health and prevention of disease (20).The oral cavity is not a unitary en-
vironment in fact, the oral cavity contains several different subsites which are com-
posed of distinct microbial communities (7). These include dental plaque, tongue dor-
sum, buccal mucosa and keratinized gingiva, which are home to very distinct commu-
nities. In fact, most bacterial species in the oral cavity are found in only a single site  
(21). An exception to this specificity is Haemophilus parainfluenzae, which is found 
in high abundance in all these sites as well as the nasopharynx (1). While H. parainflu-
enzae is responsible for the majority of cases of HACEK endocarditis (3), it is more 
commonly associated with a healthy oral microbiome (22). In fact, the abundance of 
H. parainfluenzae has been associated with beneficial immunomodulatory and anti-
proliferative effects against cancerous cells (23,24). It is therefore important to under-
stand the interactions of H. parainfluenzae within the oral cavity as this may improve 
our understanding of what maintains its healthy status and potentially prevents its 
translocation into distal sites where it may cause disease.  
Another abundant commensal found in all sites of the oral cavity and nasophar-
ynx are Mitis group Streptococci. The Mitis group is comprised of at least 13 Strepto-




species within this group are amongst the first colonizers of the human oral cavity and 
facilitate both microbial-microbial and host-microbial interactions by being anchors 
for biofilm formation and provide surface proteins to enable attachment and integra-
tion of other bacteria (26,27). A key example of this is S. mitis, which is regarded as a 
pioneering colonizer of both the oral cavity and nasopharynx (28). S. mitis has been 
shown to induce expression of human-b-defensin 2, which is a host antimicrobial pep-
tide that can kill oral pathogens and also dampen the effects of inflammation following 
coculture with oral pathogens (29,30).  
S. mitis can also influence overall oral biofilm ecology. It can release extracellular 
DNA, which is crucial for the development and stabilization of biofilms and it can also 
produce hydrogen peroxide (H2O2), which has been shown to be an effective antimi-
crobial that can shape microbial community composition (27). Given the abundant 
presence of Mitis group Streptococci in the same environments as H. parainfluenzae it 
is prudent to investigate interactions between these two commensal taxa, especially in 
the context of H2O2 response and tolerance. The goals of this dissertation are to im-
prove our understanding of H. parainfluenzae- Streptococcus sp. interaction with a fo-
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Type-II diabetes (T2D) affects over 10% of the United States population and is a grow-
ing disease worldwide that manifests with numerous comorbidities and defects in in-
flammation. This dysbiotic host response allows for infection of the host by numerous 
microorganisms. In the course of T2D disease, individuals can develop chronic infec-
tions including foot ulcers and periodontitis, which lead to further complications and 
opportunistic infections in multiple body sites. In this study, we investigated the serum 
of healthy subjects and T2D patients with (T2DP) or without periodontitis for both mi-
crobiome signatures in addition to cytokine profiles. Surprisingly, we detected the pres-
ence of Acinetobacter baumanii in the serum of 23% of T2D/T2DP individuals tested. 
In T2DP, IL-1β, TNF-α, MCP-1, IL-6, IL-8, and IFN-γ were significantly elevated in 
ABC positive subjects. As an emerging pathogen, A. baumanii infection represents a 




Type-II diabetes (T2D) is a chronic inflammatory disease affecting 10.5% of the United 
States population, with rising prevalence both in the United States and worldwide (“Na-
tional Diabetes Statistics Report | Data & Statistics | Diabetes | CDC,” 2020; Whiting et 
al., 2011). Individuals with T2D typically have numerous comorbidities, and are at 
greater risk of both opportunistic and nosocomial infections, which can result in signif-
icant morbidity, including amputations, and lost quality of life (QOL) measures (Erben 




al., 2007). Thus, care must be taken to prevent and monitor the infection status of these 
individuals, as the development of diabetic mucosal and skin lesions across the body 
can impact the host immune and diabetic responses. Key infection prevention includes 
minimizing portals of entry and colonization by numerous pathogens. One example of 
such a portal of entry is the emergence of diabetic foot ulcers, which can develop dia-
betic foot infections (DFIs). Roughly 15% of adult T2D subjects develop foot ulcers 
and ~14% of these subjects undergo amputation, with the remainder needing extensive 
debridement, negative pressure treatments and other therapies including antibiotics that 
result in prolonged hospitalization time, lengthy healing duration and increased treat-
ment costs (Driver et al., 2010; Reiber et al., 1998).  
 
In addition to DFIs, T2D subjects are ~3 times more likely to develop periodontitis 
(Emrich et al., 1991; Wu et al., 2020). Periodontitis is an inflammatory oral disease 
accompanied by a polymicrobial biofilm infection that can lead to tissue damage, 
chronic lesions and tooth/bone loss in the oral cavity (Genco et al., 2020; Irfan et al., 
2001; Mann et al., 2020). During periodontal infection, the healthy oral microbiome, 
especially in the subgingival space (along teeth below the gumline, including periodon-
tal ligament, epithelium, alveolar bone, and connective tissues), transitions to one en-
riched with several opportunistic pathogens that exacerbate inflammation and host tis-
sue damage both locally and systemically (Curtis et al., 2020; Griffen et al., 2012; Haj-
ishengallis and Lamont, 2012; Nowicki et al., 2018; Roberts and Darveau, 2015; 
Socransky et al., 1998). While protective, acute inflammation is a helpful immune re-




homeostasis (resolution). Unresolved inflammation that fails to control the trigger leads 
to chronic lesions and is a hallmark of both periodontitis and T2D.  
 
More acute bacteremia can manifest in diseases such as endocarditis or other distal in-
fections by oral microbes (Carrizales-Sepúlveda et al., 2018; Lockhart and Durack, 
1999; Parahitiyawa et al., 2009). Various systemic diseases are in fact influenced by 
microbial metabolism and host interactions. “How” and “why” immune system imbal-
ance fails to control microbial pathogenic transition remains an active area of investiga-
tion. Increasing evidence implicates periodontal diseases, especially periodontitis in 
adults, as a potential risk factor for increased morbidity and mortality from systemic 
conditions including diabetes, cardiovascular diseases, adverse pregnancy outcomes, 
and others (Genco et al., 2020; S.E. Kleinstein et al., 2020). This is due to two plausible 
mechanisms: a direct pathway leading to migration of the bacteria to distal organs and 
an indirect pathway leading to production of microbial metabolites and/or activating 
inflammatory mediators that activate the immune system locally and systemically. This 
is likely made possible as periodontitis presents as a chronic inflammatory condition of 
the tooth-supporting structures occurring with oral microbiome dysbiosis and continu-
ous inflammatory burden. Notably, oral microbes have also been detected (Dowd et al., 
2008; Gardner et al., 2013) and isolated from DFIs (Bowler and Davies, 1999; Citron et 
al., 2007). Thus, we hypothesized that T2D patients might be at a greater risk of ex-
traoral infection and may exhibit changes in microbiota that transiently occupy their 
bloodstream. We further hypothesized that these changes would be even more apparent 




DFI-colonizing oral species in their bloodstream. Our initial investigations toward these 
hypotheses utilized samples derived from previous work on resolution of inflammation 
in T2D (Freire et al., 2017) and are reported here, with unexpected results.  
 
To investigate the possibility of oral species presence in the bloodstream, we compared 
the serum V1-V3 16S microbiomes of T2D and T2DP subjects versus a healthy cohort. 
While our initial microbiome observations did reveal the presence of multiple oral taxa 
in human serum, it did not demonstrate that these were especially enriched in T2D or 
even T2DP subjects compared to non-diabetic subjects. Unexpectedly, we detected Aci-
netobacter baumanii in 23% of the T2DP subjects in our study with none detected in 
the healthy cohort. A. baumanii is an emerging infectious pathogen (Villar et al., 2014) 
notorious for its evolving antibiotic resistances (Gootz and Marra, 2008; Vázquez-
López et al., 2020), nosocomial (Ayoub Moubareck and Hammoudi Halat, 2020; Dijks-
hoorn et al., 2007) and bloodstream infections (Peleg et al., 2008). A. baumanii is part 
of a cluster of Acinetobacter species with similar clinical manifestations known as the 
AB or ABC complex (Gerner-Smidt and Tjernberg, 1993) which are highly similar via 
ribotyping.  
 
A. baumanii or ABC complex organisms present several particular risks to T2D sub-
jects, specifically higher mortality rates for those with bacteremia (Leão et al., 2016) 
and for those with higher blood glucose concentrations (Leung and Liu, 2019). A. bau-
manii has recently emerged as medically important because of the increasing number of 




in a mouse pneumonia model led to increased proinflammatory cytokines, reduced neu-
trophil infiltration into the lung, and increased extrapulmonary dissemination (Qiu et 
al., 2009). In T2D, neutrophils present failure in early chemotaxis, but a hyper-inflam-
matory feedback loop emerges to compensate initial myeloid cell failure (Sarah E Klein-
stein et al., 2020).  Patients infected with A. baumanii after burns were 9.8 times more 
likely to develop glucose intolerance and ~3x more T2D burn patients developed A. 
baumanii infections (27%) than patients without T2D (8.5%) (Furniss et al., 2005). Ad-
ditionally, A. baumanii has also been observed in DFIs, particularly alongside other 
multidrug resistant pathogens, presenting a grave concern for T2D individuals (Castel-
lanos et al., 2019; Henig et al., 2020). In addition to DFIs, ABC complex organisms can 
also spread through the body and form infections in numerous organs (Al-Anazi and Al-
Jasser, 2014; Peleg et al., 2008). 
 
In this work, we first investigated whether or not we could detect signatures of oral 
bacteria in a post hoc microbiome analysis of serum samples collected in a previous 
study (Freire et al., 2017). Our findings indicated minor, yet significant, microbiome 
compositional changes between healthy cohort, type-II diabetics (T2D) and T2D sub-
jects with periodontitis (T2DP). We discovered that nearly 1/4 of T2DP subjects in our 
study contained sequence reads identical to that of A. baumanii, which was not detected 
in any healthy, no-template, or mock control samples. The specific presence of A. bau-
manii was confirmed by further clone library and 16S rDNA Sanger sequencing. In 
addition, we assayed the host response by cytokine profiles of sera. Our findings re-




that diabetes presents the major proinflammatory forces via cytokine analysis, and per-
iodontal diseases synergistically increased that profile when compared to healthy con-
trols. When stratifying A. baumanii positive T2D versus A. baumanii negative T2D 
samples we observed unique cytokine profiles, suggesting a specific microbial impact 
on systemic inflammation. While our methodology cannot indicate if A. baumanii was 
transiently present or a subclinical colonizer of our T2DP cohort, we propose that these 
data reveal a much greater risk of currently ‘uninfected’ T2D individuals for A. bau-
manii exposure and infection than previously understood and should justify more inten-






Serum samples were generated from the population described in Table 1. A total of 81 
subjects were investigated in this study, 57 with type-II diabetes (T2D), of which 29 had 
periodontitis (T2DP) as defined by the American Association of Diabetes (ADA) 
(American Diabetes Association, 2015) and American Association of Periodontology 
(AAP) (Armitage, 1999) criteria respectively. All T2D donors were poorly-controlled 
diabetic subjects that had not taken antimicrobials, non-steroidal anti-inflammatory 
drugs or insulin sensitizers within 3 months. Diagnostic serum glucose measures were 
taken for all subjects and HbA1C was measured for diabetics to stage disease status. As 




glucose levels (p < 0.0001; Table 1). There were no significant differences in gender or 
ethnicity between healthy volunteers and diabetic patients. Diabetic patients showed 
elevated BMI and tended to be older than healthy controls (p< 0.05), consistent with 
known disease biology. Periodontal condition was further stratified among the subjects 
according to severity of irreversible tissue loss (mild, moderate, severe) and reversible 
lesions called gingivitis according to American Association of Periodontology (AAP) 
(Armitage, 1999) criteria. Periodontal condition was significantly worse in diabetic 
compared to healthy subjects (p< 0.0001). All healthy subjects had healthy periodontal 
condition compared to only 11% of diabetic patients, with 15% of diabetic subjects suf-
fering from severe periodontitis. Current and former smokers were near uniformly part 
of the T2D and T2DP groups with only 1 current smoker in the healthy group. The entire 
study population had a median age range of 53 +/- 11 years and all subjects were out-
patient and thus not part of an extended hospital stay cohort. 
 
Table 1. Clinical demographics 
of study subjects. 
    









Age (mean in 
years ± SD) 
  46 ± 
10.74 











  Female 10 (42%) 29 (51%) 39 (48.15) 0.62 
Ethnicity Caucasian 15 (63%) 26 (46%) 40 
(49.38%) 
  
  Hispanic 2 (8%) 7 (12%) 9 (11.11%)   
  African-Ameri-
can 
6 (25%) 23 (40%) 29 
(35.80%) 
  
  Asian 0 2 (4%) 2 (2.47%)   
  Other 1 (4%) 0 1 (1.23%) 0.23 
Smoking Sta-
tus (no., %) 
Smokers 1 (4%) 5 (9%) 6 (7.41%)   
  Former Smok-
ers 
0 21 (38%) 21 
(25.93%) 
  




mean ± SD) 









mean ± SD) 









































(mean ± SD) 
Normal (<5.7% 
HbA1c) 
- 5.20 ± 0.26 -   
  Pre-diabetes 
(5.7-6.4% 
HbA1C) 
- 6.13 ± 0.21 -   
  Diabetes 
(>6.4% HbA1c) 






6 (10.71%) 31 
(38.27%) 
  























  Stable Perio-
dontitis 
0 2 (3.57%) 2 (2.47%) <0.0001 
ABC Positive 
(no., %) 
Positive 0 (0%) 13 (23%) 13 
(16.05%) 
  
  Negative 19 (76%) 29 (51%) 48 
(59.26%) 
  




Count (mil. of 
cells, mean ± 
SD) 








Count (mil. of 
cells, mean ± 
SD) 








Table 1. Study subject demographics. p-values calculated by unpaired t-tests or χ2 
(two-sided p-values; italicized p<0.05 significant). SD, standard deviation; BMI, body-
mass index; ABC, A. baumanii; %, percentage; mg/dl, milligrams per deciliter; kg/m², 






Microbiome analysis controls for low template sequencing 
 
Data generated here was part of a post hoc study of serum samples collected for a pre-
vious study (Freire et al., 2017) and thus not available in the larger volumes ideal for 
16S microbiome dataset generation. Low template concentrations can produce microbi-
ome signatures not derived from that in the biological samples due to amplification of 
contaminating gDNA in sterile buffers and reagents (Kennedy et al., 2014; Kim et al., 
2017; Salter et al., 2014), which often manifests as aquatic species signatures, many of 
which are not compatible with growth in the human host (i.e. many do not even grow at 
37°C) (Kim et al., 2017). A description of no-template / reagent only control samples is 
provided in the methods. Data within this study is provided as either minimally filtered 
(mitochondrial, human and chloroplast aligned reads removed) or strict filtered (reads 
removed based on homology with reagent-only controls) and indicated as such through-
out the study. All sequence data is made available at NIH SRA Bioproject 
PRJNA664044, and all scripts used for data generation, filtering, and analyses are pro-
vided in the Supplemental Information.  
 
We were able to generate abundant data from these samples with careful consideration 
paid to controls for amplification bias and background bacterial gDNA contamination 
of commercial sterile reagents. First, we utilized amplification of a mock standard li-
brary of 8 bacterial and 2 fungal species (Fig. S1A-B) at 10 and 1 ng of total template, 
which indicated that our library preparation protocol was suitable for species-level anal-




reagent only controls, which were subjected to our sequence analysis pipeline, revealing 
frequently encountered contaminating taxa. These taxa were filtered from each human-
derived sample in the strict-filtered datasets only.  
 
V1-V3 16S microbiome diversity analyses reveal minor but significant differences be-
tween diabetic and nondiabetic groups 
 
Serum and control samples were subject to bead beater lysis and genomic DNA purifi-
cation. Purified gDNA was amplified using the V1-V3 targeted 27F-519R primer pair 
(Stackebrandt and Goodfellow, 1991; Turner et al., 1999). Quality trimmed reads were 
subjected to DADA2 analysis (Callahan et al., 2016) and aligned to the SILVA database 
(Quast et al., 2013) to determine species-level identity where possible. Rarefaction 
curve analysis was performed to ensure adequate sequencing depth (Fig. S2) and rese-
quencing of each Illumina index was performed to generate greater sequencing depth 
without further template amplification. Run to run variability between next-generation 
sequencing was found to be insignificant (Fig. S3). Data analysis and comparisons were 
performed via QIIME2 (Bolyen et al., 2019) as detailed in the methods. 
 
We first quantified alpha and beta diversity between the healthy, T2D and T2DP subject 
groups for our strict filtered (Fig. 1) and minimally filtered data (Fig. S4). For both 
datasets, species richness for T2D and T2DP groups were significantly different than 
the healthy cohort which was also significantly different when compared to T2DP in 




diversity was significantly less for healthy subjects versus T2D and greater when com-
pared to T2DP for either minimal or strict filtered datasets. Thus, we observed minor 
but significant shifts in microbiome composition between subject groups.  
 
To begin investigating which taxa contributed to this composition difference we first 
looked at a phylum level display of our taxonomically assigned data (Fig. 2). Figure 2A 
and 2B respectively indicate phylum level data for strict versus minimal filtered da-
tasets. Similar trends in phyla distribution were evident for either dataset and reveal 






Figure 1.1. 16S Alpha and Beta diversity of serum microbiomes changes with sub-
ject status. Species richness is displayed based on Faith’s phylogenetic diversity (Faith, 
1992) (A) and species evenness based on Pielou’s evenness index (Pielou, 1966)  (B) 
for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP) sam-
ples. Significance was determined by Kruskal-Wallis analysis of variance (Kruskal and 
Wallis, 1952) for each comparison indicated and Benjamini-Hochberg correction (Ben-
jamini and Hochberg, 1995) was applied to generate adjusted q-values. All data used 
was strictly filtered based on no-template control indexes.  * indicates q-value < 0.002 
compared to Healthy, ** indicates q-value < 0.0004 compared to Healthy and to T2D, 
(C) Beta-diversity Bray Curtis distances. Pairwise PERMANOVA of each category vs 
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value 







Figure 1.2. Phylum level diversity changes between subject status. DADA2 ana-
lyzed data was aligned to the SILVA database for taxonomical assignment via 




phylum level taxa and displayed for (A) strict filtered and (B) minimally filtered con-
ditions. Asterisks on the top indicate run-run sample pairs that were positive for A. 
baumanii.  
 
MED and DADA2 analysis reveal the presence of Acinetobacter baumanii 
 
Given our initial investigation into whether or not there were differences between T2D 
and T2DP microbiota and a preliminary hypothesis that oral taxa would be enriched in 
T2DP serum, we first used a minimal entropy decomposition (MED) analysis identical 
to one used previously to characterize oral microbiomes (Eren et al., 2014). Oligotyped 
“nodes” or representative sequences were aligned to both the Human Oral Microbiome 
(HOMD) (Escapa et al., 2018) and Ribosomal Database Project (RDP) (Cole et al., 
2014) databases and species were assigned based on 98% or higher sequence identity 
when comparing nodes to reference databases. We next compared species assigned data 
between subject groups by linear discriminate analysis effect size measurements 
(LEfSe) (Segata et al., 2011). Using MED analyzed data for healthy vs all T2D subjects 
(Fig. 3) we detected significant enrichments of some oral species (S. cristatus, N. fla-
vescens) but also some known reagent contaminants (R. picketti, A. broomeae). Surpris-
ingly, we observed Acinetobacter baumanii significantly enriched in the T2D popula-
tion as a whole. For MED analysis, reads assigned as A. baumanii were present from 
0.01 to 7.3 % of total reads in 8 T2D and 5 T2DP subjects. No reads assigned to A. 
baumanii were detected in any healthy subjects. DADA2 amplicon sequence variants 




match to the singular MED node assigned to A. baumanii based on 100% RDP align-
ment across its full sequence.  
 
In our DADA2 / QIIME2 based analysis we performed taxonomical assignment for each 
DADA2 amplicon sequence variant (ASV) node aligned to either the Greenegenes (De-
Santis et al., 2006) (not shown) or SILVA database version 132 (Quast et al., 2013). 
Phylum level taxonomic assignments of DADA2 data aligned to SILVA were used in 
Figure 2. ASVs are similar to MED nodes and we observed that one ASV node was a 
perfect match to the singular MED node assigned to A. baumanii based on 100% RDP 
alignment across its full sequence. This ASV was assigned only to the Acinetobacter 
genus despite a 100% full length match to A. baumanii sequence at the RDP database 
and the NCBI non-redundant database (not shown). Based on this, we manually as-
signed this ASV to A. baumanii and found that reads now assigned to A. baumanii were 
present from 0.01 to 9.1 % of total reads in 8 T2D and 5 T2DP subjects with no reads 
assigned to A. baumanii detected in any healthy subjects. This demonstrated agreement 
between both MED and DADA2-based 16S data analysis. LEfSe analysis was again 
performed on healthy vs all T2D, as well as between all three subject groups and demon-
strated again that A. baumanii was significantly elevated amongst all T2D samples (Fig. 
S5).  
 
We next looked at differences in microbiome compositions across subjects by plotting 
Bray-Curtis distances via non-metric multidimensional scaling (NMDS) while distin-




bacteria (Fig. 4). Broadly, T2D and T2DP samples had less overlap in composition 
while healthy samples intersected either group. ABC status did not seem to form a dis-
tinct microbiome cluster, suggesting that there was no unique microbiota composition 
for ABC positive subjects apart from A. baumanii sequence detection.  
 
 
Figure 1.3. Healthy vs all T2D subjects reveal a potential enrichment of A. bau-
manii. Initial Minimal Entropy Decomposition (MED) analysis of 16S data with tax-
onomy assigned based on RDP database alignment to generate species level assign-
ments was performed followed by linear discriminate analysis effect size quantifica-
tion (LEfSe). This revealed enrichment of several species / genera in T2D subjects rel-
ative to healthy. DADA2 analysis of the same dataset was aligned to the SILVA data-









Figure 1.4. Beta diversity quantification between subject groups. SILVA assigned 
taxonomy of DADA2 analyzed 16S data was used to determine Bray-Curtis dissimi-
larity between samples for strictly filtered (A) and minimally filtered (B) data. Non-
metric multidimensional scaling and statistical analysis for each subject group was 
performed in R using the vegan package as described in methods. 
 
Validating the presence of A. baumanii in T2D subjects 
 
The finding of ABC sequences was unexpected, as study participants were not hospital-
ized or under treatment for any infection(s), and we wished to confirm this result by 
other techniques. This was especially needed as the V1-V3 portion of the 16S rDNA 
sequence only differs between A. baumanii and A. nosocomialis by 1 nucleotide substi-
tution. Using PCR primers for the 16S rDNA region that encompasses nearly all differ-
entiating 16S nucleotides between Acinetobacter species we generated amplicons from 
a portion of our ABC positive samples alongside negative healthy and no-template con-
trol samples (Fig. 5). PCR products were ligated into a TA vector and individual colo-
nies were propagated and subjected to Sanger sequencing of plasmid inserts. The 
1242bp sequences were then aligned to the NCBI reference RNA sequence database 
(refseq_rna). Each sequence (12 clones across 5 samples) was identical and matched the 
A. baumanii 16S sequence across its length. This result validated our initial 16S detec-







Figure 1.5. Clone library design to verify ABC complex member identity. Ampli-
fication with oMR328-329 primers produced an amplicon between 120-1306bp of the 
A. baumanii 16S rDNA sequence. This allowed for Sanger sequencing of information 
rich nucleotides indicated above allowing for species differentiation beyond initial V1-
V3 sequencing with the 27F-519R primers. The table beneath indicated the total num-
ber of individual clones sequenced per sample and which species they aligned to with 
100% identity in the NCBI non-redundant database.  
 
 
Host cytokine responses to T2D and T2DP vs Health 
 
In addition to serum microbiota, we also quantified twenty different human cytokines 




files, we observed that proinflammatory cytokines were significantly elevated in A. bau-
mannii positive samples highlighted in the box (ABC+). MCP-1 and IL-1β, classic pro-
inflammatory cytokines, were increased in diabetic patients. Intriguingly, T2D ABC-
negative subjects did not show increase of these markers. ABC+ subjects showed sig-
nificantly higher cytokine expression levels of IL-1β, IL-6, IL-8, MCP-1, and IFN- γ 






Figure 1.6. Cytokine profile quantification reveals distinct differences between 
subject groupings and A. baumanii presence. Heat map showing immune mediator 
concentrations derived from serum of diabetic and healthy samples (red, highest ex-
pression; yellow, lowest expression). Hierarchical clustering was employed by Mor-




pheus). Observations from hierarchical clustering are shown in a tree, with A. bau-
mannii positive (ABC+) groups highlighted in the box. ABC+ groups (II, III and IV) 
showed significantly different (p < 0.01) levels of IL-1β, IL-6, IL-8, MCP-1, IFN- γ 
compared to ABC-negative (ABC-) groups (I and V).  I) Diabetic/Healthy, II) 
ABC+/ABC, III) ABC+ Diabetic/ABC- Diabetic, IV) ABC+ Diabetic/Healthy, V) 
ABC- Diabetic/Healthy. Data are clustered according to comparison groups. * = p-
value <0.01 between groups via unpaired Student’s t-test. 
 
Host cytokine responses to specific microbiota  
 
Based on the cytokine abundance data and earlier microbiome sequencing, we were able 
to determine if any specific taxa were significantly correlated with cytokine presence or 
absence in T2D subjects (Fig. 7). A. baumanii was significantly correlated with elevated 
amounts of IFN-α, IFN-γ, IL-12p70, IL-8, and TNF-α. ABC+ subjects presented cyto-
kine correlations consistent with a profile of chronic inflammation. IL-8 is a chemokine 
that impacts neutrophil phenotype and function, and excessive amounts of this cytokine 
lead to chronic activation of phagocytes (Moore and Kunkel, 2019). Excessive produc-
tion of TNF-α increases failure of resolution of inflammation on innate immune cells 
by controlling a resolution receptor (Freire and Van Dyke, 2013). Here, TNF-α showed 
a significant increase in ABC+ subjects, suggesting co-existence with ABC in the serum 
of type-II diabetics. We also performed an identical analysis for healthy subjects and 




unique profiles were found, correlated with lower levels of proinflammatory cytokines 
and co-clustered with ABC-negative samples.  
 
While low template concentration microbiome profiling presents many challenges, we 
were able to utilize numerous control steps to minimize the impact of contaminating 
taxa. We were also able to demonstrate that not only were there significant differences 
between subject groups that include taxa of likely biological origins; we also demon-
strated that specific cytokines significantly correlated with the presence of distinct taxa. 
Most surprisingly, we were able to detect A. baumanii and confirm its presence in serum 
samples of type-II diabetics not known or currently diagnosed with any underlying in-
fection. These data do not per se indicate active infection but could also indicate colo-








Figure 1.7. Host-microbial correlation resolved type-II diabetic associations with 
inflammatory cytokines. HOMD/RDP assigned taxonomy of MED analyzed 16S 
data for both T2D and T2DP samples and cytokine concentrations were analyzed via 
Pearson correlation coefficient in R using the rcorr function. Significance was deter-
mined using the asymptotic p-values generated by rcorr with * =  p-value <0.05 ** = 










Issues with amplification-based 16S studies from low template concentrations are well 
known (Kim et al., 2017; Pollock et al., 2018; Sinha et al., 2015). We began this study 
as a post hoc analysis of existing serum samples from a previous bank of anonymized 
specimens (Freire et al., 2017). As sample volumes of serum were mostly limited, we 
relied on amplification of 16S rDNA, using V1-V3 region primers to improve the like-
lihood of identifying oral taxa (Eren et al., 2014) that we hypothesized to exist in the 
diabetic with periodontitis part of our cohort. To minimize effects of amplification, we 
performed multiple high-throughput sequencing runs of amplified libraries to increase 
sequence depth as opposed to further amplification and using a higher capacity sequenc-
ing platform. Additionally, we also included numerous no-template controls throughout 
sample preparation and purification to identify as many outside contaminants as we 
could (Kennedy et al., 2014; Kim et al., 2017; Salter et al., 2014). As a further control, 
we carried out amplification of mock community libraries (Fig. S1) to determine if am-
plification bias or infidelity affected taxonomic assignment. We also used two separate 
methods for correction of Illumina-sequenced amplicon errors, DADA2 (Callahan et 
al., 2016) and minimal entropy decomposition / oligotyping (MED) (Eren et al., 2015), 
as well as comparing our data from multiple ribosomal databases for taxonomic assign-
ment (Cole et al., 2014; DeSantis et al., 2006; Quast et al., 2013). In addition to Illumina 
sequencing, we performed a separate amplification of 16S rDNA followed by Sanger 
sequencing to independently confirm the identity of putative A. baumanii sequence 




to validate our findings as far as is feasible and have taken care not to over interpret data 
presented here.   
 
We initially hypothesized that oral taxa would be enriched in the bloodstream of T2DP 
subjects, and potentially all T2D subjects, compared to healthy subjects. Our microbi-
ome data revealed changes in composition between our three subject groups (Figs. 1-4, 
S4-5). However, while we observed oral taxa in our samples, there was only enrichment 
of few oral taxa in T2DP subjects, specifically S. cristatus and N. flavescens (Fig. 3), 
which are not associated with periodontitis. Given the limited template available for 
each sample, we cannot rule out that other oral taxa are not elevated in T2DP subjects, 
but more rigorous testing of that hypothesis would require larger serum volumes and 
using a longitudinal approach on individual subjects. By far the most surprising element 
of this dataset was the detection of A. baumanii (Fig. 3, 5, S5) assigned reads unique to 
13 T2DP subjects and not present in any control or healthy subject samples.  
 
A. baumanii represents a considerable risk to T2D subjects including higher mortality 
rates (Leão et al., 2016) and a higher risk of infection in burn wounds, as well as DFIs 
(Castellanos et al., 2019; Furniss et al., 2005; Henig et al., 2020). To confirm our V1-
V3 amplicon data and to determine whether or not these were A. baumanii or another 
AB complex species, we used targeted near full-length 16S rDNA primers that allowed 
us to sequence the majority of differentiating nucleotides necessary for ribotyping. Se-
quencing individual clones of these amplicons revealed 100% matches to A. baumanii 




5). This result was surprising, as none of the subjects in our T2D/P cohort were currently 
under in-patient treatment or had any indication of underlying infection (apart from per-
iodontitis). Given the methodology here, we cannot speculate on the true infection status 
of these individuals, nor can we be certain if the A. baumanii present were circulating 
in the bloodstream or were on the skin and mixed with the sample during a blood draw. 
No matter the route of entry, we were able to determine significant cytokine profile 
changes in T2DP A. baumanii positive subjects, as well as broader inflammatory 
changes in cytokine profiles between T2DP, T2D and healthy subjects (Fig. 6).  
 
Cytokine dysregulation can impact the host locally and systemically, making the subject 
more prone to severe infections and increased tissue damage (Tisoncik et al., 2012). 
Individuals that have T2D present an increased metabolic burden, while often comorbid 
periodontal disease promotes microbial dysbiosis, with both diseases resulting in a 
chronic state of inflammation. In the present study, A. baumanii was only found in the 
serum of diabetics, where an increase in proinflammatory cytokines was also observed 
(Figs. 6, 7). We utilized an unbiased panel of 20 human cytokines to survey specific 
immune responses to T2D and T2DP compared to those of healthy individuals. While 
there are complications presented by low template sizes in our samples, cytokine pro-
filing from these same volumes were well within desired assay volumes. As mediators 
of inflammation, cytokine production feeds forward a cascade of signals that can impact 
tissue, organ and overall host immunometabolism. In T2D, IL-1β, TNF-α, MCP-1, IL-
6, IL-8, and IFN-γ were significantly elevated in ABC+ subjects and not in ABC-nega-




has been investigated as therapeutic targets for clinical management of diabetes and 
associated chronic lesions (Feng et al., 2018; Peiró et al., 2017). We previously observed 
increased TNF-α levels in cell cultured neutrophils from T2D subjects relative to cells 
derived from healthy subjects (Sarah E Kleinstein et al., 2020). Co-occurrence of bac-
teria in the serum and cytokines also differed among controls. In the current study, co-
occurrence among cytokines was more evident in diabetic subjects (100 significant co-
occurrences) versus healthy individuals (30 significant co-occurrences) (Figs. 7, S6).  A 
baumannii especially correlated with neutrophil inflammatory signaling cytokine IL-8, 
which was not observed in healthy subjects. We have previously shown differences in 
gene expression in neutrophils of T2D individuals, which are primed to mount an aber-
rant inflammatory response when compared to neutrophils of healthy individuals (Sarah 
E Kleinstein et al., 2020), consistent with production of inflammatory cytokines ob-
served here. In contrast, IL-17α, P-selectin, and E-selectin levels were increased in dia-
betics that were ABC-negative compared to ABC+ diabetics. IL-4 and IL-10 did not co-
occur with A. baumanii in any of the healthy versus diabetic groups. The cytokine re-
sults provide an initial glimpse into the host response to chronic inflammatory diseases, 
T2DP with and without the presence of A. baumannii, which may warrant further inves-
tigation in larger studies.  
 
In conclusion, this study has revealed modest serum microbiome compositional changes 
and significant cytokine profile changes between T2D subjects with or without perio-




manii was present. We also present here the potential for lurking A. baumanii coloniza-
tion in asymptomatic T2D subjects, possibly to a much larger extent than previously 
reported. In our opinion, these data present a strong justification for further monitoring 
of T2D individuals for A. baumanii colonization and support the need for a more robust 
study to characterize the potentially greater spread of A. baumanii amongst individuals 
with T2D.  
 
Limitations of the Study 
Limitations of this study primarily include small template volumes available for serum 
samples in this post hoc study. Blood and sera microbiome studies will always be more 
complex due to low bacterial template concentrations inherent to these types of sample. 
While we have done our utmost efforts to validate our main findings regarding A. bau-
manii presence, there are likely more interesting aspects to our study cohort microbiota 
that have been missed. These and other minor limitations have been indicated in the 
manuscript.  
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Subject recruitment, sampling and storage 
 
Subject recruitment has been described previously (Freire et al., 2017). Briefly, T2D 
and healthy subjects were recruited from the patient cohorts of the Center for Clinical 
and Translational Research at the Forsyth Institute under Forsyth Institute Institutional 
Review Board-approved protocols (Protocol #11-03 and #13-07). All subjects gave 
signed informed consent prior to study evaluations. Clinical periodontal data and pe-
ripheral venous blood were collected. The diagnosis of T2D was made by the subject’s 
primary care physician following American Association of Diabetes guidelines (Amer-
ican Diabetes Association, 2015). Information was collected on subject demographics 
(age, gender, self-reported ethnicity, and self-reported smoking status), body-mass in-
dex (BMI; kg/m2), blood total cholesterol, blood glucose (point-of-care), percent he-
moglobin A1C (HbA1c), and periodontal condition (Armitage, 1999). HbA1c was used 
to determine the level of glycemic control for diabetic subjects. One T2D individual 
lacked HbA1c measurements but fit based on all other diagnostic criteria (blood glucose 
>200 mg/dl) as well as cytokine profiles in accord with other T2D individuals. Neutro-
phil and monocyte cell counts were determined by lab assay (described below). Indi-
viduals were excluded if they were taking insulin sensitizers, nonsteroidal anti-inflam-




study, a total of 81 subjects (N=24 healthy, N=57 T2D) were included for analysis, all 
of whom were unrelated and over 18 years of age (range: 28-79 years of age). 
 




Frozen serum from N=81 samples (N=24 healthy, N=32 T2D and N=25 T2DP) were 
thawed on ice and aliquots were separated for DNA extraction. DNA was extracted 
using the Epicentre MasterPure Complete DNA and RNA Purification kit (Lucigen, WI, 
USA). Extraction was carried out using the manufacturer’s instructions, with modifica-
tions that enabled bead beating. Briefly, 200µL of Tissue and Cell Lysis Solution (2x), 
100µL of nuclease free water and 2µL of Proteinase K were added to Lysing matrix B 
(LMB) tubes (MP Biomedicals, Santa Ana, CA). Thereafter 100µL of serum was added 
to the tubes and placed in a Beadbeater (Biospec) for 30 seconds, then placed on ice for 
3 minutes and then repeated. Each round of DNA extractions included a no template 
control, which consisted of 100µL nuclease free water instead of serum. The samples 
were then incubated and extracted as described in the manufacturer’s instructions. Total 
DNA was precipitated using the manufacturer’s instructions, however 300 µL of MPC 
Protein Precipitation Reagent was used to accommodate the increased volume. DNA 





16s rDNA primers 27F (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGA-
GAGTTTGATYMTGGCTCAG) and 519R (GTCTCGTGGGCTCGGAGATGTG-
TATAAGAGACAGGWATTACCGCGGCKGCTG) (Stackebrandt and Goodfellow, 
1991; Turner et al., 1999) were used to amplify the V1-V3 regions of 16s rDNA in a 
50 µL reaction using 2x Q5 HiFi mastermix (New England Biolabs, Ipswitch, MA) 
and 23 µL of extracted DNA (35 cycles). 
      
Illumina MiSeq Library preparation 
 
After the first round of PCR was carried out it was cleaned with Ampure XP beads 
(Beckman Coulter, Pasadena, CA) and then visualized by agarose gel electrophoresis. 
Full indices and adapters were added using the Illumina Nextera Index Kit (Illumina, 
San Diego, CA) by running the second round of PCR (50 ng of template DNA, 5 cycles) 
in 2x Phusion HF Master Mix (New England Biolabs, Ipswitch, MA). PCR were then 
cleaned with Ampure XP beads and analyzed by agarose gel electrophoresis and using 
the Agilent BioAnalyzer DNA1000 chip (Agilent Technologies, Santa Clara, CA). Sam-
ples were then quantified and normalized prior to pooling using a Qubit fluorimeter 
(Invitrogen, Carlsbad, CA). The final pooled library was quantified with the KAPA Bi-
osystems Illumina Kit (KAPA Biosystems, Woburn, MA) via qPCR in a Roche Light-
Cycler480. Samples were sequenced (2x250 bp paired-end) on an Illumina MiSeq (Il-






Mock Community Standards Preparation 
In order to quantify potential bias due to low template concentrations, PCR amplifica-
tion, and contamination, we performed mock library assemblies with commercially 
available bacterial genomic DNA templates (Zymo Research #D6305).  We amplified 
2 libraries using 10 and 1 ng total starting templates in both sequencing runs for a total 
of 4 mock libraries synthesized.Total DNA species composition is provided in the man-
ufacturer’s instructions.  
16S clone library resequencing 
 
Primers were made to amplify regions of 16s rDNA that enable differentiation of the 
Acinetobacter species. Primers used were  
oMR328 (TAGCGGCGGACGGGTGAGTAATGCTTA) and 
oMR329 (TTCCGACTTCATGGAGTCGAGTTGCAGAC). 50 µL reactions in 2x Q5 
mastermix (New England Biolabs, Ipswitch, MA) were run for 35 cycles using 23 µL 
of DNA extracted from serum as the template. The products were then purified using 
the Qiagen PCR purification kit according to the manufacturer’s instructions. Gotaq 2x 
mastermix (Promega, Madison, WI) was used to generate ‘A’ overhangs via PCR for 5 
cycles using 10 µL of purified DNA as the template. 4µL of the resulting PCR products 
were then used to generate clones using the TOPO TA Cloning Kit (Invitrogen, Carls-
bad, CA) according to the manufacturer’s instructions which was modified to use 0.5µL 
of TOPO vector. Clones were then transformed into NEB5α cells using the manufac-
turer’s instructions and plated on LB plates supplemented with 0.1mM IPTG and 




plate prior to plating to enable blue-white screening. The plates were incubated for 24 
hours at 37°C. White colonies were inoculated into liquid cultures of LB supplemented 
with 40µg/mL kanamycin. Plasmids were extracted using QIAprep Spin Miniprep kit 
(Qiagen, Venlo, Netherlands). Inserts were sequenced using the M13 Forward 
(GTAAAACGACGGCCAGTG) and M13 Reverse (CACAGGAAACAGC-
TATGACC) primers on an Applied Biosystems 3500xl using the “BigDye” Terminator 
v3.1 Cycle sequencing kit. Sequences were analyzed using NCBI BLAST (NCBI Re-
source Coordinators, 2018). A maximum of 10 colonies were screened for each sample 
or until a sequence matched a species belonging to the Acinetobacter baumanii- calco-
aceticus complex.  
 
 Cytokine Quantification 
 
Frozen (-80°C) subject serum was brought up to room temperature and assayed using 
the Invitrogen human inflammation 20-plex ProcartaPlex cytokine panel (Thermo 
Fisher Scientific, Waltham, MA) on a Luminex 200 instrument (Luminex, Austin, TX) 
in universal assay buffer. Assayed cytokines included: MIP-1α, IL-1β, IL-4, IP-10, IL-
6, IL-8, IL-10, IL-12p70, IL-13, IL-17A, IFN-γ, GM-CSF, TNF-α, MIP-1β, IFN-α, 
MCP-1, P-Selectin, IL-1α, sICAM-1, and E-Selectin. Following manufacturer proto-
cols, all samples were run on a plate with 7 standards (diluted 1:4) and a control (uni-
versal assay buffer only), with all samples, standards, and controls run in duplicate sim-





Quality control (QC) steps were conducted according to manufacturer recommendations 
by xPONENT 4.2 software (Affymetrix eBioscience, San Diego, USA). Any standards 
with <70 or >130 % recovery of beads were invalidated. Samples were required to have 
a bead count of >30 beads recovered (all samples had >100 beads recovered and none 
were excluded at this step). Following QC, results were reported as average pg/mL for 
all measured cytokines. The lower limit of quantification (LLOQ) was determined based 
on the standard curve (after QC) as the average value of the lowest validated standards. 
Values at or below the LLOQ for each cytokine were reported at the LLOQ. As samples 
were run in two batches (with similar LLOQs for each batch), LLOQ for the cytokines 
(in pg/mL) were averaged across both runs: MIP-1α=1.79, IL-1β=5.58, IL-4=23.99, IP-
10= 1.17, IL-6=18.89, IL-8=2.48, IL-10=2.01, IL-12p70=11.72, IL-13=5.63, IL-
17A=4.63, IFN-γ=11.93, GM-CSF=14.57, TNF-α=9.66, MIP-1β=7.66, IFN-α=1.32, 
MCP-1=3.73, P-Selectin=1077.15, IL-1α=0.74, sICAM-1=442.80, and E-Selec-
tin=441.00. To compare cytokine levels between study groups, unpaired t-tests were 
used with a significance threshold of p<0.05 and no assumption of consistent standard 
deviation. 
 
Minimum Entropy Decomposition analysis of sequence libraries 
  
Poor quality reads were discarded using flexbar (Dodt et al., 2012). Reads were then 
treated as single end reads and trimmed for quality and to a length of 160bp using 
Trimmomatic (Bolger et al., 2014). Minimum Entropy Decomposition (MED) was per-




node representative sequences and their relative abundances. Taxonomic assignment of 
representative sequences were generated based on aligning 16s rRNA sequences at 
98.5% identity against the eHOMD database (Escapa et al., 2018) and further evaluated 
using the Ribosomal Database Project (RDP) database (Cole et al., 2014). MED nodes 
were assigned species level taxonomy based on >98.5% identity matches to eHOMD 
and/or RDP with eHOMD designations used as 1st priority as our intial aim was to iden-
tify oral taxa. Node frequency tables now assigned taxonomy were then used in associ-
ation with sample metadata for Linear Discriminate Effect Size analysis (LEfSe) 
(Segata et al., 2011). 
QIIME2 analysis of sequence libraries 
 
*All Scripts at end of this document. All work was performed on the University of 
Rhode Island High Performance Computing Bluewaves cluster:  
https://web.uri.edu/hpc-research-computing/cluster-specifications/ 
Data Import 
Fastq sequence data were imported using the import-fastq.sh script. Generated de-
mux.qzv files were viewed using https://view.qiime2.org/ via the “quality viewer” func-
tion to determine location for sequence quality trimming used in the following step.  
Fastq Trimming, DADA2 Analysis, Run-run Merging 
A second sequencing run of the prepared Illumina libraries was performed to ensure 




the end of the “D2-merge.sh” script we then used the Rarefaction-alpha.sh script out-
put (Fig. S2) to determine read depth (22,000) to use in downstream commands. 
Initial Alpha and Beta Diversity Measurements and Run-run Comparison Testing 
Merged libraries were used in the Alpha-Beta-An.sh script to determine initial phylo-
genetics on unfiltered data using the QIIME2 core-metrics-phylogenetic function, Al-
pha and Beta diversity calculations via QIIME2 alpha- or beta-group-significance 
functions as well as Beta diversity difference calculation (beta-group-significance) be-
tween sequencing Run 1 vs. Run 2 (Figs. S3, S4).   
Mock Community Standards Quality Control Testing 
This section uses the mocklibQC1.sh and mocklibQC2.sh scripts. Taxonomy files 
used are described below. The *-bar-plots.qzv file generated in the 1st script was 
viewed at https://view.qiime2.org/ and the level 6 data from this plot was exported as a 
.csv file which provides the reads per each taxa. This data was converted to proportion 
of total reads per each taxa and converted into the Zymo_actual.tsv file. The 
Zymo_expected.tsv file was generated by editing the Zymo_actual.tsv file with the 
proportion for each taxa present as provided in the manufacturers reference: 
https://files.zymoresearch.com/protocols/_d6305_d6306_zymobiomics_micro-
bial_community_dna_standard.pdf 
These .tsv inputs were then used in the mocklibQC2.sh script to output the visualiza-
tions seen in Figure S1.  




Initial import of the SILVA 132 classifier was performed by running the following 
command: 
wget https://data.qiime2.org/2019.7/common/silva-132-99-nb-classifier.qza  
Classifier setup was then performed using the classifier.sh script. Upon searching the 
silva-taxonomy.qzv file generated, we noted that there were no reads that matched A. 
baumanii sequences at all. We used the rep-seqs.merge.qzv file output from the 
D2merge.sh script saved as a FASTA file from within the QIIME2 viewer function 

















































One ASV from the rep-seqs.merge.qzv file (e875355f3179838110485d8f5013d4a6) 
returned a 100% match homology to the above A. baumanii sequence. This ASV was 
just annotated as Acinetobacter in the SILVA-132-99 taxonomy. We then edited the 
silva classifier taxonomy file by first exporting it using the following commands:  
module load QIIME2/2019.7 
qiime tools export \ 
 --input-path silva-taxonomy.qza \ 
 --output-path silva-taxonomy  
This output the file in *.tsv format which was then opened in a text editor and 
searched for the ASV node identity and then modified as indicated here:  
before 
e875355f3179838110485d8f5013d4a6    D_0__Bacteria;D_1__Proteobacte-
ria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D_4__Moraxel-





e875355f3179838110485d8f5013d4a6    D_0__Bacteria;D_1__Proteobacte-
ria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D_4__Moraxel-
laceae;D_5__Acinetobacter;D_6__Acinetobacter baumanii    0.9999662516375396  
The edited file was then saved as taxonomy-1.tsv and imported via the following com-
mand: 
qiime tools import \ 
  --input-path /data/mramseylab/classifiers/silva-taxonomy/taxonomy-1.tsv \ 
  --type 'FeatureData[Taxonomy]' \ 
  --input-format TSVTaxonomyFormat \ 
  --output-path silva-mod-taxonomy.qza  
qiime metadata tabulate \ 
  --m-input-file silva-mod-taxonomy.qza \ 
  --o-visualization silva-mod-taxonomy.qzv  
The silva-mod-taxonomy.qza file was used for the rest of our analyses.  
Data Filtering 
Data presented throughout the manuscript is generally described as “Minimally Fil-
tered” or “Strict Filtered”. We 1st began with all ASV assigned data from the above 




which included no-template and PCR only control indexes. This was done using the 
control-filter.sh script. Data output from the script was exported so it could be viewed 
and then used to subtract taxa from human-derived datasets in downstream filtering 
steps. Next we applied the meta-filter.sh script to our data to extract only human de-
rived samples for further analysis and filtering. After this we applied the minimal-fil-
ter.sh script. Outputs from this script were used in all “Minimally Filtered” described 
data in the manuscript. Minimal filtering included removal of instances of taxa that ap-
peared in only 2 samples or less, features (ASV sequences) that appeared less than 10 
times across all samples and any taxa with less than 20 reads per sample.  
Next we took our output files from the above control-filter.sh script and used them as 
part of the input for the auto-filter.sh script to exclude these taxa from the remaining 
minimally filtered data. While this removed many spurious taxa from our samples we 
observed high abundance of known aquatic microbial contaminant sequences not typi-
cally human associated (ex: Sphingomonas, Ralstonia). These and other taxa were 
manually excluded using the strict-filter.sh script and further removal of highly abun-
dant Pseudomonas sequences were also removed via the nopa-filter.sh script. Data 
filtered to this extent are referred to as “Strictly” filtered in the manuscript.  
Re-analysis of Filtered Data 
A reanalysis of filtered data was performed 1st for Alpha and Beta diversity measure-
ments via the alpha-beta2.sh script (Fig. 1). Further description and statistical analy-




metaMDS and Adonis functions primarily as demonstrated in the MMR20_ellip-
ses_NMDS.R script below.  
LEfSe Analysis Comparison 
Initial LEfSe analysis was performed using ASV output abundance data directly from 
the initial MED pipeline (Fig. 3). Further analysis on QIIME2 / DADA2 assigned 
strictly filtered data (Fig. S5) was performed first using the lefse-noTax.sh script to 
export and format data for analysis on the LEfSe Galaxy server (https://hut-
tenhower.sph.harvard.edu/galaxy/). This script only outputs ASV node information 
without taxonomic assignment. Manual taxonomic assignment was performed com-
paring ASV node names to the rep-seqs-merge.qza file from the D2merge.sh script. 
LEfSe analysis was performed using default settings, *.svg output files were further 












Figure S1.1. Mock library composition evaluation. A Zymogen mock community 
library was used for sequence library construction at 10 and 1 ng in duplicate between 
both sequencing runs. QIIME2 / DADA2 unfiltered data was given taxonomical assign-
ment via SILVA and assessed via the “q2-quality-control” plugin. (A) Taxon accuracy 
rate (TAR), taxon detection rate (TDR) and linear regression scores (r-squared) are plot-
ted at each taxonomic level. (B) Expected vs observed abundance of each species in the 
mock community is plotted at each taxonomic level. (C)  Distance between false posi-
tive observations vs nearest expected feature. Misclassifications were unique to envi-





Figure S1.2. Alpha-diversity at different rarefaction levels. Total observed OTUs 
(here ASVs) are plotted (A) vs sequencing depth and each sample that can accommodate 








Figure S1.3. Run to Run variability quantification. A Run vs Run Beta diversity 
comparison was performed for unfiltered data by comparing unweighted Unifrac dis-
tances as described in the methods. Pairwise PERMANOVA of Run-1 vs Run-2 (group 
size of 2, sample size of n=134 total indexes) was performed in 999 permutations re-
sulting in a pseudo-F value of 0.567, p-value of 0.999 and corrected q-value of 0.999. 
No significant differences were observed between each run.  
 
Figure S1.4. 16S Alpha and Beta diversity of serum microbiomes changes with 
subject status. Species richness is displayed based on Faith’s phylogenetic diversity 
(Faith, 1992) (A) and species evenness based on Pielou’s evenness index (Pielou, 1966) 
(B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP) 




mined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each com-
parison indicated and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) 
was applied to generate adjusted q-values.  * indicates q-value < 2e-3 vs healthy, ** 
indicates q-value < 0.024 vs healthy, (C) Beta-diversity Bray Curtis distances. Pairwise 
PERMANOVA of each category vs each (group size of 3, n=112) was performed in 999 
permutations. *** indicates q-value differs from healthy < 0.001. 
 
Figure S1.5. LEfSe Comparisons reveal taxonomical differences between subject 
groups. (A) LEfSe Cladogram plots (Segata et al., 2011) reveal general taxonomic 




and (C) compared across all 3 subject groups. Data was generated from DADA2 / 
QIIME2 analyzed data aligned to the SILVA database that was then filtered for contam-
inating taxa abundant in no-template control indexes. Pseudomonas genus / species 
level results were also removed for clarity.  
 
Figure S1.6. Cytokine correlation with specific taxa in healthy subjects. 
HOMD/RDP assigned taxonomy of MED analyzed 16S data for healthy samples and 
cytokine concentrations were analyzed via Pearson correlation coefficient in R using 
the rcorr function. Significance was determined using the asymptotic p-values gener-
ated by rcorr with * =  p-value <0.05 ** = p-value <0.01. Data are strictly filtered with 






Figure S1.7. 16S Alpha and Beta diversity of serum microbiomes changes with 
subject status. Alpha diversity is displayed based on Shannon’s index (Shannon and 
Weaver, 1975) (A) and species evenness based on Simpson’s evenness measure (Simp-
son, 1949) ) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodon-
titis (T2DP) samples. Each graph used minimally filtered data for analysis. Significance 
was determined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for 
each comparison indicated and Benjamini-Hochberg correction (Benjamini and 
Hochberg, 1995) was applied to generate adjusted q-values.  * indicates q-value < 1e-
5, ** indicates q-value < 0.007, (C) Beta-diversity unweighted Unifrac distances. Pair-
wise PERMANOVA of each category vs each (group size of 3, n=112) was performed 
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Complex polymicrobial biofilm communities are abundant in nature particularly in the 
human oral cavity where their composition and fitness can affect health. While the study 
of these communities during disease is essential and prevalent, little is known about 
interactions within the healthy plaque community. Here we describe interactions be-
tween two of the most abundant species in this healthy microbiome, Haemophilus 
parainfluenzae and Streptococcus mitis. We discovered that H. parainfluenzae typically 
exists adjacent to Mitis group streptococci in vivo which it also positively correlated 
with based on microbiome data. By comparing in vitro coculture data to ex vivo micros-
copy, we revealed that this co-occurrence is density dependent and further influenced 
by H2O2 production. We discovered that H. parainfluenzae utilizes a more redundant, 
multifactorial response to H2O2 than related organisms and that this system’s integrity 
enhances streptococcal fitness. Our results indicate that Mitis group streptococci are 
likely the in vivo source of NAD for H. parainfluenzae and also evoke patterns of carbon 
utilization in vitro for H. parainfluenzae similar to those observed in vivo. Our findings 
describe mechanistic interactions between two of the most abundant and prevalent 










Taxon-taxon interactions are of great importance for understanding the structure and 
function of natural biofilms. Many bacteria occur in nature as part of complex polymi-
crobial biofilms (1). The behavior of individual species within these biofilms is elabo-
rate and likely influenced by the spatial organization between physical and chemical 
substrates (1,2) produced by distinct species (3–5). Metagenomic and metatranscrip-
tome techniques give us an unprecedented ability to observe group composition and 
behaviors, but cannot resolve which species might be influencing one another nor de-
scribe their spatial interactions. Metabolite-based interactions can influence community 
composition through cross feeding or trophic interactions (6,7), complementation of 
auxotrophies (8) as well as competition for nutrients and production of inhibitory sub-
stances (9–12). These types of polymicrobial associations have been shown to enhance 
the resiliency, fitness, and stability of these communities (4,13,14). Maintaining stable 
oral microbial communities can preserve oral health, thus there is a clear need to identify 
the interactions between prominent species in host-associated polymicrobial communi-
ties and how they might shape not only constituency but physical structure. 
  
To delve into mechanisms underlying taxon-taxon interactions we chose to study the 
naturally occurring biofilm of human dental plaque. The human supragingival plaque 
(SUPP) biofilm has been long studied, dating to the very 1st microscopy observations of 
Antony von Leeuwenhoek in 1683 (ref. 15). Early work on both subgingival plaque and 




these environments (16) generating hypotheses about direct interaction and assembly of 
plaque structures. Recently, much more detailed biogeography of SUPP structure was 
observed (17). One notable association was between Streptococcus and other genera at 
the margins of biofilm structures. Streptococci can influence community interactions 
due to their ability to rapidly consume carbohydrates, produce large amounts of acidic 
fermentation products, and excrete antimicrobial substances including reactive oxygen 
species. These properties can support the growth of some species while excluding others 
(9,18–20). Many oral Streptococcus spp. including Mitis group members are known to 
produce various anti-microbial substances, including hydrogen peroxide (H2O2) in aer-
obic conditions. Therefore, any bacterium adjacent to these Streptococcus spp. aerobi-
cally would need to have adapted the ability to withstand H2O2 (7,21). Alongside Strep-
tococcus species within the Mitis group (S. mitis, S. oralis, S. australis, S. infantis, and 
others), Haemophilus parainfluenzae is one of the most abundant and prevalent species 
in the SUPP of healthy individuals (22–26). Whilst frequently characterized as an op-
portunistic pathogen and implicated in diseases including endocarditis (27), in the oral 
cavity H. parainfluenzae is a commensal and is associated with beneficial immunomod-
ulatory effects (28).  
 
To identify mechanisms of interaction that take place within this healthy polymicrobial 
biofilm we investigated interactions between two of its most abundant members, H. 
parainfluenzae and S. mitis. Despite the frequent co-occurrence of these species in prox-
imity in vivo, little is known about both the spatial relationship and metabolic mecha-




exist in intimate proximity in SUPP and exhibit localized density dependences that also 
exist in vitro which are driven by streptococcal H2O2 production. We also discovered a 
highly redundant H2O2 resistance system in H. parainfluenzae that is different from 
other Haemophilus species. We then observed multiple mechanisms of H. parainfluen-
zae interaction including NAD auxotrophy complementation by Mitis group strepto-
cocci and the upregulation of alternative carbon and energy pathways during in vitro 
coculture that are also observed in in vivo gene expression data. These results provide a 
robust characterization of H. parainfluenzae’s role in the oral microbiota and reveal 
ways it has evolved to exist alongside streptococci in the oral cavity and likely beyond. 
This study details interactions between two prominent members of a complex natural 
biofilm community and allows us to demonstrate mechanisms of interaction that likely 





H. parainfluenzae co-occurs with S. mitis and related streptococci in human su-
pragingival plaque  
 
To determine which species H. parainfluenzae was most likely to interact with we used 
microbiome data from 117 subjects sampled by the Human Microbiome Project (HMP). 
Analysis of HMP species-assigned metagenomic data indicated that H. parainfluenzae 




7.6% relative abundance based on sequence reads (Fig. 1). We compared the upper 
quartile (n=29) of these subjects ranked by highest H. parainfluenzae abundance to the 
remainder of subjects (n=88) via LEfSe analysis (29) to determine which species were 
significantly likely to co-occur with H. parainfluenzae (Fig. 1). Interestingly, this indi-
cated that individuals enriched in H. parainfluenzae have abundant Streptococcus sp. 
especially those in the Mitis group. These data were what led us to investigate H. parain-
fluenzae interactions with S. mitis as a Mitis group representative in order to examine 
the mechanisms of taxon-taxon interactions.  
 
 
Species-specific FISH demonstrates frequent H. parainfluenzae - S. mitis co-proximity 
 
To determine whether the large-scale co-occurrence of H. parainfluenzae and S. mitis 
was reflected in micrometer-scale spatial structure, we analyzed the organization of 
these two taxa using fluorescence in situ hybridization (FISH) and imaging. Within the 
supragingival plaque, S. mitis and related streptococci are frequent features of H. 
parainfluenzae's micron-scale environment. Visualizing these species with FISH probes 
showed that 92% of H. parainfluenzae cells in supragingival plaque are located within 
10 μm of cells labeled with a probe that hybridizes with a group of related streptococci 
including S. mitis, S. oralis, and S. infantis (Fig. 2A, Table S10, hereafter referred to as 
“S. mitis”). The median distance separating a H. parainfluenzae cell from the nearest S. 






In addition to proximity, images suggested a density-dependent relationship between 
these two taxa, with reduced densities of H. parainfluenzae in areas with the highest 
densities of S. mitis (Fig. 2C). We quantified this density effect by dividing each image 
into 1024 blocks of approximately 6 micrometers on a side (Fig. 2D) and measuring the 
density of S. mitis, H. parainfluenzae, and total bacteria within each block. The mean 
density of H. parainfluenzae increased as the percent of a block covered by S. mitis 
increased from 0 to around 20% (Fig. S1).  This trend is likely due, at least in part, to 
variation in the overall quantity of plaque in each block because the density of each 
taxon has a positive linear relationship with the overall plaque density. As the density 
of S. mitis increased above 20%, the mean H. parainfluenzae density decreased, sug-
gesting a density-dependent inhibitory effect of S. mitis on H. parainfluenzae 
growth. Given that both microbiome sequencing and microscopy imaging of in vivo su-
pragingival plaque samples indicate significant co-occurrence and co-proximity be-
tween H. parainfluenzae and S. mitis (Fig. 1,2), it is important to determine the mecha-




S. mitis eliminates H. parainfluenzae via production of H2O2 
 
Culturing these two taxa together under controlled conditions in vitro revealed a dose-
dependent interaction: H. parainfluenzae was killed by S. mitis, but only when abun-
dance of S. mitis was high relative to that of H. parainfluenzae. We used a colony bio-




and H. parainfluenzae, either separately or together, and permitted to grow for 24 hours; 
cell abundance was then assessed by resuspending the cells and plating for colony 
counts (see Methods). Cocultures inoculated at equal densities revealed that S. mitis 
reduced H. parainfluenzae numbers (Fig. 3) nearly 100-fold below inoculum density, 
indicating active killing. This effect is dose-dependent as we observed a significant re-
duction in the growth yield of H. parainfluenzae compared to monoculture when inoc-
ulums of S. mitis were either equivalent or 3-fold greater than H. parainfluenzae. How-
ever, when S. mitis inoculum was 10-fold lower than H. parainfluenzae, there was no 
significant change in the growth yield of H. parainfluenzae compared to monoculture. 
 
The mechanism of dose-dependent killing of H. parainfluenzae involves H2O2 produc-
tion by S. mitis. The reduction of H. parainfluenzae numbers in coculture was abolished 
if the cocultured strain of S. mitis lacked pyruvate oxidase (ΔspxB) and thus unable to 
produce H2O2. Figure 3 demonstrates that H. parainfluenzae growth yield when cocul-
tured with S. mitis ΔspxB is not significantly different from H. parainfluenzae mono-
culture at any ratio tested, indicating that S. mitis-produced H2O2 is responsible for H. 
parainfluenzae inhibition. Additional coculture experiments indicate that H. parainflu-
enzae was unable to grow in pH neutralized supernatants of S. mitis unless they were 
pre-treated with exogenous catalase (data not shown), further supporting the finding that 
H2O2 production limits H. parainfluenzae growth in these conditions and that acid pro-
duction is not sufficient to inhibit H. parainfluenzae. Thus, our observed density-de-
pendent exclusion of H. parainfluenzae by S. mitis in ex-vivo samples (Fig. 2) can be 





Although the density-dependent killing of H. parainfluenzae by S. mitis implies an an-
tagonistic interaction, the presence of H. parainfluenzae enhances S. mitis growth yield 
in biofilm coculture (Fig. S2). This enhancement was abolished when S. mitis was co-
cultured with H. parainfluenzae ΔoxyR but not with other catalase or cytochrome pe-
roxidase mutants either individual or combined (Fig. S2A). The addition of exogenous 
catalase elevated S. mitis monoculture yields near to those observed in coculture without 
catalase which suggests that H2O2 detoxification is primarily responsible for this en-
hanced yield (Fig. S2B). However, a >10-fold yield enhancement was still observed in 
coculture with H. parainfluenzae supplemented with exogenous catalase indicating fur-
ther interactions that benefit S. mitis fitness. The role of H2O2 decomposition in S. mitis 
yield increase was further confirmed when comparing mono vs coculture of S. mitis vs 
its ΔspxB mutant where the mutant demonstrated greater yield in monoculture and co-
culture vs the wild-type with a modest increase coculture yield (Fig. S2C) reminiscent 
of the wild-type coculture with exogenous catalase.   
 
Individual H2O2 sensitive genes do not affect the fitness of H. parainfluenzae in cocul-
ture with S. mitis 
 
The presence of S. mitis within a few micrometers of most H. parainfluenzae cells in 
natural plaque suggests that H2O2 and other inhibitory or promotive compounds ex-
creted by S. mitis are reasonably expected to perfuse the substrate in which most H. 




gene products in H. parainfluenzae by constructing gene deletions and assessing the 
fitness of the deletion strains after H2O2 exposure. Genes in H. parainfluenzae relevant 
to peroxide metabolism include oxyR whose gene product is a global transcriptional 
regulator responsive to H2O2. Also present is a single catalase (katA) essential for H2O2 
resistance in H. influenzae (33). Additionally, H. parainfluenzae possesses a cyto-
chrome c peroxidase (ccp), orthologs of which are important for peroxide resistance in 
other Pasteurellaceae (34), Campylobacter jejuni (35), and H. influenzae (36). We also 
made deletions of the peroxiredoxin (prx), peroxiredoxin-glutaredoxin (pdgX) and glu-
cose-6-phosphate dehydrogenase (g6p) genes known to contribute to oxidative stress 
protection in H. influenzae and other species (37–40). 
 
We quantified changes in H2O2 resistance by a zone of inhibition assay (Fig. 4A), in 
which an agar plate inoculated with a lawn of wild-type or deletion-strain H. parainflu-
enzae is exposed to a small filter saturated with H2O2 and sensitivity is measured as the 
diameter of the zone of inhibition. As expected, the largest increase in sensitivity was 
observed in H. parainfluenzae with deletions of the global H2O2-responsive transcrip-
tional regulator ΔoxyR, while all other individual gene deletion mutants were less sen-
sitive to H2O2. A ΔkatA+Δccp double mutant demonstrated a significant increase in 
sensitivity compared to individual mutants, indicating a combinatorial effect of these 
gene products. Surprisingly, MIC concentrations for many mutants were minor and 
nearly identical (Table S1) indicating that individual contributions of these genes to 
H2O2 tolerance are minimal. We next used the colony biofilm model to test the fitness 




to be essential for H. parainfluenzae survival in coculture, while deletion of individual 
genes typically controlled by OxyR showed no significant difference compared to 
wildtype which contrasts greatly to similar mutants in H. influenzae (katA) (33) and 
other species (41–43). However, the ΔkatA+Δccp mutants’ growth yield was signifi-
cantly inhibited in S. mitis coculture again indicating an additive effect of these gene 
products on H2O2 resistance. These data demonstrate that the mechanism of H. parain-
fluenzae resistance to H2O2 involves a complex multifactorial system unlike other Hae-
mophilus spp. yet characterized. 
 
S. mitis and other Streptococcus sp. support H. parainfluenzae growth  
 
Like other Haemophilus sp., H. parainfluenzae is a NAD auxotroph and must obtain 
NAD, nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) from the 
host or other microorganisms (44). We found that human saliva was unable to support 
H. parainfluenzae growth unless NAD was added (data not shown) suggesting that ad-
jacent microbes are the source of NAD for H. parainfluenzae in the oral cavity. As 
Corynebacterium and Streptococcus are two of the most abundant genera in SUPP, we 
tested if species from these genera could complement NAD auxotrophy. Spot assays on 
H. parainfluenzae lawns on medium lacking NAD showed robust growth of H. parain-
fluenzae adjacent to S. mitis and S. sanguinis but no other taxa (Fig. 5). These data 




proximity. It is notable that the two species that significantly correlate with H. parain-
fluenzae in microbiome data (Fig. 1) also enhance its growth most strongly in the ab-
sence of NAD compared to other Streptococcus spp.  
 
In vitro transcriptional responses of H. parainfluenzae to S. mitis 
 
Transcriptome analysis of H. parainfluenzae in aerobic coculture with S. mitis indicated 
a multifaceted response to oxidative stress. We observed that H. parainfluenzae signif-
icantly differentially expressed 387 genes greater than 2-fold in coculture (Tables 
S2&S3), compared to monoculture. Surprisingly, the differentially expressed genes did 
not include catalase; however, based on transcript abundance catalase is well expressed 
under both conditions. Among genes typically involved in oxidative stress responses, 
dps, which encodes an iron sequestration protein, had a 2.2-fold increase in coculture 
suggesting that H. parainfluenzae is sequestering free intracellular Fe2+, to prevent ox-
idative damage. Surprisingly however, several other genes involved in H2O2 were re-
pressed in coculture, including ccp, pdgX, thioredoxin (trxA), glutaredoxin (grx) and 
thiol peroxidase (tsa), demonstrating the complex nature of the oxidative stress response 
in this species. H. parainfluenzae stress responses were induced in coculture, likely due 
to H2O2–related damage by S. mitis. We observed modest but significant upregulation 
of the hfq chaperone encoding gene, universal stress protein E (uspE) and repression of 
lexA. LexA is involved in the repression of genes involved in the SOS response of E. 
coli (44). Hfq is known to be involved in the stress responses of many species (45). 
Paralogs of the Universal stress proteins including uspE, are known to be involved in 




in coculture including those encoding DNA ligase, exodeoxyribonuclease V beta chain 
and endonuclease V.  
 
Streptococcus spp. are known to rapidly consume carbohydrates, and transcriptional 
data suggest that H. parainfluenzae in coculture switches from carbohydrate consump-
tion to alternative sources of carbon and energy. There was increased expression of 
genes suggesting the breakdown of glycerophospholipids resulting in the uptake and 
utilization of glycerol, including the predicted extracellular patatin-like phospholipase 
(2.5-fold), lysophospholipase L2 (3.8-fold), glycerol uptake facilitator protein (5.3-
fold), glycerol kinase (3.4-fold), and a fatty acid degradation regulator (2.1-fold). Addi-
tionally, there was an increase in expression of fructose 1,6 bisphosphatase (2.8-fold), 
indicating active gluconeogenesis, consistent with H. parainfluenzae growth on 3-car-
bon intermediates such as glycerol. There was also evidence of the uptake and catabo-
lism of the sialic acid, N-acetylneuraminic acid as suggested by an increase in expres-
sion of SHS family sialic acid transporter (2-fold), sialic acid utilization regulator (3.6-
fold), N-acetylneuraminate lyase (2-fold), N-acetylmannosamine kinase (3.8-fold), and 
N-acetylmannosamine-6-phosphate 2-epimerase (3.1-fold). Lastly, there was an in-
crease in the expression of genes involved in the oligopeptide transport system, oppA 
(3-fold), oppB (2.2-fold), oppC (2.3-fold), oppD (2.7-fold), and oppF (2.4-fold). These 
data together suggest uptake of alternate carbon and energy sources in coculture. S. mitis 





In vivo transcriptional responses of H. parainfluenzae vs in vitro  
 
We hypothesized that in vivo gene expression of H. parainfluenzae is largely influenced 
by S. mitis due to their in vivo proximity (Fig. 2) and that our in vitro coculture data may 
be predictive of H. parainfluenzae behavior in vivo. To quantify this, we compared in 
vitro H. parainfluenzae transcriptomes to two separate in vivo metatranscriptome da-
tasets from healthy SUPP (47,48). We aligned metatranscriptomes to the H. parainflu-
enzae genome generating a dataset of H. parainfluenzae transcription within the com-
plex plaque biofilm. We then compared these samples to our in vitro monoculture and 
then determined which genes differentially expressed in vivo are also expressed in in 
vitro coculture. 
 
Comparing significantly differentially expressed gene patterns shared between all 3 da-
tasets (in vitro coculture and both in vivo metatranscriptomes) we observed that 18 genes 
were mutually upregulated including genes involved in glycerol catabolism, gluconeo-
genesis, and pili biogenesis (Table S4). We also observed 22 genes that were mutually 
downregulated including those involved in stringent response, methionine metabolism, 
and fur (Table S5, Fig. 6B). In individual metatranscriptome comparisons we saw even 
more genes that were significantly differentially expressed in the presence of S. mitis in 
vitro. This included repression of ccp, genes involved in methionine metabolism, strin-
gent response, metal transport genes, fur, and induction of genes involved in glycerol 
catabolism, gluconeogenesis, cell stress, DNA damage/repair related pathways, and 





These data suggest that aspects of H. parainfluenzae transcriptional responses in SUPP 
can be recapitulated in in vitro coculture with S. mitis. One notably absent overlap be-
tween in vitro cocultures vs in vivo datasets was the upregulation of genes involved in 
lactate oxidation observed in vivo. Since most Streptococcus sp. produce lactate as a 
metabolic end product (18), many oral taxa have evolved the ability to utilize lactate as 
a carbon source. Metatranscriptome data suggests that H. parainfluenzae catabolizes 
lactate in vivo, which it did not do in coculture indicating that further carbon source 
competition and crossfeeding is occurring in vivo that did not occur in vitro on complex 
medium. Overall, these data indicate numerous overlaps of in vitro H. parainfluenzae 














Our findings reveal multiple factors that can dictate the spatial organization and behav-
ior of two abundant oral commensal bacteria in vivo. The availability and distribution 




oral biofilm structures and in mixed communities of soil bacteria, where bacterial res-
piration creates a reduced environment enabling the growth of strict anaerobes in the 
biofilm interior (2,17). An important facet of oxygen availability is the production of 
H2O2 by some microbes, which can be an important mechanism of protection against 
invading or competing species in a variety of environments from the oral cavity (21) to 
the surface of the oceans (49). Also, the exchange of nutrients including electron donors 
and cofactors or nutrients between taxa can determine growth and interaction between 
them (8,50). Here we demonstrate that streptococcal metabolism can dictate both spatial 
organization and constituency within a naturally occurring multispecies biofilm.   
 
The production of H2O2 by early colonizing Streptococcus sp. is regarded as an im-
portant mechanism of protecting commensals from invading species and is believed to 
play a role in determining species composition (21). Our in vitro findings show that S. 
mitis can inhibit or kill H. parainfluenzae in a dose-dependent manner via the produc-
tion of H2O2. This appears to be mirrored in our in vivo findings where streptococci 
seemingly exclude H. parainfluenzae above a certain density. We assert that this density 
dependent interaction between these taxa is important for driving heterogeneity and spa-
tial organization within this complex community.  
  
Given the close association between H. parainfluenzae and H2O2 producing streptococci 
we investigated mechanisms of H2O2 resistance in H. parainfluenzae and demonstrated 




stantially differs from other closely related species, including H. influenzae. We demon-
strated that while loss of OxyR caused a significant increase in H2O2 sensitivity, loss of 
catalase or other individual gene products that provide H2O2 resistance did not (Fig. 4A, 
Table S1) which directly contrasts with the importance of catalase in H. influenzae, 
whose deletion leads to its inability to survive high concentrations of H2O2 (refs. 33,37). 
Streptococcal H2O2 production is thought to provide a competitive advantage in vivo 
and presents a source of stress that coexisting bacterial species must tolerate. This ability 
to deal with streptococci-produced H2O2 has been demonstrated in multiple species 
(10,21,32,51). Given that H. parainfluenzae is found closely associated with S. mitis in 
SUPP and co-occur together in other sites of the oral cavity (52), an intriguing hypoth-
esis is that this redundant system is born from H. parainfluenzae’s constant proximity 
to a H2O2 producer in multispecies biofilms. Evaluating the regulation of this redundant 
system is under current investigation by our group. We also noted that the fitness of S. 
mitis in vitro was reduced when cocultured with H. parainfluenzae strains impaired in 
H2O2 resistance (Fig. S2) and that when exogenous H2O2 detoxification occurred this 
fitness was restored (Fig. S2B).  However, we also observed that H. parainfluenzae still 
further increased S. mitis yield when H2O2 was not a factor indicating further mutual 
benefit beyond H2O2 responses.  
 
Paradoxically, H. parainfluenzae can be inhibited by, but is found adjacent to, S. mitis. 
This could be due to the ability of S. mitis to complement the NAD auxotrophy of H. 




to restore H. parainfluenzae’s growth, but some oral streptococci and S. mitis in partic-
ular could (Fig. 5) while host saliva could not. Perhaps this explains why 92% of H. 
parainfluenzae cells lie within 10 µm of S. mitis in vivo (Fig 2A). It is interesting to note 
that both H. parainfluenzae and S. mitis are found as commensals not just in the same 
sites of the human oral cavity (52), but also in other sites in the nasopharynx (53,54). 
Thus, Streptococcus sp.-produced NAD could, therefore, be an important determinant 
of H. parainfluenzae’s ability to survive and colonize various sites of the human body. 
While this may appear to be disadvantageous to H. parainfluenzae, it is also possible 
given the ubiquitous nature of Mitis group streptococci in the oral cavity, that H. parain-
fluenzae evolved this auxotrophy due to the constant availability of extracellular NAD. 
This is reminiscent of other cases in which auxotrophy development confers a fitness 
advantage (55).     
 
When comparing the H. parainfluenzae coculture in vitro transcriptome to in vivo SUPP 
metatranscriptomes (Fig. 6) we observed similar patterns of carbon catabolism includ-
ing the shift from utilization of sugars to small organic acids and alcohols while down-
regulating genes in the stringent response suggesting greater access to peptides.  Given 
their in vivo proximity, it is extremely likely that Mitis group streptococci are what in-
duce these same H. parainfluenzae behaviors in vivo, highlighting a facet of our reduc-
tionist approach that can uniquely explain behaviors in a complex multispecies in vivo 
biofilm. One notable pathway absent from our in vitro cocultures was lactate oxidation, 




Streptococcus spp. by cross-feeding on this fermentation product (7). In vivo, meta-
transcriptome data indicated that H. parainfluenzae was also upregulating lactate oxi-
dation gene products which would be expected in the more diverse, competitive SUPP 
environment compared to in vitro coculture alone.   
 
H. parainfluenzae and S. mitis are found abundantly not just in supragingival plaque but 
also in other sites of the human oral cavity (26,52). The abundance of these two taxa 
has been associated with health and their reduction is associated with the development 
of oral squamous cell carcinomas (24,56). Both taxa have also been shown to prevent 
the adhesion and attachment of the oral pathogen Porphyromonas gingivalis (57) and 
their mutual proximity has been observed at the genus level (17). Therefore, further 
investigating the mechanistic interactions that take place between these two species 
could provide insights into maintaining their presence and thus prevention of disease. 
Overall, there is a wealth of information and techniques available to study the compo-
sition, structure, and gene expression of complex multispecies communities. However, 
specific mechanisms that exist between individual members of these communities can 
be hard to discern from broad observational methods. Using a reductionist approach on 
two highly abundant and prevalent species in the oral cavity we determined how these 
taxa can support growth of each other and dictate their micron-scale distribution within 
this environment while suggesting additional mechanisms in use in the greater in vivo 
community.  





Strains and Media 
 
Strains and plasmids used in this study are listed in Table S11. Unless indicated, Strep-
tococcus mitis was cultured using Brain Heart Infusion (BHI) broth or solid agar sup-
plemented with Yeast extract (YE), Haemophilus parainfluenzae had additional supple-
mentation with 15µg/ml Nicotinamide Adenine Dinucleotide (Sigma-Aldrich) and 
15µg/ml Hemin (Sigma-Aldrich) - (BHI-YE-HP).  Escherichia coli was grown on Luria 
Broth (LB). H. parainfluenzae and S. mitis were grown at 37℃ and 5% CO2, E. coli at 
37℃ in standard atmospheric conditions with liquid cultures shaken at 200 RPM. An-
tibiotics were used at the following concentrations: kanamycin 40µg/ml, vancomycin 
5µg/ml, and spectinomycin 50µg/ml for E. coli and H. parainfluenzae.  200µg/ml spec-
tinomycin was used for selection of H. parainfluenzae transformants.  
 
Genomic and plasmid DNA isolation 
 
H. parainfluenzae Genomic DNA was isolated using the DNeasy Blood & Tissue kit 
(Qiagen) according to the manufacturer's instructions. Plasmid isolations were per-
formed using QIAprep spin miniprep kits (Qiagen).  
 
Genetic manipulation of H. parainfluenzae 
 
Gene deletions were generated using derivatives of a suicide vector pMRKO (7) as 
listed in Table S8. H. parainfluenzae was transformed via conjugation and mutants 




and H. parainfluenzae transformation are outlined in the supplementary methods sec-
tion.   
                
Read abundance data  
 
MetaPhlAn (58) species-assigned metagenomic sequence data from the Human Micro-
biome Project (Human Microbiome Project Consortium 2012) for the “Supragingival 
Plaque” oral site was 1st sorted based on predicted read abundance for Haemophilus 
parainfluenzae. Using the top quartile (highest 25% of samples enriched for H. parain-
fluenzae) we compared these samples to the bottom 75% and performed LEfSe analysis 
(29) to predict species significantly encountered at higher H. parainfluenzae abundance. 
LDA of a log10 score ≥ 3 were deemed significant.  
 
Plaque Collection, Fixation, and Storage 
 
Supragingival plaque was collected according to a protocol approved by New England 
IRB; all donors provided informed consent. Donors were instructed to refrain from prac-
ticing oral hygiene for 24 h before plaque collection. Plaque samples were collected 
from 7 donors by supervised self-sampling using a toothpick to scrape the supragingival 
surface of the teeth, avoiding the gingival margin. We fixed the plaque in a solution of 
2% paraformaldehyde (PFA) in PBS buffer on ice for 2 to 6 h.  The PFA was removed 
by three washes with 10 mM Tris HCl buffer (pH 7.5). The samples were stored in a 





DNA FISH and Mounting 
 
Aliquots of plaque were dried on UltraStick Slides (Thermo Scientific) for 10 min at 
46°C. The plaque was hybridized with 2 μM of each probe in a 900 mM NaCl, 20 mM 
Tris HCl (pH 7.5), 0.01% SDS, and 20% formamide hybridization buffer for 3 h in a 
humid chamber at 46°C. Non-hybridized probe was removed by washing the slides in 
prewarmed 215 mM NaCl, 20 mM Tris HCl (pH 7.5), and 5 mM EDTA wash buffer 
for 15 min at 48°C. The slides were rocked once during the wash incubation. The slides 
were rinsed in chilled deionized water and allowed to mostly air-dry before the samples 
were mounted in ProLong Gold Antifade mounting medium (ThermoFisher) under a 




We imaged the hybridized plaque with an LSM 780 Confocal Microscope (Zeiss) with 
a Plan-Apochromat 40x/1.4 NA objective. Each field of view was simultaneously ex-
cited by linear scanning with 405, 488, 561, and 633 nm laser lines. The emission spec-
tra were decomposed by linear unmixing using ZEN software (Zeiss) using reference 
spectra recorded from pure cultures of reference cells (Leptotrichia buccalis) hybridized 
with the Eub338 probe labeled with the appropriate fluorophore as described above. To 
obtain a random sample of the masses of plaque large enough to permit spatial analysis, 
we scanned transects spaced every 5 μm along the coverslip at 40x magnification and 
imaged every mass of plaque that was at least 70 μm in diameter and 250 μm away from 




view that satisfied these criteria or as many fields of view as were present on the slide. 
To maximize the number of bacteria captured in each image, we imaged the focal plane 





To allow quantitative analysis of the spatial distribution of the taxa of interest, we used 
FIJI to create binarized S. mitis, H. parainfluenzae, and bacterial mass images (59) as 
described in the supplementary methods section. 
 
We evaluated the pair correlations between S. mitis and H. parainfluenzae over different 
distances using a linear dipole analysis performed in Daime 2.2 (refs. 60,61). For this 
analysis, the reference space in each image was restricted to the area in the binary bac-
terial biomass image. We used all possible dipoles with lengths ranging from 0.15 to 
99.90 μm in steps of 0.45 μm. 
 
We evaluated trends between the local densities of both taxa, by dividing each field of 
view into 1024 6.64 μm by 6.64 μm blocks, discarding blocks that did not contain any 
of the binary bacterial mass image, and calculating the fraction of each block that was 
covered by the S. mitis and H. parainfluenzae binary images. 
 





Colony biofilm assays were carried out as described previously (31). Briefly, equal vol-
umes of H. parainfluenzae and/or S. mitis were spotted either in mono or coculture on 
sterile 25mm 0.2 µm polycarbonate membranes (MilliporeSigmaTM) and placed on 
BHIYE HP agar plates. H. parainfluenzae was spotted at an OD600 of 1 and S. mitis at 
OD600 of either 0.1, 1 or 3. The plates were then incubated for 24 hours at 37°C in 5% 
CO2. The membranes were then transferred to sterile media, mixed to ensure complete 
resuspension of the colony into the media; serially diluted and plated for CFU enumer-
ation. S. mitis was enumerated by counting CFUs on BHI-YE and H. parainfluenzae on 
BHI-YEHP with 5 µg/ml vancomycin. 
 
Disk diffusion assays 
 
Cultures of H. parainfluenzae were grown anaerobically in BHI-YEHP overnight. All 
strains were then adjusted to an OD600 of 1 and 100µl was spread plated on BHIYE HP 
plates and incubated aerobically for 2 hours at 37°C in 5% CO2. 5 µl of 30% H2O2 was 
then added to a sterile 5mm paper disk and plates were incubated for 24 hours at 37°C 
in 5% CO2. The diameters of the zones of inhibition were then measured using a caliper 
in at least 3 axes. 
 
Coculture transcriptome sample preparation 
 
RNASeq analyses were carried out on mono and coculture samples following the colony 
biofilm assays described above. Briefly, H. parainfluenzae was spotted on the polycar-




incubated for 22 hours at 37°C in 5% CO2. The membranes were then transferred onto 
fresh media for 4 hours and immediately placed in RNAlater solution (AmbionTM). Ex-
periments were carried out in biological duplicates. RNA extraction, library preparation 
and sequencing were then carried out by the Microbial ‘Omics Core facility at the Broad 
Institute. Sequences are submitted to the NIH SRA Gene Expression Omnibus (GEO) 




The H. parainfluenzae ATCC 33392 genome (GCA_000191405.1) was obtained from 
NCBI and annotation were generated using RAST under default settings (62–64). 
RNASeq reads were aligned, mapped and differentially expressed genes were analyzed 
using bowtie2 (ref. 65), HTSeq (66) and DESeq2 (ref. 67) with a Unix based pipeline, 
generated in this paper (available at https://github.com/dasithperera-hub/RNASeq-anal-
ysis-toolkit). This pipeline was also used to carry out a pathway analysis by mapping 
DEGs to KEGG orthology (https://www.genome.jp/kegg-bin/get_htext?ko00001). This 
allowed for improved annotations and the identification of potential pathways that are 
involved in coculture. The same pipeline was used to analyze H. parainfluenzae gene 
expression in published metatranscriptome datasets (47,48).  
 






Overnight cultures of H. parainfluenzae were washed 3 times in 1x Phosphate buffered 
saline (PBS) and diluted to an OD600 of 0.1 and spread plated on a plate containing BHI-
YE supplemented with Hemin and 20units/ml catalase. 5µL of bacteria at an OD600 of 
1 was added to a sterile paper disk and incubated for 48 hours. Strains used for spotting 





Figure 2.1: Read abundance data and predicted correlations between taxa in su-
pragingival plaque. Human Microbiome Project (HMP) metagenome data of su-
pragingival plaque was used to plot the relative abundance and prevalence of species 
of interest including Haemophilus parainfluenzae (blue), several Mitis group strepto-
cocci and all remaining Streptococcus spp. (dark grey). (Top Right) The top 25% of 
subjects based on H. parainfluenzae abundance were compared to the remainder via 








































Figure 2.2. H. parainfluenzae distribution is related to the density of S. mitis in 
vivo (A) Histogram of the distance to the nearest S. mitis cell, measured edge-to-edge, 
from each of the 37,591 H. parainfluenzae cells in 41 fields of view. (B) Pair correla-
tions between H. parainfluenzae and S. mitis cells. The lighter lines represent the 
bounds of the 95% confidence interval for the correlation values. The dashed line rep-
resents the null hypothesis: the pair correlation equals one. n = 41 fields of view. (C) 
Plaque with sparsely distributed H. parainfluenzae (cyan). (D) Plaque with high abun-
dances of both S. mitis (magenta) and H. parainfluenzae. (i) Most H. parainfluenzae 
cells are within a few microns of the nearest S. mitis cell. Generally, H. parainfluenzae 
are randomly distributed with respect to S. mitis. (ii) H. parainfluenzae avoids the 







Figure 2.3: H. parainfluenzae growth is inhibited by Streptococcus mitis produced 
H2O2 in a dose dependent manner. H. parainfluenzae (Hp) CFU counts in mono and 
coculture with wildtype (Sm) or a pyruvate oxidase mutant (𝛥spxB) of S. mitis. Hp had 
an initial inoculum using 10µL at an OD600 of 1, which corresponds to 4.65x106 
CFU/ml. Wildtype (Sm) and S. mitis 𝛥spxB with initial inoculums using 10µL at an 
OD600 of either 0.1, 1 or 3 which corresponds to an average of 2.45x105, 1.55x106 or 
3.45x106 CFU/ml. Data are mean CFU counts with error bars indicating standard devi-













































Figure 2.4: H. parainfluenzae resistance to H2O2 relies on the contribution of mul-
tiple genes. We assessed the sensitivity of wildtype H. parainfluenzae (WT) to H2O2 
or coculture yield with S. mitis vs mutants lacking oxyR, catalase (katA), cytochrome c 
peroxidase (ccp), peroxiredoxin (prx), glutaredoxin-peroxiredoxin (pdgX), DNA-bind-































































(A) Zones of inhibition by 30% H2O2 exposure (areas of no visible H. parainfluenzae 
growth) were measured after 24 hours and fold change calculated compared to 
wildtype. Data are the mean fold change relative to WT; error bars indicate standard 
deviation for n≥3. All strains were significantly different from WT, while 𝛥katA-𝛥ccp 
was significantly different from 𝛥katA (padj < 0.05), based on t-test with Bonferroni 
correction. (B) WT and mutant H. parainfluenzae CFU following 24h coculture with 
S. mitis. H. parainfluenzae inocula were 4.65 x106 CFU/ml. S. mitis inoculum was 
2.45x105 CFU/ml. Data are represented as mean CFU, error bars indicate standard de-















Figure 2.5: Streptococcus-produced Nicotinamide Adenine Dinucleotide (NAD) 
supports H. parainfluenzae growth. Cultures of S. mitis, S. sanguinis, S. gordonii, S. 
cristatus, Corynebacterium matruchotii and C. durum were grown overnight, normal-
ized based on optical density, and spotted onto paper discs over lawns of H. parainflu-
enzae spread on solid agar medium lacking NAD. Plates were incubated for 48h be-
fore observation. Rings near the disc indicate H. parainfluenzae growth. NAD was 












Figure 2.6: Comparison of coculture gene expression with meta-transcriptome 
datasets. Mono vs coculture RNASeq results (in vitro) for H. parainfluenzae indi-
cated 387 significantly differentially expressed genes (DEG) above 2-fold. By com-
paring in vitro monoculture to in vivo metatranscriptome reads from Benítez-Páez 
2014 (Meta 1) and Jorth 2014 (Meta 2) we were able to generate two sets of in vivo-
specific DEGs to determine differences in (A) significantly upregulated or (B) signifi-
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Table S2.1: Minimum inhibitory concentrations in BHI-YE HP for H2O2 











37.19 fig|6666666.571729.peg.656 hypothetical protein 
12.14 fig|6666666.571729.peg.1162 4-alpha-glucanotransferase (amylomaltase) 
(EC 2.4.1.25);Ontology_term 
10.87 fig|6666666.571729.peg.747 Type IV pilin PilA 
9.92 fig|6666666.571729.peg.1163 1%2C4-alpha-glucan (glycogen) branching en-
zyme%2C GH-13-type (EC 2.4.1.18);Ontol-
ogy_term 
9.42 fig|6666666.571729.peg.1164 Limit dextrin alpha-1%2C6-maltotetraose-hy-
drolase (EC 3.2.1.196);Ontology_term 
6.52 fig|6666666.571729.peg.744 Leader peptidase (Prepilin peptidase) (EC 
3.4.23.43) / N-methyltransferase (EC 2.1.1.-
);Ontology_term 
6.35 fig|6666666.571729.peg.265 Vitamin B12 ABC transporter%2C ATP-bind-
ing protein BtuD 
5.65 fig|6666666.571729.peg.102 GALNS arylsulfatase regulator (Fe-S oxidore-
ductase) 
5.56 fig|6666666.571729.peg.173 Putative ABC transporter of substrate X%2C 
permease subunit I 
5.37 fig|6666666.571729.peg.1645 DNA ligase 
5.36 fig|6666666.571729.peg.40 Hydroxymethylpyrimidine ABC trans-
porter%2C transmembrane component 
5.34 fig|6666666.571729.peg.593 hypothetical protein 
5.3 fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
5.13 fig|6666666.571729.peg.32 Type IV pilus biogenesis protein PilM 
5.08 fig|6666666.571729.peg.105 Sodium-Choline Symporter 





4.81 fig|6666666.571729.peg.592 hypothetical protein 
4.72 fig|6666666.571729.peg.1288 Type III restriction-modification system meth-
ylation subunit (EC 2.1.1.72);Ontology_term 
4.67 fig|6666666.571729.peg.595 FIG00847847: hypothetical protein 
4.67 fig|6666666.571729.peg.174 Putative ABC transporter of substrate X%2C 
permease subunit II 
4.65 fig|6666666.571729.peg.254 hypothetical protein 
4.63 fig|6666666.571729.peg.1235 Oligopeptide/dipeptide ABC transporter%2C 
permease protein / Oligopeptide/dipeptide 
ABC transporter%2C ATP-binding protein 
4.6 fig|6666666.571729.peg.131 Site-specific tyrosine recombinase XerC 
4.58 fig|6666666.571729.peg.690 hypothetical protein 
4.54 fig|6666666.571729.peg.95 Phosphoribosylformylglycinamidine syn-
thase%2C synthetase subunit (EC 6.3.5.3) / 
Phosphoribosylformylglycinamidine syn-
thase%2C glutamine amidotransferase subunit 
(EC 6.3.5.3);Ontology_term 
4.5 fig|6666666.571729.peg.274 hypothetical protein 
4.47 fig|6666666.571729.peg.101 small multidrug resistance family (SMR) pro-
tein 
4.47 fig|6666666.571729.peg.25 AAA+ ATPase superfamily protein 
YifB/ComM%2C associated with DNA re-
combination 
4.41 fig|6666666.571729.peg.1865 Dihydrofolate reductase (EC 1.5.1.3);Ontol-
ogy_term 
4.4 fig|6666666.571729.peg.649 hypothetical protein 
4.16 fig|6666666.571729.peg.501 hypothetical protein 
4.14 fig|6666666.571729.peg.930 hypothetical protein 
4.09 fig|6666666.571729.peg.596 Efflux ABC transporter%2C ATP-binding pro-
tein 
3.99 fig|6666666.571729.peg.502 hypothetical protein 
3.99 fig|6666666.571729.peg.323 DNA transformation protein TfoX 
3.97 fig|6666666.571729.peg.257 Tryptophanase (EC 4.1.99.1);Ontology_term 
3.92 fig|6666666.571729.peg.849 Guanylate kinase (EC 2.7.4.8);Ontology_term 
3.88 fig|6666666.571729.peg.252 hypothetical protein 
3.84 fig|6666666.571729.peg.249 Lysophospholipase L2 (EC 3.1.1.5);Ontol-
ogy_term 
3.82 fig|6666666.571729.peg.435 Biofilm PGA synthesis deacetylase PgaB (EC 
3.-) 
3.8 fig|6666666.571729.peg.792 N-acetylmannosamine kinase (EC 
2.7.1.60);Ontology_term 
3.76 fig|6666666.571729.peg.969 Trehalose operon transcriptional repressor 
3.75 fig|6666666.571729.peg.1138 Dihydrolipoamide succinyltransferase compo-
nent (E2) of 2-oxoglutarate dehydrogenase 




3.66 fig|6666666.571729.peg.648 Mobile element protein 
3.6 fig|6666666.571729.peg.793 Sialic acid utilization regulator%2C RpiR fam-
ily 
3.54 fig|6666666.571729.peg.172 Putative ABC transporter of substrate X%2C 
ATP-binding subunit 
3.54 fig|6666666.571729.peg.1075 Uncharacterized integral membrane protein 
GSU2901 
3.52 fig|6666666.571729.peg.402 3'(2')%2C5'-bisphosphate nucleotidase (EC 
3.1.3.7);Ontology_term 
3.51 fig|6666666.571729.peg.470 hypothetical protein 
3.48 fig|6666666.571729.peg.689 hypothetical protein 
3.48 fig|6666666.571729.peg.1189 Zn-ribbon-containing%2C possibly nucleic-
acid-binding protein 
3.44 fig|6666666.571729.peg.171 Protein SlyX 
3.43 fig|6666666.571729.peg.1122 Phage integrase 
3.43 fig|6666666.571729.peg.1247 Iron(III) ABC transporter%2C ATP-binding 
protein 
3.38 fig|6666666.571729.peg.61 Glycerol kinase (EC 2.7.1.30);Ontology_term 
3.38 fig|6666666.571729.peg.17 Oligopeptide ABC transporter%2C substrate-
binding protein OppA (TC 3.A.1.5.1) 
3.37 fig|6666666.571729.peg.544 dTDP-glucose 4%2C6-dehydratase (EC 
4.2.1.46);Ontology_term 
3.35 fig|6666666.571729.peg.403 hypothetical protein 
3.32 fig|6666666.571729.peg.1681 hypothetical protein 
3.3 fig|6666666.571729.peg.134 Shikimate 5-dehydrogenase I alpha (EC 
1.1.1.25);Ontology_term 
3.29 fig|6666666.571729.peg.2 Methionine ABC transporter ATP-binding pro-
tein 
3.27 fig|6666666.571729.peg.1011 CRISPR-associated endonuclease Cas9 
3.24 fig|6666666.571729.peg.1141 Succinyl-CoA ligase [ADP-forming] alpha 
chain (EC 6.2.1.5);Ontology_term 
3.23 fig|6666666.571729.peg.896 5'-deoxynucleotidase YfbR (EC 3.1.3.89);On-
tology_term 
3.22 fig|6666666.571729.peg.161 hypothetical protein 
3.2 fig|6666666.571729.peg.475 Transcriptional regulator%2C AsnC family 
3.19 fig|6666666.571729.peg.1639 Transcriptional factor MdcH 
3.19 fig|6666666.571729.peg.1191 Cysteine desulfurase (EC 2.8.1.7) > sulfur 
transfer pathway protein CsdA;Ontology_term 
3.16 fig|6666666.571729.peg.778 Cytochrome c552 precursor (EC 1.7.2.2);On-
tology_term 
3.14 fig|6666666.571729.peg.791 N-acetylmannosamine-6-phosphate 2-epi-
merase (EC 5.1.3.9);Ontology_term 
3.13 fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 
1.4.1.4);Ontology_term 
3.08 fig|6666666.571729.peg.525 D-glycerate transporter (predicted) 




3.06 fig|6666666.571729.peg.20 Oligopeptide ABC transporter%2C ATP-bind-
ing protein OppD (TC 3.A.1.5.1) 
3.05 fig|6666666.571729.peg.748 1%2C6-anhydro-N-acetylmuramyl-L-alanine 
amidase 
3.04 fig|6666666.571729.peg.1260 hypothetical protein 
3.03 fig|6666666.571729.peg.1137 2-oxoglutarate dehydrogenase E1 component 
(EC 1.2.4.2);Ontology_term 
3.03 fig|6666666.571729.peg.21 Oligopeptide ABC transporter%2C ATP-bind-
ing protein OppF (TC 3.A.1.5.1) 
3.03 fig|6666666.571729.peg.1113 Uncharacterized DUF218 membrane proteinn 
PM0506 
3 fig|6666666.571729.peg.560 hypothetical protein 
3 fig|6666666.571729.peg.1814 Alanyl-tRNA synthetase (EC 6.1.1.7);Ontol-
ogy_term 
2.99 fig|6666666.571729.peg.1192 Micrococcal nuclease (thermonuclease) homo-
logs 
2.99 fig|6666666.571729.peg.1477 Uncharacterized protein MSMEG_6412 
2.98 fig|6666666.571729.peg.176 Sodium-dependent anion transporter family 
2.95 fig|6666666.571729.peg.1246 ABC transporter%2C substrate-binding protein 
(cluster 8%2C B12/iron complex) 
2.95 fig|6666666.571729.peg.1927 Carbonic anhydrase%2C alpha class (EC 
4.2.1.1);Ontology_term 
2.95 fig|6666666.571729.peg.929 hypothetical protein 
2.93 fig|6666666.571729.peg.106 Predicted permeases 
2.91 fig|6666666.571729.peg.965 Permease of the drug/metabolite transporter 
(DMT) superfamily 
2.91 fig|6666666.571729.peg.100 5'-nucleotidase (EC 3.1.3.5)%3B 2'%2C3'-cy-
clic-nucleotide 2'-phosphodiesterase (EC 
3.1.4.16)%3B Putative UDP-sugar hydrolase 
(EC 3.6.1.45);Ontology_term 
2.89 fig|6666666.571729.peg.1147 UPF0115 protein YfcN 
2.89 fig|6666666.571729.peg.1234 Putative glutathione transporter%2C permease 
component 
2.89 fig|6666666.571729.peg.511 DNA uptake protein and related DNA-binding 
proteins 
2.88 fig|6666666.571729.peg.1502 Ferric iron ABC transporter%2C iron-binding 
protein 
2.87 fig|6666666.571729.peg.1325 Ribulosamine/erythrulosamine 3-kinase poten-
tially involved in protein deglycation 
2.85 fig|6666666.571729.peg.1287 Type III restriction-modification system re-
striction subunit (EC 3.1.21.5);Ontology_term 
2.85 fig|6666666.571729.peg.436 Biofilm PGA outer membrane secretin PgaA 
2.84 fig|6666666.571729.peg.242 Fructose-1%2C6-bisphosphatase%2C GlpX 
type (EC 3.1.3.11);Ontology_term 
2.75 fig|6666666.571729.peg.3 Methionine ABC transporter permease protein 





2.74 fig|6666666.571729.peg.1273 Universal stress protein E 
2.73 fig|6666666.571729.peg.158 Endonuclease V (EC 3.2.2.17);Ontology_term 
2.7 fig|6666666.571729.peg.256 hypothetical protein 
2.69 fig|6666666.571729.peg.1038 Tripeptide aminopeptidase (EC 3.4.11.4);On-
tology_term 
2.68 fig|6666666.571729.peg.720 hypothetical protein 
2.67 fig|6666666.571729.peg.130 Histone acetyltransferase HPA2 and related 
acetyltransferases 
2.67 fig|6666666.571729.peg.261 hypothetical protein 
2.66 fig|6666666.571729.peg.775 NrfD protein 
2.66 fig|6666666.571729.peg.258 Tyrosine-specific transport protein 
2.65 fig|6666666.571729.peg.434 Biofilm PGA synthesis N-glycosyltransferase 
PgaC (EC 2.4.-.-);Ontology_term 
2.65 fig|6666666.571729.peg.1258 hypothetical protein 
2.65 fig|6666666.571729.peg.1017 Cell division inhibitor Slr1223 (YfcH in 
EC)%2C contains epimerase/dehydratase and 
DUF1731 domains 
2.63 fig|6666666.571729.peg.1719 Aldose 1-epimerase (EC 5.1.3.3);Ontol-
ogy_term 
2.62 fig|6666666.571729.peg.1720 Galactokinase (EC 2.7.1.6);Ontology_term 
2.62 fig|6666666.571729.peg.33 Multimodular transpeptidase-transglycosylase 
(EC 2.4.1.129) (EC 3.4.-.-);Ontology_term 
2.61 fig|6666666.571729.peg.433 AagD 
2.61 fig|6666666.571729.peg.19 Oligopeptide ABC transporter%2C permease 
protein OppC (TC 3.A.1.5.1) 
2.6 fig|6666666.571729.peg.259 hypothetical protein 
2.59 fig|6666666.571729.peg.1916 Glycosyl transferase 
2.59 fig|6666666.571729.peg.1083 Peptide transport system ATP-binding protein 
sapF (TC 3.A.1.5.5) 
2.59 fig|6666666.571729.peg.148 Nitrate/nitrite response regulator protein NarP 
2.59 fig|6666666.571729.peg.583 FIGfam138462: Acyl-CoA synthetase%2C 
AMP-(fatty) acid ligase 
2.59 fig|6666666.571729.peg.1315 hypothetical protein 
2.58 fig|6666666.571729.peg.1775 Ribosome LSU-associated GTP-binding pro-
tein HflX 
2.57 fig|6666666.571729.peg.1774 RNA-binding protein Hfq 
2.56 fig|6666666.571729.peg.1657 VgrG protein 
2.55 fig|6666666.571729.peg.159 hypothetical protein 
2.55 fig|6666666.571729.peg.104 Choline-sulfatase (EC 3.1.6.6);Ontology_term 
2.55 fig|6666666.571729.peg.1595 Ribonucleotide reductase of class III (anaero-
bic)%2C activating protein (EC 1.97.1.4);On-
tology_term 




2.54 fig|6666666.571729.peg.1085 ABC transporter%2C permease protein 2 
(cluster 5%2C nickel/peptides/opines) 
2.54 fig|6666666.571729.peg.1678 hypothetical protein 
2.53 fig|6666666.571729.peg.322 Patatin-like phospholipase 
2.51 fig|6666666.571729.peg.160 hypothetical protein 
2.5 fig|6666666.571729.peg.18 Oligopeptide ABC transporter%2C permease 
protein OppB (TC 3.A.1.5.1) 
2.49 fig|6666666.571729.peg.1406 Lysine exporter LysO 
2.49 fig|6666666.571729.peg.855 Glutamine synthetase adenylyl-L-tyrosine 
phosphorylase (EC 2.7.7.89) / Glutamate-am-
monia-ligase adenylyltransferase (EC 
2.7.7.42);Ontology_term 
2.49 fig|6666666.571729.peg.842 hypothetical protein 
2.48 fig|6666666.571729.peg.23 GTP-binding protein EngB 
2.48 fig|6666666.571729.peg.1726 Galactose/methyl galactoside ABC trans-
porter%2C permease protein MglC (EC 
3.6.3.17);Ontology_term 
2.46 fig|6666666.571729.peg.1380 Phosphoenolpyruvate carboxylase (EC 
4.1.1.31);Ontology_term 
2.45 fig|6666666.571729.peg.1243 TonB-dependent receptor%3B Outer mem-
brane receptor for ferrienterochelin and colic-
ins 
2.45 fig|6666666.571729.peg.1786 tRNA(Ile)-lysidine synthetase (EC 
6.3.4.19);Ontology_term 
2.45 fig|6666666.571729.peg.1877 hypothetical protein 
2.43 fig|6666666.571729.peg.1 D-glycero-beta-D-manno-heptose-1%2C7-
bisphosphate 7-phosphatase (EC 3.1.3.82);On-
tology_term 
2.42 fig|6666666.571729.peg.1447 Allophanate hydrolase 2 subunit 1 (EC 
3.5.1.54);Ontology_term 
2.42 fig|6666666.571729.peg.84 Aspartate--ammonia ligase (EC 6.3.1.1);Ontol-
ogy_term 
2.41 fig|6666666.571729.peg.933 hypothetical protein 
2.41 fig|6666666.571729.peg.41 Hydroxymethylpyrimidine ABC trans-
porter%2C ATPase component 
2.41 fig|6666666.571729.peg.1359 Putative high-affinity iron permease 
2.4 fig|6666666.571729.peg.1236 Oligopeptide ABC transporter%2C ATP-bind-
ing protein OppF (TC 3.A.1.5.1) 
2.4 fig|6666666.571729.peg.400 6-phosphogluconolactonase (EC 3.1.1.31)%2C 
eukaryotic type;Ontology_term 
2.4 fig|6666666.571729.peg.658 Ribosome-associated inhibitor A 
2.39 fig|6666666.571729.peg.1391 ATPase component NikO of energizing mod-
ule of nickel ECF transporter 
2.39 fig|6666666.571729.peg.1223 Exodeoxyribonuclease V beta chain (EC 
3.1.11.5);Ontology_term 
2.37 fig|6666666.571729.peg.1233 ABC transporter%2C substrate-binding protein 




2.37 fig|6666666.571729.peg.1455 NADP-dependent malic enzyme (EC 
1.1.1.40);Ontology_term 
2.36 fig|6666666.571729.peg.7 hypothetical protein 
2.36 fig|6666666.571729.peg.1475 Aerobic respiration control sensor protein 
ArcB (EC 2.7.13.3);Ontology_term 
2.36 fig|6666666.571729.peg.600 3-oxoacyl-[acyl-carrier-protein] synthase III 
(EC 2.3.1.41);Ontology_term 
2.35 fig|6666666.571729.peg.1139 Predicted hydroxymethylpyrimidine trans-
porter CytX 
2.34 fig|6666666.571729.peg.1936 Uncharacterized protein YfgD%2C not an ar-
senate reductase 
2.34 fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 
6.3.4.13);Ontology_term 
2.34 fig|6666666.571729.peg.1724 Galactose/methyl galactoside ABC trans-
porter%2C substrate-binding protein MglB 
(EC 3.6.3.17);Ontology_term 
2.34 fig|6666666.571729.peg.1140 Succinyl-CoA ligase [ADP-forming] beta 
chain (EC 6.2.1.5);Ontology_term 
2.34 fig|6666666.571729.peg.281 hypothetical protein 
2.33 fig|6666666.571729.peg.730 Rod shape-determining protein RodA 
2.33 fig|6666666.571729.peg.728 D-alanyl-D-alanine carboxypeptidase (EC 
3.4.16.4);Ontology_term 
2.32 fig|6666666.571729.peg.1723 Galactose operon repressor%2C GalR-LacI 
family of transcriptional regulators 
2.31 fig|6666666.571729.peg.1636 Putative DNA-binding protein in cluster with 
Type I restriction-modification system 
2.31 fig|6666666.571729.peg.1257 hypothetical protein 
2.3 fig|6666666.571729.peg.1003 Ribonuclease G 
2.3 fig|6666666.571729.peg.263 hypothetical protein 
2.29 fig|6666666.571729.peg.920 Anaerobic respiratory reductase chaperone 
2.29 fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransfer-
ase (EC 2.1.1.190);Ontology_term 
2.26 fig|6666666.571729.peg.1402 Hydrogenase-4 component B 
2.26 fig|6666666.571729.peg.1547 Cystathionine beta-lyase (EC 4.4.1.8);Ontol-
ogy_term 
2.25 fig|6666666.571729.peg.1248 Vitamin B12 ABC transporter%2C permease 
protein BtuC 
2.25 fig|6666666.571729.peg.538 Glycosyltransferase 
2.25 fig|6666666.571729.peg.1401 Hydrogenase-4 component C 
2.24 fig|6666666.571729.peg.423 deoxyribose-phosphate aldolase( EC:4.1.2.4 
);Ontology_term 
2.23 fig|6666666.571729.peg.284 Shikimate 5-dehydrogenase I gamma (EC 
1.1.1.25);Ontology_term 
2.23 fig|6666666.571729.peg.683 Aerobic respiration control response regulator 
ArcA 





2.21 fig|6666666.571729.peg.653 Phosphoserine phosphatase (EC 3.1.3.3);On-
tology_term 
2.21 fig|6666666.571729.peg.578 FIG021862: membrane protein%2C exporter 
2.2 fig|6666666.571729.peg.119 Chloride channel protein EriC 
2.19 fig|6666666.571729.peg.934 Pentapeptide repeat family protein 
2.18 fig|6666666.571729.peg.1682 T6SS component Hcp 
2.17 fig|6666666.571729.peg.1255 ABC-type antimicrobial peptide transport sys-
tem%2C permease component 
2.17 fig|6666666.571729.peg.175 Possible ABC transporter%2C periplasmic 
substrate X binding protein precursor 
2.17 fig|6666666.571729.peg.913 ImpA 
2.17 fig|6666666.571729.peg.776 NrfC protein 
2.17 fig|6666666.571729.peg.1232 DNA protection during starvation protein 
2.15 fig|6666666.571729.peg.1084 Peptide ABC transporter%2C ATP-binding 
protein SapD 
2.15 fig|6666666.571729.peg.1588 Hypothetical protein VC0266 (sugar utilization 
related?) 
2.13 fig|6666666.571729.peg.686 IMP cyclohydrolase (EC 3.5.4.10) / Phosphori-
bosylaminoimidazolecarboxamide formyl-
transferase (EC 2.1.2.3);Ontology_term 
2.13 fig|6666666.571729.peg.153 Uncharacterized protein EC-HemY in Proteo-
bacteria (unrelated to HemY-type PPO in 
GramPositives) 
2.13 fig|6666666.571729.peg.1638 putative 5'(3')-deoxyribonucleotidase 
2.13 fig|6666666.571729.peg.339 hypothetical protein 
2.13 fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontol-
ogy_term 
2.11 fig|6666666.571729.peg.112 tRNA 5-methylaminomethyl-2-thiouridine 
synthesis sulfur carrier protein TusA 
2.11 fig|6666666.571729.peg.960 Inner membrane protein YedI 
2.11 fig|6666666.571729.peg.1631 AAA ATPase%2C central region 
2.09 fig|6666666.571729.peg.1901 Outer membrane protein P2 precursor 
2.09 fig|6666666.571729.peg.693 hypothetical protein 
2.09 fig|6666666.571729.peg.1112 Oxygen-insensitive NAD(P)H nitroreductase 
(EC 1.-.-.-) / Dihydropteridine reductase (EC 
1.5.1.34);Ontology_term 
2.07 fig|6666666.571729.peg.696 Na+/H+ antiporter NhaB 
2.06 fig|6666666.571729.peg.177 Putative metabolite transport protein YjhB 
2.06 fig|6666666.571729.peg.1369 pseudoazurin 
2.06 fig|6666666.571729.peg.763 Phosphatidate cytidylyltransferase (EC 
2.7.7.41);Ontology_term 
2.06 fig|6666666.571729.peg.1976 UDP-2%2C3-diacylglucosamine diphospha-
tase (EC 3.6.1.54);Ontology_term 
2.06 fig|6666666.571729.peg.697 Transcriptional regulator for fatty acid degra-




2.05 fig|6666666.571729.peg.1209 tRNA pseudouridine(65) synthase (EC 
5.4.99.26);Ontology_term 
2.05 fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport sys-
tem%2C periplasmic component 
2.05 fig|6666666.571729.peg.382 LSU rRNA pseudouridine(746) synthase (EC 
5.4.99.29) @ tRNA pseudouridine(32) syn-
thase (EC 5.4.99.28);Ontology_term 
2.05 fig|6666666.571729.peg.729 Septum-associated rare lipoprotein A 
2.02 fig|6666666.571729.peg.266 thiamine-phosphate pyrophosphorylase( 
EC:2.5.1.3 );Ontology_term 
2.02 fig|6666666.571729.peg.1919 FIG00696423: hypothetical protein 
2.02 fig|6666666.571729.peg.1721 Galactokinase (EC 2.7.1.6);Ontology_term 
2.01 fig|6666666.571729.peg.279 Ribonuclease BN 
2 fig|6666666.571729.peg.1979 hypothetical protein 
 
 






FIG00697202: hypothetical protein 
-5.51 fig|6666666.571729.peg.8
82 






UPF0394 inner membrane protein YeeE 
-4.62 fig|6666666.571729.peg.6
80 
LSU ribosomal protein L36p @ LSU ribosomal 
protein L36p%2C zinc-independent 
-4.56 fig|6666666.571729.peg.1
296 





drolase type 2 
-4.37 fig|6666666.571729.peg.1
825 




O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) 




Transcription elongation factor GreA 
-4.22 fig|6666666.571729.peg.6
65 









Protein IscX%2C believed to be involved in as-
sembly of Fe-S clusters 
-3.98 fig|6666666.571729.peg.1
700 

























Cell division protein ZapB 
-3.41 fig|6666666.571729.peg.1
305 








Putative glutamine amidotransferase YafJ 
-3.32 fig|6666666.571729.peg.8
38 
Uracil permease @ Uracil:proton symporter UraA 
-3.31 fig|6666666.571729.peg.3
38 







DNA primase DnaG 
-3.21 fig|6666666.571729.peg.1
819 









ase (EC 2.1.1.166);Ontology_term 
-3.07 fig|6666666.571729.peg.1
743 
Tol-Pal system-associated acyl-CoA thioesterase 
-3.03 fig|6666666.571729.peg.3
60 
LSU ribosomal protein L22p (L17e) 
-2.94 fig|6666666.571729.peg.1
051 
Modulator of drug activity B 
-2.94 fig|6666666.571729.peg.6
32 
Twin-arginine translocation protein TatB 
-2.92 fig|6666666.571729.peg.3
57 
LSU ribosomal protein L23p (L23Ae) 
-2.91 fig|6666666.571729.peg.1
892 
LSU ribosomal protein L31p @ LSU ribosomal 











tase%2C FabA form (EC 4.2.1.59) @ Trans-2-de-








SSU ribosomal protein S17p (S11e) 
-2.88 fig|6666666.571729.peg.4
7 








Copper(I) chaperone CopZ 
-2.86 fig|6666666.571729.peg.1
409 
Outer membrane stress sensor protease 
DegQ%2C serine protease 
-2.86 fig|6666666.571729.peg.1
733 


















Uncharacterized protease YegQ 
-2.76 fig|6666666.571729.peg.1
87 







LSU ribosomal protein L3p (L3e) 
-2.74 fig|6666666.571729.peg.1
710 










Pyruvate kinase (EC 2.7.1.40);Ontology_term 
-2.7 fig|6666666.571729.peg.7
74 
Cytochrome c-type heme lyase subunit nrfE%2C 
nitrite reductase complex assembly 
-2.69 fig|6666666.571729.peg.1
602 
FIG024746: hypothetical protein 
-2.69 fig|6666666.571729.peg.3
58 















SSU ribosomal protein S19p (S15e) 
-2.65 fig|6666666.571729.peg.6
30 




Frataxin homolog CyaY%2C facilitates Fe-S 
cluster assembly%2C interacts with IscS 
-2.63 fig|6666666.571729.peg.7
3 







SSU ribosomal protein S10p (S20e) 
-2.59 fig|6666666.571729.peg.1
858 
Glutathionylspermidine synthase (EC 6.3.1.8) / 












Ferric uptake regulation protein FUR 
-2.57 fig|6666666.571729.peg.1
013 
LSU ribosomal protein L25p 
-2.57 fig|6666666.571729.peg.1
169 
Transcription termination protein NusB 
-2.55 fig|6666666.571729.peg.1
542 
HesA/MoeB/ThiF family protein > sulfur transfer 
pathway protein CsdL 
-2.55 fig|6666666.571729.peg.9
89 




Uncharacterized protein YbfG 
-2.52 fig|6666666.571729.peg.1
750 
Holliday junction ATP-dependent DNA helicase 
RuvA (EC 3.6.4.12);Ontology_term 
-2.51 fig|6666666.571729.peg.5
65 
FIG01269488: protein%2C clustered with riboso-
mal protein L32p 
-2.51 fig|6666666.571729.peg.1
485 
Transcriptional activator MetR 
-2.49 fig|6666666.571729.peg.1
692 
T6SS lysozyme-like component TssE 
-2.48 fig|6666666.571729.peg.3
61 
SSU ribosomal protein S3p (S3e) 
-2.47 fig|6666666.571729.peg.1
846 















Iron(III) dicitrate transport system%2C periplas-
mic iron-binding protein FecB (TC 3.A.1.14.1) 
-2.42 fig|6666666.571729.peg.4
16 








LSU ribosomal protein L27p 
-2.41 fig|6666666.571729.peg.1
793 
Membrane protein involved in the export of O-
antigen and teichoic acid 
-2.41 fig|6666666.571729.peg.1
86 




LSU ribosomal protein L31p @ LSU ribosomal 
protein L31p%2C zinc-independent 
-2.36 fig|6666666.571729.peg.2
26 




33 kDa chaperonin HslO 
-2.35 fig|6666666.571729.peg.8
39 









transferase (EC 2.1.1.200);Ontology_term 
-2.33 fig|6666666.571729.peg.5
7 










Molybdate-binding domain of ModE 
-2.32 fig|6666666.571729.peg.1
297 








Stringent starvation protein B 
-2.31 fig|6666666.571729.peg.1
566 




ase (EC 3.5.1.18);Ontology_term 
-2.3 fig|6666666.571729.peg.9
05 






FIG023677: hypothetical protein 
-2.29 fig|6666666.571729.peg.1
742 
Tol-Pal system protein TolQ 
-2.28 fig|6666666.571729.peg.1
732 
Chaperone protein HscB 
-2.28 fig|6666666.571729.peg.7
55 






Excinuclease ABC subunit A 
-2.26 fig|6666666.571729.peg.7
35 







Peptide chain release factor 1 
-2.26 fig|6666666.571729.peg.1
039 








FAD:protein FMN transferase (EC 2.7.1.180) @ 








Putative phosphatase YigL%2C haloacid dehalo-
genase-like phosphatase family 
-2.23 fig|6666666.571729.peg.8
43 








Methionine repressor MetJ 
-2.21 fig|6666666.571729.peg.5
31 
GTP-binding protein TypA/BipA 
-2.2 fig|6666666.571729.peg.1
716 
Apolipoprotein N-acyltransferase / Copper home-
ostasis protein CutE 
-2.2 fig|6666666.571729.peg.1
850 
FIG002060: uncharacterized protein YggL 
-2.19 fig|6666666.571729.peg.7
82 
LSU ribosomal protein L33p @ LSU ribosomal 
protein L33p%2C zinc-independent 
-2.19 fig|6666666.571729.peg.1
42 













SSU ribosomal protein S9p (S16e) 
-2.16 fig|6666666.571729.peg.6
82 
tmRNA-binding protein SmpB 
-2.16 fig|6666666.571729.peg.1
808 











LSU ribosomal protein L5p (L11e) 
-2.15 fig|6666666.571729.peg.8
79 
LemA family protein 
-2.15 fig|6666666.571729.peg.3
62 














LSU ribosomal protein L20p 
-2.11 fig|6666666.571729.peg.6
75 
LSU ribosomal protein L21p 
-2.1 fig|6666666.571729.peg.1
437 
Ribonucleotide reductase of class Ia (aero-













thiouridine(34) synthesis protein MnmG 
-2.09 fig|6666666.571729.peg.1
303 
Translation initiation factor 3 
-2.07 fig|6666666.571729.peg.1
907 
LSU ribosomal protein L9p 
-2.07 fig|6666666.571729.peg.1
818 




















Ribonucleotide reductase of class III (anaero-




LSU ribosomal protein L29p (L35e) 
-2.01 fig|6666666.571729.peg.4
96 












Thiol:disulfide interchange protein DsbC 
-2 fig|6666666.571729.peg.1
929 





Table S2.4: H. parainfluenzae genes induced in in vitro coculture and both in vivo meta-
transcriptomes 
id Description 
fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
fig|6666666.571729.peg.32 Type IV pilus biogenesis protein PilM 
fig|6666666.571729.peg.40 Hydroxymethylpyrimidine ABC transporter transmem-
brane component 
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);On-
tology_term 
fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport system periplasmic 
component 
fig|6666666.571729.peg.1681 hypothetical protein 
fig|6666666.571729.peg.25 AAA+ ATPase superfamily protein YifB/ComM associ-
ated with DNA recombination 
fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontol-
ogy_term 
fig|6666666.571729.peg.119 Chloride channel protein EriC 
fig|6666666.571729.peg.95 Phosphoribosylformylglycinamidine synthase synthetase 
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine 
synthase glutamine amidotransferase subunit (EC 
6.3.5.3);Ontology_term 
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontol-
ogy_term 
fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransferase (EC 
2.1.1.190);Ontology_term 




fig|6666666.571729.peg.242 Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);On-
tology_term 
fig|6666666.571729.peg.502 hypothetical protein 
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term 
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term 
fig|6666666.571729.peg.61 Glycerol kinase (EC 2.7.1.30);Ontology_term 
 
Table S2.5: H. parainfluenzae genes repressed in in vitro coculture and both in vivo meta-
transcriptomes 
id Description 
fig|6666666.571729.peg.903 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-suc-
cinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontol-
ogy_term 
fig|6666666.571729.peg.905 Chaperone protein DnaK 
fig|6666666.571729.peg.1409 Outer membrane stress sensor protease DegQ serine prote-
ase 
fig|6666666.571729.peg.1340 Transcription elongation factor GreA 
fig|6666666.571729.peg.1811 Methionine repressor MetJ 
fig|6666666.571729.peg.1850 FIG002060: uncharacterized protein YggL 
fig|6666666.571729.peg.980 hypothetical protein 
fig|6666666.571729.peg.430 33 kDa chaperonin HslO 
fig|6666666.571729.peg.904 hypothetical protein 
fig|6666666.571729.peg.906 hypothetical protein 
fig|6666666.571729.peg.69 hypothetical protein 
fig|6666666.571729.peg.496 2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontol-
ogy_term 
fig|6666666.571729.peg.57 L-cystine ABC transporter substrate-binding protein TcyA 
fig|6666666.571729.peg.73 Purine nucleoside phosphorylase (EC 2.4.2.1);Ontol-
ogy_term 
fig|6666666.571729.peg.1316 Stringent starvation protein B 
fig|6666666.571729.peg.1858 Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathi-
onylspermidine amidohydrolase (EC 3.5.1.78);Ontol-
ogy_term 
fig|6666666.571729.peg.1884 Nucleoid-associated protein YaaK 
fig|6666666.571729.peg.1861 Phosphatidylserine decarboxylase (EC 4.1.1.65);Ontol-
ogy_term 
fig|6666666.571729.peg.226 Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontol-
ogy_term 
fig|6666666.571729.peg.1013 LSU ribosomal protein L25p 
fig|6666666.571729.peg.948 Ferric uptake regulation protein FUR 





Table S2.6: H. parainfluenzae genes upregulated in in vitro coculture and in vivo meta-
transcriptome Benítez-Páez et al., (2014) 
id Description 
fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
fig|6666666.571729.peg.32 Type IV pilus biogenesis protein PilM 
fig|6666666.571729.peg.40 Hydroxymethylpyrimidine ABC transporter transmem-
brane component 
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);On-
tology_term 
fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport system periplasmic 
component 
fig|6666666.571729.peg.1681 hypothetical protein 
fig|6666666.571729.peg.25 AAA+ ATPase superfamily protein YifB/ComM associ-
ated with DNA recombination 
fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontol-
ogy_term 
fig|6666666.571729.peg.119 Chloride channel protein EriC 
fig|6666666.571729.peg.95 Phosphoribosylformylglycinamidine synthase synthetase 
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine 
synthase glutamine amidotransferase subunit (EC 
6.3.5.3);Ontology_term 
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontol-
ogy_term 
fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransferase (EC 
2.1.1.190);Ontology_term 
fig|6666666.571729.peg.173 Putative ABC transporter of substrate X permease subunit I 
fig|6666666.571729.peg.686 IMP cyclohydrolase (EC 3.5.4.10) / Phosphoribosylami-
noimidazolecarboxamide formyltransferase (EC 
2.1.2.3);Ontology_term 
fig|6666666.571729.peg.896 5'-deoxynucleotidase YfbR (EC 3.1.3.89);Ontology_term 
fig|6666666.571729.peg.242 Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);On-
tology_term 
fig|6666666.571729.peg.502 hypothetical protein 
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term 
fig|6666666.571729.peg.3 Methionine ABC transporter permease protein 
fig|6666666.571729.peg.792 N-acetylmannosamine kinase (EC 2.7.1.60);Ontology_term 
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term 
fig|6666666.571729.peg.61 Glycerol kinase (EC 2.7.1.30);Ontology_term 
 
 
Table S2.7: H. parainfluenzae genes downregulated in in vitro coculture and in vivo meta-
transcriptome Benítez-Páez et al., (2014) 
id Description 




fig|6666666.571729.peg.903 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-suc-
cinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontol-
ogy_term 
fig|6666666.571729.peg.1768 hypothetical protein 
fig|6666666.571729.peg.905 Chaperone protein DnaK 
fig|6666666.571729.peg.1409 Outer membrane stress sensor protease DegQ serine prote-
ase 
fig|6666666.571729.peg.1340 Transcription elongation factor GreA 
fig|6666666.571729.peg.1811 Methionine repressor MetJ 
fig|6666666.571729.peg.1700 Cytochrome c551 peroxidase (EC 1.11.1.5);Ontology_term 
fig|6666666.571729.peg.1850 FIG002060: uncharacterized protein YggL 
fig|6666666.571729.peg.980 hypothetical protein 
fig|6666666.571729.peg.430 33 kDa chaperonin HslO 
fig|6666666.571729.peg.904 hypothetical protein 
fig|6666666.571729.peg.906 hypothetical protein 
fig|6666666.571729.peg.665 UPF0033 protein YeeD 
fig|6666666.571729.peg.1242 Iron(III) ABC transporter solute-binding protein 
fig|6666666.571729.peg.1809 Copper(I) chaperone CopZ 
fig|6666666.571729.peg.1012 DedA protein 
fig|6666666.571729.peg.1818 Heat shock protein 60 kDa family chaperone GroEL 
fig|6666666.571729.peg.67 hypothetical protein 
fig|6666666.571729.peg.69 hypothetical protein 
fig|6666666.571729.peg.496 2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontol-
ogy_term 
fig|6666666.571729.peg.57 L-cystine ABC transporter substrate-binding protein TcyA 
fig|6666666.571729.peg.73 Purine nucleoside phosphorylase (EC 2.4.2.1);Ontol-
ogy_term 
fig|6666666.571729.peg.782 LSU ribosomal protein L33p @ LSU ribosomal protein 
L33p zinc-independent 
fig|6666666.571729.peg.1316 Stringent starvation protein B 
fig|6666666.571729.peg.1858 Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathi-
onylspermidine amidohydrolase (EC 3.5.1.78);Ontol-
ogy_term 
fig|6666666.571729.peg.46 SSU ribosomal protein S21p 
fig|6666666.571729.peg.1797 Soluble lytic murein transglycosylase (EC 4.2.2.n1) 
fig|6666666.571729.peg.1731 Uncharacterized protein YbfG 
fig|6666666.571729.peg.1884 Nucleoid-associated protein YaaK 
fig|6666666.571729.peg.717 Uncharacterized protease YegQ 
fig|6666666.571729.peg.838 Uracil permease @ Uracil:proton symporter UraA 
fig|6666666.571729.peg.1299 LSU ribosomal protein L20p 
fig|6666666.571729.peg.1730 Chaperone protein HscA 





fig|6666666.571729.peg.1800 Glutamyl-tRNA synthetase (EC 6.1.1.17);Ontology_term 
fig|6666666.571729.peg.226 Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontol-
ogy_term 
fig|6666666.571729.peg.1013 LSU ribosomal protein L25p 
fig|6666666.571729.peg.948 Ferric uptake regulation protein FUR 




Table S2.8: H. parainfluenzae genes induced in in vitro coculture and in vivo meta-
transcriptome Jorth et al., (2014) 
 
id Description 
fig|6666666.571729.peg.1083 Peptide transport system ATP-binding protein sapF (TC 
3.A.1.5.5) 
fig|6666666.571729.peg.747 Type IV pilin PilA 
fig|6666666.571729.peg.656 hypothetical protein 
fig|6666666.571729.peg.1288 Type III restriction-modification system methylation subu-
nit (EC 2.1.1.72);Ontology_term 
fig|6666666.571729.peg.40 Hydroxymethylpyrimidine ABC transporter transmem-
brane component 
fig|6666666.571729.peg.1084 Peptide ABC transporter ATP-binding protein SapD 
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontol-
ogy_term 
fig|6666666.571729.peg.25 AAA+ ATPase superfamily protein YifB/ComM associ-
ated with DNA recombination 
fig|6666666.571729.peg.254 hypothetical protein 
fig|6666666.571729.peg.1645 DNA ligase 
 
fig|6666666.571729.peg.583 FIGfam138462: Acyl-CoA synthetase AMP-(fatty) acid 
ligase 
fig|6666666.571729.peg.160 hypothetical protein 
fig|6666666.571729.peg.1223 Exodeoxyribonuclease V beta chain (EC 3.1.11.5);Ontol-
ogy_term 
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);On-
tology_term 
fig|6666666.571729.peg.32 Type IV pilus biogenesis protein PilM 
fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
fig|6666666.571729.peg.1192 Micrococcal nuclease (thermonuclease) homologs 
fig|6666666.571729.peg.95 Phosphoribosylformylglycinamidine synthase synthetase 
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine 
synthase glutamine amidotransferase subunit (EC 
6.3.5.3);Ontology_term 




fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontol-
ogy_term 
fig|6666666.571729.peg.1141 Succinyl-CoA ligase [ADP-forming] alpha chain (EC 
6.2.1.5);Ontology_term 
fig|6666666.571729.peg.242 Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);On-
tology_term 
fig|6666666.571729.peg.102 GALNS arylsulfatase regulator (Fe-S oxidoreductase) 
fig|6666666.571729.peg.382 LSU rRNA pseudouridine(746) synthase (EC 5.4.99.29) @ 
tRNA pseudouridine(32) synthase (EC 5.4.99.28);Ontol-
ogy_term 
fig|6666666.571729.peg.649 hypothetical protein 
fig|6666666.571729.peg.1287 Type III restriction-modification system restriction subunit 
(EC 3.1.21.5);Ontology_term 
fig|6666666.571729.peg.1163 14-alpha-glucan (glycogen) branching enzyme GH-13-type 
(EC 2.4.1.18);Ontology_term 
fig|6666666.571729.peg.1475 Aerobic respiration control sensor protein ArcB (EC 
2.7.13.3);Ontology_term 
fig|6666666.571729.peg.595 FIG00847847: hypothetical protein 
fig|6666666.571729.peg.18 Oligopeptide ABC transporter permease protein OppB (TC 
3.A.1.5.1) 
fig|6666666.571729.peg.403 hypothetical protein 
fig|6666666.571729.peg.61 Glycerol kinase (EC 2.7.1.30);Ontology_term 
fig|6666666.571729.peg.592 hypothetical protein 
fig|6666666.571729.peg.322 Patatin-like phospholipase 
fig|6666666.571729.peg.593 hypothetical protein 
fig|6666666.571729.peg.648 Mobile element protein 
fig|6666666.571729.peg.597 hypothetical protein 
fig|6666666.571729.peg.173 Putative ABC transporter of substrate X permease subunit I 
fig|6666666.571729.peg.172 Putative ABC transporter of substrate X ATP-binding sub-
unit 
fig|6666666.571729.peg.1147 UPF0115 protein YfcN 
fig|6666666.571729.peg.475 Transcriptional regulator AsnC family 
fig|6666666.571729.peg.1258 hypothetical protein 
fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransferase (EC 
2.1.1.190);Ontology_term 
fig|6666666.571729.peg.119 Chloride channel protein EriC 
fig|6666666.571729.peg.1122 Phage integrase 
fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport system periplasmic 
component 
fig|6666666.571729.peg.134 Shikimate 5-dehydrogenase I alpha (EC 1.1.1.25);Ontol-
ogy_term 
fig|6666666.571729.peg.1681 hypothetical protein 
fig|6666666.571729.peg.252 hypothetical protein 
fig|6666666.571729.peg.693 hypothetical protein 




fig|6666666.571729.peg.1636 Putative DNA-binding protein in cluster with Type I re-
striction-modification system 
fig|6666666.571729.peg.501 hypothetical protein 
fig|6666666.571729.peg.323 DNA transformation protein TfoX 
fig|6666666.571729.peg.1477 Uncharacterized protein MSMEG_6412 
fig|6666666.571729.peg.969 Trehalose operon transcriptional repressor 
fig|6666666.571729.peg.1916 Glycosyl transferase 
fig|6666666.571729.peg.423 deoxyribose-phosphate aldolase( EC:4.1.2.4 );Ontol-
ogy_term 
fig|6666666.571729.peg.161 hypothetical protein 
fig|6666666.571729.peg.1209 tRNA pseudouridine(65) synthase (EC 5.4.99.26);Ontol-
ogy_term 
fig|6666666.571729.peg.720 hypothetical protein 
fig|6666666.571729.peg.730 Rod shape-determining protein RodA 
fig|6666666.571729.peg.502 hypothetical protein 
fig|6666666.571729.peg.855 Glutamine synthetase adenylyl-L-tyrosine phosphorylase 
(EC 2.7.7.89) / Glutamate-ammonia-ligase adenylyltrans-
ferase (EC 2.7.7.42);Ontology_term 
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term 
fig|6666666.571729.peg.470 hypothetical protein 
fig|6666666.571729.peg.525 D-glycerate transporter (predicted) 
fig|6666666.571729.peg.1189 Zn-ribbon-containing possibly nucleic-acid-binding protein 
fig|6666666.571729.peg.1786 tRNA(Ile)-lysidine synthetase (EC 6.3.4.19);Ontol-
ogy_term 
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term 
fig|6666666.571729.peg.960 Inner membrane protein YedI 
fig|6666666.571729.peg.1017 Cell division inhibitor Slr1223 (YfcH in EC) contains epi-
merase/dehydratase and DUF1731 domains 
fig|6666666.571729.peg.578 FIG021862: membrane protein exporter 
fig|6666666.571729.peg.1011 CRISPR-associated endonuclease Cas9 
fig|6666666.571729.peg.176 Sodium-dependent anion transporter family 
fig|6666666.571729.peg.1248 Vitamin B12 ABC transporter permease protein BtuC 
fig|6666666.571729.peg.19 Oligopeptide ABC transporter permease protein OppC (TC 
3.A.1.5.1) 
fig|6666666.571729.peg.689 hypothetical protein 
fig|6666666.571729.peg.1260 hypothetical protein 
fig|6666666.571729.peg.258 Tyrosine-specific transport protein 
fig|6666666.571729.peg.148 Nitrate/nitrite response regulator protein NarP 
fig|6666666.571729.peg.21 Oligopeptide ABC transporter ATP-binding protein OppF 
(TC 3.A.1.5.1) 





fig|6666666.571729.peg.1235 Oligopeptide/dipeptide ABC transporter permease protein / 
Oligopeptide/dipeptide ABC transporter ATP-binding pro-
tein 
fig|6666666.571729.peg.1631 AAA ATPase central region 
fig|6666666.571729.peg.763 Phosphatidate cytidylyltransferase (EC 2.7.7.41);Ontol-
ogy_term 
fig|6666666.571729.peg.653 Phosphoserine phosphatase (EC 3.1.3.3);Ontology_term 
fig|6666666.571729.peg.1236 Oligopeptide ABC transporter ATP-binding protein OppF 
(TC 3.A.1.5.1) 
fig|6666666.571729.peg.104 Choline-sulfatase (EC 3.1.6.6);Ontology_term 




Table S2.9: H. parainfluenzae genes repressedin in vitro coculture and in vivo meta-
transcriptome Jorth et al., (2014) 
id Description 
fig|6666666.571729.peg.1646 Thioredoxin 
fig|6666666.571729.peg.905 Chaperone protein DnaK 
fig|6666666.571729.peg.1013 LSU ribosomal protein L25p 
fig|6666666.571729.peg.1850 FIG002060: uncharacterized protein YggL 
fig|6666666.571729.peg.1409 Outer membrane stress sensor protease DegQ serine prote-
ase 
fig|6666666.571729.peg.1884 Nucleoid-associated protein YaaK 
fig|6666666.571729.peg.73 Purine nucleoside phosphorylase (EC 2.4.2.1);Ontol-
ogy_term 
fig|6666666.571729.peg.948 Ferric uptake regulation protein FUR 
fig|6666666.571729.peg.1793 Membrane protein involved in the export of O-antigen and 
teichoic acid 
fig|6666666.571729.peg.903 O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-suc-
cinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontol-
ogy_term 
fig|6666666.571729.peg.338 Hybrid peroxiredoxin hyPrx5 (EC 1.11.1.15);Ontol-
ogy_term 
fig|6666666.571729.peg.1737 tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase 
(EC 2.1.1.200);Ontology_term 
fig|6666666.571729.peg.906 hypothetical protein 
fig|6666666.571729.peg.1340 Transcription elongation factor GreA 
fig|6666666.571729.peg.353 hypothetical protein 
fig|6666666.571729.peg.1811 Methionine repressor MetJ 
fig|6666666.571729.peg.1482 hypothetical protein 




fig|6666666.571729.peg.1858 Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathi-
onylspermidine amidohydrolase (EC 3.5.1.78);Ontol-
ogy_term 
fig|6666666.571729.peg.142 Ketol-acid reductoisomerase (NADP(+)) (EC 1.1.1.86);On-
tology_term 
fig|6666666.571729.peg.1108 hypothetical protein 
fig|6666666.571729.peg.1168 67-dimethyl-8-ribityllumazine synthase (EC 2.5.1.78);On-
tology_term 
fig|6666666.571729.peg.764 Alanine transaminase (EC 2.6.1.2);Ontology_term 
fig|6666666.571729.peg.57 L-cystine ABC transporter substrate-binding protein TcyA 
fig|6666666.571729.peg.430 33 kDa chaperonin HslO 
fig|6666666.571729.peg.904 hypothetical protein 
fig|6666666.571729.peg.1728 Protein IscX believed to be involved in assembly of Fe-S 
clusters 
fig|6666666.571729.peg.1929 SOS-response repressor and protease LexA (EC 
3.4.21.88);Ontology_term 
fig|6666666.571729.peg.1316 Stringent starvation protein B 
fig|6666666.571729.peg.666 UPF0394 inner membrane protein YeeE 
fig|6666666.571729.peg.632 Twin-arginine translocation protein TatB 
fig|6666666.571729.peg.1123 Pyruvate kinase (EC 2.7.1.40);Ontology_term 
fig|6666666.571729.peg.1464 GTP cyclohydrolase II (EC 3.5.4.25);Ontology_term 
fig|6666666.571729.peg.1214 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabA 
form (EC 4.2.1.59) @ Trans-2-decenoyl-[acyl-carrier-pro-
tein] isomerase (EC 5.3.3.14);Ontology_term 
fig|6666666.571729.peg.226 Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontol-
ogy_term 
fig|6666666.571729.peg.841 Nitric-oxide reductase (EC 1.7.99.7) quinol-dependent;On-
tology_term 
fig|6666666.571729.peg.1861 Phosphatidylserine decarboxylase (EC 4.1.1.65);Ontol-
ogy_term 
fig|6666666.571729.peg.980 hypothetical protein 
fig|6666666.571729.peg.1303 Translation initiation factor 3 
fig|6666666.571729.peg.871 DNA polymerase III chi subunit (EC 2.7.7.7);Ontol-
ogy_term 
fig|6666666.571729.peg.359 SSU ribosomal protein S19p (S15e) 
fig|6666666.571729.peg.1643 Arginine ABC transporter ATP-binding protein ArtP 
fig|6666666.571729.peg.1741 Tol biopolymer transport system TolR protein 
fig|6666666.571729.peg.1338 23S rRNA (uridine(2552)-2'-O)-methyltransferase (EC 
2.1.1.166);Ontology_term 
fig|6666666.571729.peg.1516 Thiol peroxidase Tpx-type (EC 1.11.1.15);Ontology_term 
fig|6666666.571729.peg.1644 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28);On-
tology_term 
fig|6666666.571729.peg.1587 Ribonucleotide reductase of class III (anaerobic) large sub-
unit (EC 1.17.4.2);Ontology_term 




fig|6666666.571729.peg.1305 Threonyl-tRNA synthetase (EC 6.1.1.3);Ontology_term 
fig|6666666.571729.peg.989 Iron compound ABC transporter permease protein 
fig|6666666.571729.peg.1341 D-alanyl-D-alanine carboxypeptidase (EC 3.4.16.4);Ontol-
ogy_term 
fig|6666666.571729.peg.1096 Thiol:disulfide interchange protein DsbC 
fig|6666666.571729.peg.949 Flavodoxin 1 
fig|6666666.571729.peg.1494 Deoxycytidine triphosphate deaminase (EC 3.5.4.13);On-
tology_term 
fig|6666666.571729.peg.358 LSU ribosomal protein L2p (L8e) 
fig|6666666.571729.peg.1602 FIG024746: hypothetical protein 
fig|6666666.571729.peg.1729 Ferredoxin 2Fe-2S 
fig|6666666.571729.peg.496 2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontol-
ogy_term 
fig|6666666.571729.peg.1566 UPF0307 protein YjgA 
 
Figure S2.1: Total bacteria and H. parainfluenzae density relative to S. mitis. Bar heights 
represent the mean densities of (A) Eub338-labeled bacteria and (B) H. parainfluenzae with 
respect to the mean S. mitis densities for 16,205 blocks of 6.64 μm by 6.64 μm, from 41 fields 
of view. The number of blocks for each range of S. mitis densities is shown in S1A. The error 


















Figure S2.2:  H. parainfluenzae H2O2 detoxification aids S. mitis growth. (A) S. mitis CFU 
when cocultured with H. parainfluenzae WT and indicated H2O2 resistance gene deletion mu-
tants. Data are mean CFU, error bars indicate standard deviation for n=3. *denotes  p< 0.001 
by Student's t-test compared to monoculture CFU. (B) S. mitis CFU in mono and coculture 




CFU counts of S. mitis (Sm) and the pyruvate oxidase mutant of S. mitis (𝛥spxB) in mono and 
coculture with wildtype H. parainfluenzae (Hp). Hp had an initial inoculum of 4.65 x 106 
CFU/ml. Wildtype (Sm) and S. mitis 𝛥spxB with initial inoculums of 2.45x105, 1.55x106 or 
3.45x106 CFU/ml. Data are mean CFU and error bars indicate standard deviation for n≥3. *de-






Figure S2.3: H. parainfluenzae transcriptional response to S. mitis. (A) Pathways induced 
in H. parainfluenzae when cocultured with S. mitis based on number of genes that have > 2-
fold increase in expression. (B) Pathways repressed when H. parainfluenzae is cocultured with 







Table S2.10: DNA FISH probes 
Probe Fluorophore Target Taxon Probe Sequence 5’-3’ Reference 
Eub338 Dual At655 Bacteria (domain) GCTGCCTCCCGTAGGAGT Amann et al. 1990 
Pas111 Dual Dy615 Pasteurallaceae (family) TCCCAAGCATTACTCACC Valm et al. 2011 
Str405 RRX Streptococcus (genus) TAGCCGTCCCTTTCTGGT Paster et al. 1998 
Smit651 Dual Dy415 S. mitis CCCCTCTTGCACTCAA Wilbert et al. 2020 




Table S2.11: Strains used in this study 
Plasmids Identifier Host Details 
pDP863K MR0203 NEB5-ɑ 
pMRKO (1) derivative used for the deletion of the 
katA gene in H.parainfluenzae via allelic exchange 
pDP865K MR0259 NEB5-ɑ 
pMRKO derivative used for the deletion of the oxyR 
gene in H.parainfluenzae via allelic exchange 
pDP801K MR0275 NEB5-ɑ 
A pMRKO derivative used for the deletion of the 
ccp gene in H.parainfluenzae via allelic exchange 
pDP111K MR0307 NEB5-ɑ 
A pMRKO derivative used for the deletion of the 
g6p gene in H.parainfluenzae via allelic exchange 
pDP821K MR0314 NEB5-ɑ 
A pMRKO derivative used for the deletion of the 
pdgx gene in H.parainfluenzae via allelic exchange 
pEAKO MR0254 NEB5-ɑ 
pMRKO containing a sacB cassette used in generat-
ing clean deletion vectors  
pKC865
K MR0323 NEB5-ɑ 
A pEAKO derivative used for the deletion of the prx 
gene in H.parainfluenzae via clean deletion 
pDP863C MR0339 NEB5-ɑ 
A pEAKO derivative used for the deletion of the 





Species Identifier Strain Details 
E. coli   NEB5-ɑ Cloning strain (New England Biolabs) 










enzae MR0205 ΔkatA 
KatA deletion of H. parainfluenzae made via allelic 




enzae MR0266 ΔoxyR 
OxyR deletion of H. parainfluenzae made via allelic 




enzae MR0277 Δccp 
Cytochrome C Peroxidase deletion of H. parainflu-





enzae MR0312 Δg6p 
Glucose-6 phosphate dehydrogenase deletion of H. 
parainfluenzae made via allelic exchange with a 




enzae MR0316 Δpdgx 
Peroxiredoxin/Glutaredoxin deletion of H. parain-
fluenzae made via allelic exchange with a kanamy-




enzae MR0341 Δprx 
Peroxiredoxin deletion of H. parainfluenzae made 





enzae MR0406 ΔccpkatA  
Catalase and Cytochrome C peroxidase double dele-
tion, constructed using the markerless deletion of the 





enzae MR0359 ΔprxkatA 
Peroxiredoxin and Catalase double deletion, con-
structed using the markerless deletion of the catalase 
gene in the Δprx strain of H. parainfluenzae.  
S. mitis MR0181 
ATCC 
49456 Streptococcus mitis ATCC 49456TM 








Gene deletion in H. parainfluenzae 
1kb flanking regions of the target gene were amplified via PCR using Q5 High-fidelity 2X Mas-
termix and primers indicated in Table S9. For allelic exchange, these fragments were assembled 
to flank a kanamycin resistance cassette via isothermal assembly using the NEBuilder HiFi 
DNA Assembly MasterMix (New England Biolabs) and cloned into pMRKO. This resulting 
reaction was then transformed into NEB5α competent cells using the manufacturer's instructions 
(New England Biolabs). Plasmid constructs were verified via restriction digests and Sanger se-
quencing. After screening, plasmids were transformed into the donor strain MFD-pir, using the 
TSS transformation method (6). 
  
These strains were then used to conjugate into H. parainfluenzae. Briefly, washed cells of H. 
parainfluenzae overnight cultures were subjected to heat-shock (46°C for 6 minutes) and com-
bined with the donor strain by spread plating on a BHI-YE HP agar plate supplemented with 
0.3 mM di-amino pimelate (DAP). Plates were then incubated overnight at 37°C in 5% CO2. 
Cells were then harvested, and dilutions were plated on BHI-YE HP with 40 µg/ml of kanamy-
cin and incubated for 24-48 hours at 37°C in 5% CO2. Mutants were then screened by testing 
for sensitivity to spectinomycin (spectinomycin resistance cassette on pMRKO backbone), PCR 
and Sanger sequencing.  
  
The markerless deletion of genes in H. parainfluenzae involved modifications to the above pro-
tocol. 1kb flanking regions were amplified and cloned into a pMRKO derivative containing a 
sacB gene (pEAKO - Table S8). Plasmids were then transformed into H. parainfluenzae via 
conjugation as described above. After transformation, cells were subjected to counterselection 
by plating on BHI-YE HP containing 10% sucrose for 4-5 days. Mutants were then screened 







To allow quantitative analysis of the spatial distribution of the taxa of interest, we used FIJI to 
create binarized S. mitis, H. parainfluenzae, and bacterial mass images. A slight misalignment 
of the Smit651 channel was brought into closer alignment with the other channels by shifting it 
up by 2 pixels, cropping 3 pixels off each edge, and re-scaling the channel image to regain the 
original 2,048 by 2,048 resolution. The noise in each channel was reduced by applying a median 
filter with a radius of 3 pixels. To create a bacterial biomass mask, the Eub338 channel was 
automatically segmented by thresholding with the global Otsu method (7) and dilating the seg-
mented area by 3 pixels. The S. mitis channel was created by segmenting the Str405 and Smit651 
channels with the local Bernsen and global RenyiEntropy automatic thresholding methods, re-
spectively (8,9). Both segmented images were combined using the Boolean "AND" operator to 
retain the pixels appearing in both images.  The H. parainfluenzae channel was created by seg-
menting the Pas111 and Hpar441 channels with the local Bernsen and global RenyiEntropy 
automatic thresholding methods, respectively. Both segmented images were combined using 
the Boolean "AND" operator. To ensure that there was a sufficiently large area of H. parainflu-
enzae in the images for reliable analysis, only the 41 fields of view in which at least 1% of the 
bacteria mass was covered by H. parainfluenzae in the associated binary image were used for 
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The abundant commensal bacterium, Haemophilus parainfluenzae has been shown to 
be closely associated with hydrogen peroxide producing Streptococcus sp. in vivo. The 
response of H. parainfluenzae to streptococci-produced hydrogen peroxide revealed a 
redundant OxyR-controlled mechanism of dealing with this antimicrobial. Little is 
known about the mechanism of how H. parainfluenzae achieves this redundancy and 
why it evolved in this manner. Through transcriptome analyses we discovered that there 
appears to be a reduced preference for catalase, suggesting a mechanism for its redun-
dancy which is currently under further investigation. The overall effects of being ex-
posed to H2O2 on a consistent basis is not known. However, studies in other species 
have shown that H2O2 can induce the SOS response, which has been shown to be a 
mechanism of generating genetic diversity as a means of surviving stress. Interestingly, 
H. parainfluenzae has been shown to possess a high degree of strain variation within 
the human oral cavity. We observed that H. parainfluenzae appears to elicit an SOS-
like response to H2O2 based on transcriptome analyses, suggesting a potential mecha-















Haemophilus parainfluenzae is a Gram-negative facultative anaerobe and commensal 
of the human nasopharynx and oral cavity (1,2). It has previously been shown to be 
found in close proximity to Mitis group Streptococci in supragingival plaque and are 
found to overlap in other sites of the oral cavity and nasopharynx (2,3). Mitis group 
Streptococci are known to rapidly consume high-energy carbohydrates and produce 
the inhibitory anti-microbial, hydrogen peroxide (H2O2) and use it as a competitive ad-
vantage against other species. Therefore, in order to constantly co-exist alongside Mi-
tis group Streptococci, H. parainfluenzae would need to tolerate H2O2.  We have pre-
viously shown that H. parainfluenzae can tolerate S. mitis produced H2O2 except at 
high S. mitis inoculums and that H. parainfluenzae’s response to H2O2 involves a re-
dundant system involving multiple genes that aid in detoxification of H2O2, which is 
in contrast to other closely related species (2). The mechanism by which H. parainflu-
enzae achieves this redundancy and what benefit this type of system bestows is cur-
rently unknown and warrants investigation. 
To examine the overall response to H2O2, we carried out transcriptome analyses to de-
termine the genes that are affected following the deletion of oxyR, the transcriptional 
regulator that controls response to H2O2. These data indicated that catalase is not the 
gene most affected by loss of oxyR, which is in contrast to close relatives like H. influ-
enzae where loss of oxyR results in a 334-fold loss in catalase expression (4), com-
pared to a 35-fold decline in H. parainfluenzae. This is consistent with our previous 
findings where catalase is redundant in this species (2). We also demonstrated that 




strain more resistant to H2O2 than wildtype, suggesting that the regulation of catalase 
could explain its redundancy. Therefore, we sought to examine the OxyR regulon by 
carrying out Chromatin Immunoprecipitation sequencing (ChIPSeq); however, we 
found that C-terminal tagging of OxyR resulted in either the tag being inaccessible or 
affected the function of the protein, preventing binding of the tagged protein to DNA, 
preventing us from further investigation. Further work is currently being done to eval-
uate this hypothesis and new tag types need to be tested.   
 
A key feature about H. parainfluenzae in vivo is that there is a high degree of genome 
variability within this species that has resulted in strain specific niche associations 
(5,6). Given that H. parainfluenzae is found in close association with Mitis group 
Streptococci and is found in the same host body sites, it would be interesting to deter-
mine whether Streptococcus sp. produced H2O2 could play a role in the genetic diver-
sity seen in strains of H. parainfluenzae. Apart from its anti-microbial activity, H2O2 
can have other effects on a cell. It has been shown to result in DNA damage, including 
the formation of double and single-strand breaks (7,8). The addition of H2O2 has been 
shown to induce the SOS response in Escherichia coli which can result in mutagenesis 
(9). In fact, the induction of the SOS system in E. coli has been implicated in the gen-
eration of a transient genome-wide state of hypermutation that can be induced as a 
mechanism of generating genetic variability in times of stress (10). The overall effects 
of H2O2 on H. parainfluenzae are currently unknown despite H2O2 likely being a fre-
quent feature of H. parainfluenzae’s microenvironment due to its proximity to Strepto-





To investigate this, we re-examined previous transcriptome analyses (2) that suggested 
that when H. parainfluenzae is cocultured with S. mitis aerobically there appears to be 
induction of an SOS-like response involving DNA polymerase IV (DNA pol IV) 
among other genes. DNA pol IV is a low fidelity polymerase that lacks proof reading 
activity and has thus been shown to be an important component of the SOS re-
sponse(11). This response is similar to mechanisms of induced mutagenesis seen with 
E. coli in response to H2O2 (12,13); however, the lack of induction of key genes in-
cluding recA suggested only partial induction of this system. This was corroborated by 
our assays involving experimentally evolved strains of H. parainfluenzae that sug-
gested that there were only minor changes in the genome following a coculture period 
of 30 days (this paper). Further transcriptome analyses showed induction of a more 
complete SOS-like response following addition of H2O2, suggesting that the concen-
tration of S. mitis used in the previous assays may have been insufficient to induce a 
complete response.  
 
Results 
H. parainfluenzae redundant H2O2 response is influenced by OxyR 
 
To determine which genes are controlled either directly or indirectly by OxyR, we car-
ried out transcriptome comparisons via RNASeq following addition of a sublethal 
dose of H2O2 in wildtype H. parainfluenzae vs a strain lacking the regulator OxyR 
(DoxyR). We observed the induction of 23 genes and repression of 46 genes when 




is oxyR itself (63-fold), suggesting a mechanism of autoregulation, which is a con-
sistent property of many LysM- type regulators (14). The expression of DNA protec-
tion during starvation (dps) is increased 37-fold in wildtype compared to DoxyR while 
catalase (katA) is increased 20-fold. Other enzymes capable of reacting with H2O2 are 
also significantly induced more that 3-fold, including peroxiredoxin (prx) and cyto-
chrome C peroxidase (ccp). This response appears to contrast that of H. influenzae 
where catalase is the gene most affected (334-fold) following loss of OxyR (4), sug-
gesting a reduced preference for catalase in H. parainfluenzae. Genes involved in the 
pentose phosphate pathway are also significantly induced greater than 2-fold including 
glucose-6-phosphate dehydrogenase (g6pD), 6-phosphogluconolactonase, transketo-
lase, transaldolase. This is consistent with autoregulation of OxyR as NADPH pro-
duced by the pentose phosphate is important for the activity of glutathione reductase 
(4-fold increased in wildtype), which along with glutaredoxin (4-fold increase) and 
thioredoxin (2.5-fold increase) are involved in the reduction of OxyR, which is im-
portant for recycling OxyR (15). The gene with the greatest repression in wildtype 
compared to DoxyR is an iron transport system permease (fecD), repressed 3.8-fold, 
while a few other transporters involved in lipid and fatty acid metabolism are also re-
pressed (Table S2).  
 
Regulation of genes by OxyR enables redundant response to H2O2 
 
To rule out the possibility of a malfunctioning catalase being responsible for catalase 




strong constitutively active promoter in theDoxyR strain background. This generated a 
strain four-times more tolerant to H2O2 than the wildtype (Fig. 1), demonstrating that 
the catalase protein is functional, and that it is likely the mechanism of catalase regula-
tion that is responsible for its reduced importance in this species.  
 
As previous data indicated that deletion of oxyR was essential for survival of H. 
parainfluenzae following exposure to S. mitis produced H2O2, but deletion of katA and 
multiple other genes showed no effects(2), it is important to determine whether these 
genes are under the control of OxyR.  To determine whether catalase and other genes 
involved in H2O2 detoxification are likely directly controlled by the same regulator, we 
carried out a motif prediction analysis using the tool MEME (16). This suggested that 
genes including katA, prx and ccp contained a putative protein binding site with simi-
larities to that of an OxyR binding site in other species (Fig. 3), however there also ap-
pears to be some redundancy in this potential consensus site. As expected OxyR itself 
contains a domain that is predicted to bind to DNA in a helix-turn-helix conformation, 
based on computational prediction (data not shown).  
 
In order to confirm the identity of the genes that are directly controlled by OxyR and 
to quantify the relative occupancies of OxyR at different location we attempted to 
carry out ChIPSeq (chromatin immunoprecipitation sequencing). This initially in-
volved generating a strain of H. parainfluenzae with the chromosomal copy of oxyR 
modified to encode OxyR with a vesicular stomatitis virus-glycoprotein (VSV-G) 




was confirmed by sequencing. Chromatin Immunoprecipitation quantitative-polymer-
ase chain reaction (ChIP-qPCR) was then carried out to look for enrichment of known 
OxyR controlled genes. However, after several attempts we failed to observe enrich-
ment of katA, dps or oxyR following ChIP (Table 1), suggesting that either OxyR does 
not control these genes or that the OxyR VSV-G tag cannot be accessed. To rule out 
the latter, we constructed a strain where oxyR was modified to encode OxyR with a 
tandem affinity purification (TAP) epitope tag. However, this resulted in a phenotype 
similar to that of DoxyR (Fig. 2), indicating that the function of OxyR is severely af-
fected by the presence of the TAP tag. Due to time constrains we decided to find alter-
native methods of testing our hypotheses.  
 
The addition of H2O2 elicits an SOS response in H. parainfluenzae  
 
Apart from resulting in the induction of the OxyR regulon, H2O2 can have other effects 
on the cell. To determine the effects of H2O2 on H. parainfluenzae we compared the 
transcriptomes of H. parainfluenzae grown aerobically with the addition of H2O2 to a 
strain grown aerobically without addition of H2O2 (Table S3-S4). This showed the sig-
nificant induction of 313 genes greater than 2-fold (Table S3). Unsurprisingly, this in-
cluded genes typically induced by H2O2 including dps and g6pD, prx and iron trans-
porters, notably katA was not induced, suggesting maximal induction of catalase with-
out addition of exogenous H2O2. Interestingly, we observed induction of genes that 
suggest initiation of an SOS-like response. This included induction of genes like DNA 




recX (4.2-fold), DNA repair proteins recN (3.2-fold) and recA (2-fold) as well as 
genes involved in competence, including type IV pilin pilA (9.1-fold), type IV biogen-
esis protein pilM (3.4-fold), regulator of competence tfox (2.6-fold), competence pro-
tein comEC (4.5-fold). Induction of competence is a mechanism of DNA uptake and a 
key component of horizontal gene transfer (17). Competence has also been shown to 
be a mechanism of inducing the SOS-response in Vibrio cholerae (18), while H2O2 it-
self can trigger the SOS response in E.coli (19). DNA pol IV and RecA play key roles 
in the SOS response (11,20) and its induction has been shown to be an important 
mechanism of adaptation and diversification (21).    
 
Coculture with S. mitis results in partial expression of genes involved in SOS response 
due to H2O2 and only minor changes in protein coding sequences 
 
We examined previously generated RNASeq data (2), that looked at gene expression 
in H. parainfluenzae in coculture with S. mitis, compared to monoculture. This analy-
sis indicated the induction of some of the genes implicated in the SOS response. This 
includes pilA (10.9-fold), pilM (5.2-fold), tfox (4.0-fold), impA (2.2-fold), DNA pol IV 
(2.0-fold) and competence protein comEA (2.9-fold). The expression of other key 
genes including comEC and recA appear to be modestly higher in coculture; however, 
this difference is not significant, suggesting variability between the coculture repli-





H. parainfluenzae genome shows only minor changes following coculture with S. mitis 
   
To determine whether H. parainfluenzae shows evidence of some level of diversifica-
tion following coculture with S. mitis we analyzed reads generated from RNASeq ex-
periments involving H. parainfluenzae in monoculture and coculture with S. mitis. 
This analysis was carried out using the GATK pipeline (22) and involved detection of 
single nucleotide polymorphisms (SNPs) and insertion-deletion (INDELs) in the reads 
compared to the reference genome. This analysis detected only minor, insignificant 
differences between the mono and coculture reads (Table 2).  
 
Since the analysis of RNASeq reads involved only coding sequences and was carried 
out following a single 24 hour mono or coculture incubation, we hypothesized that 
there would be greater observable differences if the conditions involved multiple ex-
posures to S. mitis and utilized whole genome sequencing and these differences were 
due to S. mitis produced H2O2. We therefore subcultured H. parainfluenzae over a 
course of 10 consecutive 24-hour periods of either mono or coculture with either 
wildtype or S. mitis DspxB and examined whole genome sequences for sequentially 
passaged strains vs the initial inoculum. This analysis showed no detectable SNPs in 
monoculture or coculture with DspxB S. mitis. However, we detected 1 SNP in both 
the replicates involving coculture with wildtype S. mitis (Table 3). We hypothesize 
that more significant differences may be observed following a longer duration and this 









H. parainfluenzae is a commensal of the human oral cavity and is associated with ben-
eficial immunomodulatory effects (23). Since H. parainfluenzae was previously shown 
to coexist alongside the H2O2 producing Mitis group Streptococci (2), it is important 
to understand the overall effects of H2O2 on H. parainfluenzae. Our findings reveal a 
complex, redundant OxyR- controlled response to H2O2, that suggest a reduced affin-
ity for catalase. We also observed what appears to be induction of an SOS response in 
the presence of H2O2, however this appears to be attenuated in our coculture experi-
mental design. 
 
The transcriptional regulator, OxyR is responsible for the overall response to H2O2 in 
many species including E. coli, Salmonella typhimurium and H. influenzae (24,25). 
We therefore looked at the effects of the deletion of OxyR on H. parainfluenzae. We 
previously showed that OxyR was essential for survival of H. parainfluenzae in cocul-
ture with S. mitis (2). In this study we looked at the genes affected by deletion of 
OxyR, through transcriptome analysis. This suggested the autoregulation of OxyR as 
the expression of oxyR was among the genes that were affected, which is consistent 
with other OxyR systems (15,25). Genes involved in the reduction of oxidized OxyR 




ing its own response. The observation of oxyR being the gene most affected in this da-
taset is also interesting, as similar datasets in close relatives including H. influenzae 
show catalase as being the gene most affected with over 300-fold effect in that spe-
cies(4), while in H. parainfluenzae catalase is the 3rd most affected gene with a 20-fold 
effect. This suggests that gene regulation by OxyR may be responsible for the redun-
dant H2O2 response seen in H. parainfluenzae. This is further corroborated by the ob-
servation that the overexpression of catalase in the DoxyR strain resulted in a strain 
that is more tolerant to H2O2 than wildtype, suggesting that catalase is sufficiently 
functional, and that regulation may play a role in redundancy; however, plasmid copy 
number and effects of being under a strong promoter may be factors that could limit 
our inferences. To further evaluate this, we are currently working on generating a 
strain of H. parainfluenzae, where the catalase gene has been replaced by catalase 
from H. influenzae, which could absolve the limitations of the previous construct. To 
evaluate whether regulation of catalase alone plays a role in redundancy we are cur-
rently working on replacing the catalase promoter region of H. parainfluenzae with the 
catalase promoter region of H. influenzae to determine whether this increases the af-
finity of OxyR for the catalase promoter, and therefore, increase the relative expres-
sion of catalase.    
 
Since H. parainfluenzae has been shown to possess a high degree of strain variation 
(5,6) and is associated with the H2O2 producing Mitis group Streptococci we hypothe-
sized that constant exposure to H2O2 might be a potential mechanism of genome diver-




parainfluenzae induced the expression of genes implicated in the SOS response. This 
response in other species has been shown to be a mechanism of generating genome di-
versity in response to stress (21). However, transcriptome analyses involving H. 
parainfluenzae in mono or coculture with S. mitis showed only a handful of these 
genes being expressed in coculture. Subsequently we didn’t observe any significant 
differences in number of nucleotide changes between mono and coculture. We hypoth-
esized that coculturing H. parainfluenzae with S. mitis over multiple passages would 
enable us to see a greater number of nucleotide differences between mono and cocul-
ture. However, after 10 rounds of coculture with S. mitis we only observed 1 SNP in 
each replicate. It is interesting to note that there were no SNPs in either monoculture 
or coculture with DspxB. A potential flaw in this experimental design is that this in-
volved a single colony being passaged overtime in either mono or coculture. We hy-
pothesize that greater changes maybe observed if this assay involved a pool of colo-
nies rather than a single colony as this would enable the detection of greater variation.  
 
In this study, we investigated the effects of H2O2 on H. parainfluenzae and observed 
differences in the OxyR regulon of H. parainfluenzae compared to closely related spe-
cies suggesting that gene regulation by OxyR is responsible for the redundant response 
to H2O2 we observed previously(2). We observed evidence of induction of the SOS re-
sponse in H. parainfluenzae following the addition of H2O2 however, this was attenu-
ated in coculture with S. mitis suggesting insufficient H2O2 production or exposure in 
our experimental conditions, which was mirrored by our findings that failed to detect 




increased inoculum of S. mitis; however, we observed poor survival of H. parainfluen-
zae. Therefore, balancing survival and induction should be a key consideration in fu-
ture experimental design. 
 
Materials and Methods 
Strains and Media 
Strains and plasmids used in this study are listed in table 4. Unless indicated S. mitis 
was cultured using Brain Heart Infusion BHI broth or solid agar supplemented with 
Yeast extract (BHIYE). H. parainfluenzae was cultured using BHIYE, supplemented 
with 14µg/ml Nicotinamide Adenine Dinucleotide (Sigma-Aldrich) and 14µg/ml He-
min (Sigma-Aldrich) - (BHIYE-HP). H. parainfluenzae and S. mitis were grown at 
37℃ and 5% CO2. E. coli was grown on Luria broth (LB) at 37℃ in standard atmos-
pheric conditions with liquid cultures shaken at 200 RPM. Antibiotics were used at the 
following concentrations: Kanamycin 40µg/ml, and Spectinomycin 50µg/ml for E. 
coli, 200µg/ml for H. parainfluenzae. 
 
 
OxyR transcriptome sample preparation 
RNASeq analyses were carried out on strains using a colony biofilm model (2,26). 
Briefly, equal numbers of either wildtype or DoxyR H. parainfluenzae were spotted on 
sterile 25mm 0.2µm polycarbonate membranes that were placed on BHIYE HP agar 
plates. The plates were then incubated for 20 hours at 37℃ and 5% CO2, then trans-




membranes were transferred to pre-warmed plates containing 50µM H2O2 and incu-
bated for an additional 20 minutes. Membranes were then immediately placed in 
RNAlater solution (AmbionTM). Experiments were carried out in biological duplicates. 
 
RNA extraction and sequencing 
RNA was extracted using the Direct-zolTM RNA MiniPrep Plus kit (Zymo Research) 
according to manufacturer’s instructions. Ribsomal RNA was then depleted using the 
Ribo-zero rRNA removal kit (Illumina) according to the manufacturer’s instructions. 
The resulting products were then purified using the RNease MinElute cleanup kit (Qi-
agen). Library prep and sequencing were carried out as part of an Illumina RNA-Seq 
library preparation workshop. 
 
Transcriptome analyses 
Genome data for H. parainfluenzae ATCC 33392 was obtained from NCBI and ge-
nome annotations were generated using RAST as previously described (2). 
RNASeq reads were aligned, mapped and differentially expressed genes analyzed us-
ing our previously built pipeline, the RNASeq-analysis-toolkit (2).  
 
Effects of catalase overexpression 
The catalase gene of H. parainfluenzae was amplified and ligated into pJAK16 
(ATCC) using gibson assembly, where it was placed under the control of a tac pro-




sulting plasmid was then transformed into DoxyR H. parainfluenzae via electro-
poration as described previously (27). The Minimum inhibitory concentration for 
H2O2 was then calculated via 2-fold serial dilutions.  
 
OxyR VSV-G and TAP-tag strain construction 
To determine the genes directly controlled by OxyR and quantify the relative occu-
pancy of OxyR at different promoter regions, we sort to carry out ChIPSeq. To carry 
out these experiments we sort to generate a strain of H. parainfluenzae containing a 
VSV-G-tagged OxyR. A VSV-G-tagged OxyR was generated using a well-established 
method of tagging proteins (28). Briefly, the last 381bp of oxyR and a DNA sequence 
for the VSV-G protein were cloned into a non-replicating plasmid (pMRKO) using 
Gibson assembly. To ensure accurate translation of the VSV-G tag, the DNA sequence 
was generated after accounting for codon bias using the Kazusa tool (29). An alanine 
linker separating the oxyR fragment and VSV-G epitope tag was also generated to en-
sure that the tag would be generated in frame. Cells in which a single homologous re-
combination event occurred were selected on Spectinomycin and sequenced to con-
firm the generation of OxyR-VSV-G genotypically. To ensure that the generation of 
OxyR-VSV-G did not affect the function of OxyR we carried zone of inhibition assays 
for H2O2 to confirm that the strain had similar sensitivity to wildtype H. parainfluen-





ChIP-qPCR of OxyR 
To evaluate whether the OxyR tag is accessible and functioning as expected we sort to 
carry out ChIP-qPCR. ChIP was carried out as outlined previously (30). Briefly, mid-
log cells of wildtype H. parainfluenzae and OxyR-VSV-G H. parainfluenzae treated 
with 50mM H2O2 and OxyR-VSV-G H. parainfluenzae grown anaerobically were har-
vested and then crosslinked using 1% formaldehyde. Crosslinking was abated using 
250mM Glycine. Cells were then washed with PBS and stored at -80°C. The resulting 
pellets were then washed in sonication buffer (20mM KHEPES, 50mM Kcl, 0.5mM 
DTT, 10% Glycerol and protease inhibitor). Cells were then sonicated at an amplitude 
of 40% with a pulse setting of 6 seconds on, 2 seconds off using the Sonic Dismem-
brator Model 500 (Fisher). ChIP was then carried out in biological triplicate using 
anti-VSV-G agarose beads (Sigma). Prior to ChIP, aliquots were obtained as input 
controls. qPCR was then carried out to determine whether there was enrichment of 
known OxyR controlled promoter sites following ChIP. We tested for the enrichment 
of the promoter regions of katA, dps, oxyR vs enrichment for the control gene DNA 
gyrase gyrA.    
 
OxyR Motif prediction  
To predict which genes are most likely to be directly controlled by OxyR we sort to 
detect conserved motifs in the promoter region of genes that had the potential to be 
controlled by OxyR. To determine these motifs we used regions 150bp upstream of 




DoxyR. These were then submitted to MEME (31) for the detection of conserved bind-
ing motifs.       
 
Detection of SNPs and INDELs from coculture RNASeq reads 
To evaluate the possibility of genomic variation following coculture we examined nu-
cleotide differences following mono and coculture using reads generated from previ-
ous RNASeq experiments (2). This analysis was carried out using the best practices 
principles and GATK analysis for the detection of RNASeq short variant discovery 
(32). Briefly, this involved reads generated from biological duplicates of H. parainflu-
enzae in monoculture and coculture with S. mitis. These reads were then mapped to 
the reference using Burrows-Wheeler Aligner (BWA) (33), duplicated reads con-
densed, quality recalibrated and variants called using the recommended tools within 
the GATK best practices pipeline and package (32).      
 
 
Detection of SNPs and INDELs in genome following multiple rounds of coculture 
As the analysis of RNASeq reads failed to show significant differences between mono 
and coculture we reasoned that this may have been due to the post hoc nature of our 
experimental design, as we were examining nucleotide differences only in protein cod-
ing sequences following a single round of coculture. We hypothesized that we would 
see greater differences if we were to examine whole genome sequences following 




two colonies of H. parainfluenzae were cultured and passaged either through mono-
culture, coculture with S. mitis or coculture with DspxB S.mitis for 10 rounds of culture 
using a colony biofilm model (2,34). The latter was carried out to determine whether 
S. mitis produced H2O2 plays a role in any differences. Following the last round of cul-
ture, genomic DNA was isolated from the initial day 0 strains as well as the final day 
strains generated from mono and coculture using the MasterPure Complete DNA kit 
(Lucigen). The purified DNA was then submitted for Illumina sequencing at the Mi-
crobial Genome Sequencing Center, Pittsburgh, PA. The detection of SNPs and indels 
were carried out using samtools and bcftools (35). Briefly, reads were aligned using 
BWA (33), genomes indexed and likelihood scores calculated using samtools and var-






Figure 1: Effect of catalase overexpression on sensitivity to H2O2. Minimum inhib-
itory concentration assays for H2O2 were carried out on wildtype H. parainfluenzae 









(WT), H. parainfluenzae lacking catalase (DkatA), OxyR (DoxyR) and overexpression 
of catalase in DoxyR (katA+ DoxyR).  
 
 










Figure 2: Zone of inhibition assays for H2O2. Zone of inhibition assays for H2O2 
were carried out on (left to right) wildtype H. parainfluenzae (WT), H. parainfluenzae 
lacking OxyR (DoxyR) and H. parainfluenzae OxyR-TAP tag. 
 
   
gyrA  input 17.04 17.01 17
gyrA ChIP 26.26 26.18 26.14
katA  input 16.5 16.48 16.41
katA ChIP 25.72 25.68 25.67
dps input 16.24 16.19 16.2
dps ChIP 25.6 25.47 25.5
oxyR input 16.77 16.76 16.77



















Figure 3: MEME motif prediction analysis of putative OxyR binding sites. Con-
served putative OxyR binding sites were computationally predicted to be located 
within 150bp of the start sites of katA, ccp, prx. Ambiguous nucleotides in the pre-
dicted binding motif are denoted by noncanonical base denominations (R=AG, Y=CT, 







Table 2: Quantification of SNPs in RNASeq reads in H. parainfluenzae following 
















 Condition Number of SNPs 
H. parainfluenzae monoculture rep1 10 
H. parainfluenzae monoculture rep2 12 
H. parainfluenzae coculture with S.mitis rep1 50 




Table 3: Quantification of SNPs in H. parainfluenzae following mono and cocul-












Condition Number of 
SNPs 
H. parainfluenzae monoculture rep1 0 
H. parainfluenzae monoculture rep2 0 
H. parainfluenzae coculture with S.mitis rep1 1 
H. parainfluenzae coculture with S. mitis rep2 1 
H. parainfluenzae coculture with DspxB S.mitis rep1 0 
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Table S1: Genes induced in DoxyR compared to wildtype following addition of 
H2O2 
Fold 
change ID Description 
3.76 fig|6666666.571729.peg.1371 
Iron(III) dicitrate transport system per-
mease protein FecD (TC 3.A.1.14.1) 
3.23 fig|6666666.571729.peg.847 
Long-chain-fatty-acid--CoA ligase (EC 
6.2.1.3);Ontology_term 
3.18 fig|6666666.571729.peg.635 High-affinity choline uptake protein BetT 
3.13 fig|6666666.571729.peg.1840 hypothetical protein 
3.12 fig|6666666.571729.peg.30 Competence protein C%3B Chromosome segregation ATPases 
3.04 fig|6666666.571729.peg.1590 Xanthine permease 
3.01 fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
2.82 fig|6666666.571729.peg.1443 Cytosine permease 
2.74 fig|6666666.571729.peg.295 
Lipid A export permease/ATP-binding 
protein MsbA 
2.60 fig|6666666.571729.peg.1748 Chromosome segregation ATPases 
2.51 fig|6666666.571729.peg.1229 hypothetical protein 
2.43 fig|6666666.571729.peg.296 
COG1132: ABC-type multidrug transport 
system%2C ATPase and permease com-
ponents 
2.31 fig|6666666.571729.peg.1095 hypothetical protein 
2.30 fig|6666666.571729.peg.176 
Sodium-dependent anion transporter fam-
ily 
2.29 fig|6666666.571729.peg.1995 




hydratase%2C FabA form (EC 4.2.1.59) 
@ Trans-2-decenoyl-[acyl-carrier-protein] 





Diaminopimelate decarboxylase and/or di-
aminopimelate epimerase leader peptide 
2.18 fig|6666666.571729.peg.241 Cell division protein ZapB 
2.10 fig|6666666.571729.peg.474 
Uncharacterized inner membrane protein 
RarD 
2.05 fig|6666666.571729.peg.1274 
ABC-type Co2+ transport system%2C 
periplasmic component 
2.03 fig|6666666.571729.peg.1810 
Transcriptional regulator%2C MerR fam-
ily 
2.00 fig|6666666.571729.peg.313 
TonB-dependent hemin%2C ferrichrome 
receptor 




Table S2: Genes repressed in in DoxyR compared to wildtype following addition 
of H2O2 
Fold 
change ID Description 
-62.81 fig|6666666.571729.peg.337 
Hydrogen peroxide-inducible genes ac-
tivator > OxyR 
-37.41 fig|6666666.571729.peg.1232 
DNA protection during starvation pro-
tein (dps) 
-20.38 fig|6666666.571729.peg.1459 





-7.09 fig|6666666.571729.peg.929 hypothetical protein 
-7.01 fig|6666666.571729.peg.930 hypothetical protein 
-6.31 fig|6666666.571729.peg.1548 
Alkyl hydroperoxide reductase subunit 
C-like protein 
-5.03 fig|6666666.571729.peg.1700 






Superoxide dismutase [Cu-Zn] precur-
sor (EC 1.15.1.1);Ontology_term 
-4.34 fig|6666666.571729.peg.1898 
Glutathione reductase (EC 1.8.1.7);On-
tology_term 





-3.59 fig|6666666.571729.peg.84 Aspartate--ammonia ligase (EC 6.3.1.1);Ontology_term 
-3.59 fig|6666666.571729.peg.813 
Manganese ABC transporter%2C ATP-
binding protein SitB 
-3.55 fig|6666666.571729.peg.1126 
Glucose-6-phosphate isomerase (EC 
5.3.1.9);Ontology_term 
-3.40 fig|6666666.571729.peg.1464 




ase (EC 1.4.1.4);Ontology_term 





Manganese ABC transporter%2C inner 
membrane permease protein SitC 
-2.86 fig|6666666.571729.peg.399 DUF1176 domain-containing protein 
-2.86 fig|6666666.571729.peg.1430 
NAD(P) transhydrogenase N-domain 
of subunit alpha (EC 1.6.1.2) / NAD(P) 
transhydrogenase C-domain of subunit 
alpha (EC 1.6.1.2);Ontology_term 
-2.78 fig|6666666.571729.peg.934 Pentapeptide repeat family protein 
-2.73 fig|6666666.571729.peg.2003 
Frataxin homolog CyaY%2C facilitates 
Fe-S cluster assembly%2C interacts 
with IscS 





Manganese ABC transporter%2C 
periplasmic-binding protein SitA 
-2.62 fig|6666666.571729.peg.933 hypothetical protein 
-2.61 fig|6666666.571729.peg.776 NrfC protein 
-2.57 fig|6666666.571729.peg.1413 




pendent zinc metalloprotease FtsH 
-2.50 fig|6666666.571729.peg.1646 Thioredoxin 
-2.48 fig|6666666.571729.peg.826 
ABC transporter involved in cyto-
chrome c biogenesis%2C CcmB subu-
nit 
-2.42 fig|6666666.571729.peg.16 Transaldolase (EC 2.2.1.2);Ontol-ogy_term 
-2.41 fig|6666666.571729.peg.777 
Cytochrome c-type protein NrfB pre-
cursor 
-2.39 fig|6666666.571729.peg.949 Flavodoxin 1 
-2.36 fig|6666666.571729.peg.829 
Cytochrome c-type biogenesis protein 
CcmE%2C heme chaperone 
-2.32 fig|6666666.571729.peg.1429 
NAD(P) transhydrogenase subunit beta 
(EC 1.6.1.2);Ontology_term 
-2.30 fig|6666666.571729.peg.1412 




Fumarate reductase flavoprotein subu-
nit (EC 1.3.5.4);Ontology_term 
-2.26 fig|6666666.571729.peg.398 DUF1176 domain-containing protein 
-2.15 fig|6666666.571729.peg.1403 Hydrogenase-4 component A 
-2.10 fig|6666666.571729.peg.1392 
Formate dehydrogenase H (EC 1.2.1.2) 
@ selenocysteine-containing;Ontol-
ogy_term 





DEAD-box ATP-dependent RNA hel-
icase DeaD ( CshA) (EC 3.6.4.13);On-
tology_term 
-2.05 fig|6666666.571729.peg.26 [4Fe-4S] cluster carrier protein NfuA 
-2.04 fig|6666666.571729.peg.662 Lipoprotein NlpI 
 
 
Table S3: Genes induced in H. parainfluenzae following addition of H2O2 
Fold 
change ID Description 
34.51 fig|6666666.571729.peg.602 hypothetical protein 
31.85 fig|6666666.571729.peg.1707 hypothetical protein 
24.78 fig|6666666.571729.peg.1635 DNA translocase FtsK 
19.94 fig|6666666.571729.peg.816 hypothetical protein 
19.80 fig|6666666.571729.peg.1271 hypothetical protein 
13.75 fig|6666666.571729.peg.1301 hypothetical protein 
12.75 fig|6666666.571729.peg.941 
Sulfate and thiosulfate binding pro-
tein CysP 
11.05 fig|6666666.571729.peg.1232 
DNA protection during starvation 
protein 
9.96 fig|6666666.571729.peg.888 
Type II secretory pathway%2C pseu-
dopilin PulG 
9.89 fig|6666666.571729.peg.1893 
Outer membrane receptor pro-
teins%2C mostly Fe transport 
9.80 fig|6666666.571729.peg.30 
Competence protein C%3B Chromo-
some segregation ATPases 




8.98 fig|6666666.571729.peg.93 hypothetical protein 
8.19 fig|6666666.571729.peg.1633 
Serine/threonine protein phosphatase 
(EC 3.1.3.16);Ontology_term 
7.98 fig|6666666.571729.peg.159 hypothetical protein 
7.75 fig|6666666.571729.peg.890 hypothetical protein 
7.74 fig|6666666.571729.peg.842 hypothetical protein 
7.56 fig|6666666.571729.peg.629 
NADP-specific glutamate dehydro-
genase (EC 1.4.1.4);Ontology_term 
7.50 fig|6666666.571729.peg.677 
Uncharacterized inner membrane 
transporter YhbE 
6.93 fig|6666666.571729.peg.1182 





6.17 fig|6666666.571729.peg.1638 putative 5'(3')-deoxyribonucleotidase 
6.12 fig|6666666.571729.peg.889 
Type II secretory pathway%2C com-
ponent PulJ 
6.05 fig|6666666.571729.peg.586 Acyl carrier protein 
6.02 fig|6666666.571729.peg.1631 AAA ATPase%2C central region 
5.92 fig|6666666.571729.peg.1634 
NAD-dependent protein deacetylase 
of SIR2 family 
5.85 fig|6666666.571729.peg.268 hypothetical protein 
5.78 fig|6666666.571729.peg.942 
Precorrin-2 oxidase (EC 1.3.1.76) @ 
Sirohydrochlorin ferrochelatase ac-
tivity of CysG (EC 4.99.1.4) / Uro-
porphyrinogen-III methyltransferase 
(EC 2.1.1.107);Ontology_term 5.60 fig|6666666.571729.peg.945 
Sulfate adenylyltransferase subunit 1 
(  2.7.7.4);Ontology_term 
5.48 fig|6666666.571729.peg.939 







transporter%2C ATPase component 
5.41 fig|6666666.571729.peg.1780 
Iron compound ABC uptake trans-
porter permease protein 
5.23 fig|6666666.571729.peg.1028 
Inorganic triphosphatase (EC 
3.6.1.25);Ontology_term 
5.03 fig|6666666.571729.peg.1736 Iron-sulfur cluster regulator IscR 
4.96 fig|6666666.571729.peg.678 
Uncharacterized inner membrane 
transporter YhbE 
4.95 fig|6666666.571729.peg.431 IroE protein 
4.93 fig|6666666.571729.peg.1636 
Putative DNA-binding protein in 




doxin] (EC 1.8.4.10);Ontology_term 
4.79 fig|6666666.571729.peg.501 hypothetical protein 
4.70 fig|6666666.571729.peg.366 LSU ribosomal protein L24p (L26e) 
4.68 fig|6666666.571729.peg.1994 hypothetical protein 
4.65 fig|6666666.571729.peg.2004 
Diaminopimelate decarboxylase 
and/or diaminopimelate epimerase 
leader peptide 
4.64 fig|6666666.571729.peg.1942 
Ferric siderophore transport sys-
tem%2C biopolymer transport pro-
tein ExbB 
4.64 fig|6666666.571729.peg.502 hypothetical protein 
4.60 fig|6666666.571729.peg.1288 
Type III restriction-modification sys-




ase (EC 1.1.1.49);Ontology_term 
4.56 fig|6666666.571729.peg.1894 
TonB-dependent receptor%3B Outer 
membrane receptor for ferrientero-
chelin and colicins 






tence protein ComEC/Rec2 
4.49 fig|6666666.571729.peg.339 hypothetical protein 
4.47 fig|6666666.571729.peg.1302 hypothetical protein 
4.37 fig|6666666.571729.peg.84 
Aspartate--ammonia ligase (EC 
6.3.1.1);Ontology_term 
4.34 fig|6666666.571729.peg.1230 
Sel1 domain protein repeat-contain-
ing protein 
4.32 fig|6666666.571729.peg.1049 
DNA polymerase IV (EC 
2.7.7.7);Ontology_term 
4.30 fig|6666666.571729.peg.1632 hypothetical protein 
4.29 fig|6666666.571729.peg.1481 Putative permease 
4.26 fig|6666666.571729.peg.940 
Sulfate transport system permease 
protein CysT 
4.21 fig|6666666.571729.peg.320 Regulatory protein RecX 
4.14 fig|6666666.571729.peg.1959 L-lactate dehydrogenase 
4.12 fig|6666666.571729.peg.587 Acyl carrier protein 
4.12 fig|6666666.571729.peg.407 hypothetical protein 
4.12 fig|6666666.571729.peg.1408 hypothetical protein 
4.11 fig|6666666.571729.peg.744 
Leader peptidase (Prepilin peptidase) 
(EC 3.4.23.43) / N-methyltransferase 
(EC 2.1.1.-);Ontology_term 
4.09 fig|6666666.571729.peg.691 hypothetical protein 







4.00 fig|6666666.571729.peg.92 hypothetical protein 
3.96 fig|6666666.571729.peg.633 
Twin-arginine translocation protein 
TatA 
3.92 fig|6666666.571729.peg.261 hypothetical protein 
3.84 fig|6666666.571729.peg.672 hypothetical protein 
3.80 fig|6666666.571729.peg.596 
Efflux ABC transporter%2C ATP-
binding protein 
3.80 fig|6666666.571729.peg.208 Protein YihD 
3.79 fig|6666666.571729.peg.72 hypothetical protein 
3.79 fig|6666666.571729.peg.465 Integrase 
3.79 fig|6666666.571729.peg.835 hypothetical protein 
3.77 fig|6666666.571729.peg.1417 Na+/H+ antiporter 
3.76 fig|6666666.571729.peg.186 
Molybdopterin-guanine dinucleotide 
biosynthesis protein MobB 
3.72 fig|6666666.571729.peg.992 SSU ribosomal protein S15p (S13e) 
3.71 fig|6666666.571729.peg.66 hypothetical protein 
3.71 fig|6666666.571729.peg.907 hypothetical protein 
3.71 fig|6666666.571729.peg.1149 Protein YecM 
3.70 fig|6666666.571729.peg.464 Integrase 
3.69 fig|6666666.571729.peg.376 
LSU ribosomal protein L36p @ LSU 
ribosomal protein L36p%2C zinc-de-
pendent 
3.68 fig|6666666.571729.peg.1570 






Periplasmic nitrate reductase compo-
nent NapD 
3.68 fig|6666666.571729.peg.1985 
Transcriptional regulator%2C MerR 
family 
3.68 fig|6666666.571729.peg.2011 16S rRNA processing protein RimM 
3.67 fig|6666666.571729.peg.160 hypothetical protein 




3.62 fig|6666666.571729.peg.1482 hypothetical protein 
3.60 fig|6666666.571729.peg.814 
Manganese ABC transporter%2C 
periplasmic-binding protein SitA 
3.60 fig|6666666.571729.peg.597 hypothetical protein 
3.60 fig|6666666.571729.peg.252 hypothetical protein 
3.58 fig|6666666.571729.peg.1220 Anticodon nuclease 
3.57 fig|6666666.571729.peg.1841 SAM-dependent methyltransferase 
3.52 fig|6666666.571729.peg.254 hypothetical protein 
3.52 fig|6666666.571729.peg.1743 
Tol-Pal system-associated acyl-CoA 
thioesterase 
3.51 fig|6666666.571729.peg.1412 
DNA for glycosyltransferase%2C 
lytic transglycosylase%2C dTDP-4-
rhamnose reductase 
3.50 fig|6666666.571729.peg.1238 RNA:NAD 2'-phosphotransferase 
3.50 fig|6666666.571729.peg.1952 
Carbonic anhydrase (EC 4.2.1.1);On-
tology_term 




3.49 fig|6666666.571729.peg.949 Flavodoxin 1 
3.48 fig|6666666.571729.peg.256 hypothetical protein 
3.47 fig|6666666.571729.peg.560 hypothetical protein 
3.47 fig|6666666.571729.peg.1576 hypothetical protein 





3.42 fig|6666666.571729.peg.1601 FIG035246: DoxX family protein 
3.40 fig|6666666.571729.peg.32 
Type IV pilus biogenesis protein 
PilM 
3.40 fig|6666666.571729.peg.435 
Biofilm PGA synthesis deacetylase 
PgaB (EC 3.-) 
3.39 fig|6666666.571729.peg.1779 
Iron compound ABC uptake trans-
porter permease protein 
3.38 fig|6666666.571729.peg.879 LemA family protein 
3.34 fig|6666666.571729.peg.1794 Intracellular septation protein IspA 
3.32 fig|6666666.571729.peg.262 hypothetical protein 
3.32 fig|6666666.571729.peg.1122 Phage integrase 
3.29 fig|6666666.571729.peg.1656 hypothetical protein 
3.29 fig|6666666.571729.peg.1943 
Biopolymer transport protein 
ExbD/TolR 
3.28 fig|6666666.571729.peg.67 hypothetical protein 






tem response regulator CpxR 
3.23 fig|6666666.571729.peg.1438 hypothetical protein 
3.23 fig|6666666.571729.peg.1445 Lactam utilization protein LamB 
3.22 fig|6666666.571729.peg.1846 
Transcriptional regulator%2C AcrR 
family 
3.21 fig|6666666.571729.peg.916 
Putative molybdenum transport 
ATP-binding protein modF 
3.20 fig|6666666.571729.peg.470 hypothetical protein 
3.20 fig|6666666.571729.peg.1231 Sel1-like repeat 
3.19 fig|6666666.571729.peg.22 Membrane protein LAPB 
3.19 fig|6666666.571729.peg.1584 DNA repair protein RecN 
3.16 fig|6666666.571729.peg.592 hypothetical protein 
3.12 fig|6666666.571729.peg.379 
SSU ribosomal protein S4p (S9e) @ 
SSU ribosomal protein S4p 
(S9e)%2C zinc-independent 
3.11 fig|6666666.571729.peg.1579 Protein SprT 
3.11 fig|6666666.571729.peg.253 hypothetical protein 
3.09 fig|6666666.571729.peg.161 hypothetical protein 






Manganese ABC transporter%2C in-
ner membrane permease protein SitC 









3.02 fig|6666666.571729.peg.1654 hypothetical protein 
3.00 fig|6666666.571729.peg.1291 
Molybdopterin synthase sulfur car-
rier subunit 
2.96 fig|6666666.571729.peg.1987 
Dihydroneopterin aldolase (EC 
4.1.2.25);Ontology_term 
2.96 fig|6666666.571729.peg.503 hypothetical protein 
2.96 fig|6666666.571729.peg.538 Glycosyltransferase 
2.95 fig|6666666.571729.peg.877 Uncharacterized protein YdiJ 
2.94 fig|6666666.571729.peg.535 hypothetical protein 
2.93 fig|6666666.571729.peg.64 hypothetical protein 
2.93 fig|6666666.571729.peg.369 SSU ribosomal protein S8p (S15Ae) 
2.92 fig|6666666.571729.peg.248 hypothetical protein 
2.89 fig|6666666.571729.peg.500 hypothetical protein 
2.88 fig|6666666.571729.peg.1655 hypothetical protein 
2.87 fig|6666666.571729.peg.476 Na+/H+ antiporter NhaA type 
2.86 fig|6666666.571729.peg.1428 hypothetical protein 
2.82 fig|6666666.571729.peg.1272 
Fumarate and nitrate reduction regu-
latory protein 




2.81 fig|6666666.571729.peg.118 SSU ribosomal protein S12p (S23e) 
2.81 fig|6666666.571729.peg.1765 hypothetical protein 
2.81 fig|6666666.571729.peg.1645 DNA ligase 
2.79 fig|6666666.571729.peg.10 hypothetical protein 
2.78 fig|6666666.571729.peg.455 
Transcriptional regulator%2C MarR 
family 
2.78 fig|6666666.571729.peg.1969 Tyrosine-specific transport protein 
2.77 fig|6666666.571729.peg.1277 Mobile element protein 
2.74 fig|6666666.571729.peg.914 ImpA 
2.74 fig|6666666.571729.peg.322 Patatin-like phospholipase 
2.73 fig|6666666.571729.peg.380 
DNA-directed RNA polymerase al-
pha subunit (EC 2.7.7.6);Ontol-
ogy_term 
2.72 fig|6666666.571729.peg.235 
Permease of the drug/metabolite 
transporter (DMT) superfamily 
2.71 fig|6666666.571729.peg.896 
5'-deoxynucleotidase YfbR (EC 
3.1.3.89);Ontology_term 
2.71 fig|6666666.571729.peg.403 hypothetical protein 
2.71 fig|6666666.571729.peg.1237 FIG00847315: hypothetical protein 
2.70 fig|6666666.571729.peg.606 hypothetical protein 
2.69 fig|6666666.571729.peg.1544 
Putative Ton-B dependent hemine 
receptor 
2.69 fig|6666666.571729.peg.662 Lipoprotein NlpI 




2.67 fig|6666666.571729.peg.929 hypothetical protein 
2.65 fig|6666666.571729.peg.265 
Vitamin B12 ABC transporter%2C 
ATP-binding protein BtuD 
2.63 fig|6666666.571729.peg.5 hypothetical protein 






Type II secretory pathway%2C com-
ponent PulF%3B Type IV fimbrial 








2.59 fig|6666666.571729.peg.263 hypothetical protein 
2.58 fig|6666666.571729.peg.1681 hypothetical protein 
2.58 fig|6666666.571729.peg.590 hypothetical protein 
2.58 fig|6666666.571729.peg.402 
3'(2')%2C5'-bisphosphate nucleo-
tidase (EC 3.1.3.7);Ontology_term 
2.57 fig|6666666.571729.peg.370 LSU ribosomal protein L6p (L9e) 
2.56 fig|6666666.571729.peg.184 
Dipeptide ABC transporter%2C sub-
strate-binding protein DppA (TC 
3.A.1.5.2) 
2.56 fig|6666666.571729.peg.946 
Sulfite reductase [NADPH] flavo-
protein alpha-component (EC 
1.8.1.2);Ontology_term 
2.56 fig|6666666.571729.peg.323 DNA transformation protein TfoX 
2.55 fig|6666666.571729.peg.1974 
Transcriptional regulator of glmS 
gene%2C DeoR family 





SSU ribosomal protein S14p (S29e) 
@ SSU ribosomal protein S14p 
(S29e)%2C zinc-independent 
2.54 fig|6666666.571729.peg.837 
DnaA inactivator Hda (shorter hom-
olog of DnaA) 
2.53 fig|6666666.571729.peg.1868 hypothetical protein 
2.53 fig|6666666.571729.peg.1386 
Transcriptional regulator%2C MerR 
family 
2.52 fig|6666666.571729.peg.1183 
Transcription termination protein 
NusA 
2.52 fig|6666666.571729.peg.964 
Permease of the drug/metabolite 
transporter (DMT) superfamily 
2.50 fig|6666666.571729.peg.986 
ABC transporter%2C ATP-binding 
protein 
2.50 fig|6666666.571729.peg.746 









Holliday junction ATP-dependent 
DNA helicase RuvA (EC 
3.6.4.12);Ontology_term 
2.47 fig|6666666.571729.peg.679 GTP-binding protein Obg 
2.46 fig|6666666.571729.peg.1100 TonB-dependent receptor 
2.46 fig|6666666.571729.peg.1287 
Type III restriction-modification sys-
tem restriction subunit (EC 
3.1.21.5);Ontology_term 





2.44 fig|6666666.571729.peg.60 Glycerol uptake facilitator protein 
2.43 fig|6666666.571729.peg.635 





2.42 fig|6666666.571729.peg.1172 L-lysine permease 
2.42 fig|6666666.571729.peg.1523 
Ferric iron ABC transporter%2C 
ATP-binding protein 
2.41 fig|6666666.571729.peg.65 hypothetical protein 
2.41 fig|6666666.571729.peg.999 
Glycine cleavage system transcrip-
tional activator GcvA 
2.40 fig|6666666.571729.peg.1865 
Dihydrofolate reductase (EC 
1.5.1.3);Ontology_term 
2.40 fig|6666666.571729.peg.325 hypothetical protein 
2.39 fig|6666666.571729.peg.1603 FIG023677: hypothetical protein 
2.38 fig|6666666.571729.peg.1581 
Para-aminobenzoate synthase%2C 
amidotransferase component (EC 
2.6.1.85);Ontology_term 
2.38 fig|6666666.571729.peg.1187 
Chorismate mutase I (EC 5.4.99.5) / 




Possible protease sohB (EC 
3.4.21.-);Ontology_term 
2.37 fig|6666666.571729.peg.7 hypothetical protein 
2.37 fig|6666666.571729.peg.1658 hypothetical protein 
2.36 fig|6666666.571729.peg.540 
UDP-glucose 4-epimerase (EC 
5.1.3.2);Ontology_term 
2.35 fig|6666666.571729.peg.1905 Fumarate reductase subunit C 
2.34 fig|6666666.571729.peg.1916 Glycosyl transferase 
2.33 fig|6666666.571729.peg.441 
Permease of the drug/metabolite 






Biotin operon repressor / Biotin--







Exodeoxyribonuclease III (EC 
3.1.11.2);Ontology_term 
2.33 fig|6666666.571729.peg.1756 hypothetical protein 
2.33 fig|6666666.571729.peg.1694 T6SS component TssB (ImpB/VipA) 
2.32 fig|6666666.571729.peg.155 
ABC transporter%2C permease pro-
tein (cluster 3%2C basic aa/gluta-
mine/opines) 
2.32 fig|6666666.571729.peg.100 
5'-nucleotidase (EC 3.1.3.5)%3B 
2'%2C3'-cyclic-nucleotide 2'-phos-
phodiesterase (EC 3.1.4.16)%3B Pu-
tative UDP-sugar hydrolase (EC 
3.6.1.45);Ontology_term 2.32 fig|6666666.571729.peg.1759 hypothetical protein 
2.31 fig|6666666.571729.peg.1547 
Cystathionine beta-lyase (EC 
4.4.1.8);Ontology_term 
2.31 fig|6666666.571729.peg.373 LSU ribosomal protein L30p (L7e) 
2.31 fig|6666666.571729.peg.154 
ABC transporter%2C permease pro-
tein (cluster 3%2C basic aa/gluta-
mine/opines) 
2.30 fig|6666666.571729.peg.1128 Protein tyrosine/serine phosphatase 
2.30 fig|6666666.571729.peg.55 Sulfate transporter%2C CysZ-type 
2.29 fig|6666666.571729.peg.1691 T6SS component TssF (ImpG/VasA) 
2.27 fig|6666666.571729.peg.971 
Glycogen phosphorylase (EC 
2.4.1.1);Ontology_term 
2.27 fig|6666666.571729.peg.1637 
NAD-dependent protein deacetylase 
of SIR2 family 
2.26 fig|6666666.571729.peg.57 
L-cystine ABC transporter%2C sub-
strate-binding protein TcyA 
2.25 fig|6666666.571729.peg.49 
Thymidine kinase (EC 2.7.1.21);On-
tology_term 
2.25 fig|6666666.571729.peg.404 Predicted membrane protein 




2.24 fig|6666666.571729.peg.1909 Primosomal replication protein N 
2.23 fig|6666666.571729.peg.875 
COG2315: Uncharacterized protein 
conserved in bacteria 
2.23 fig|6666666.571729.peg.377 SSU ribosomal protein S13p (S18e) 
2.23 fig|6666666.571729.peg.1711 
Phospholipid ABC transporter-bind-
ing protein MlaB 
2.22 fig|6666666.571729.peg.813 
Manganese ABC transporter%2C 
ATP-binding protein SitB 
2.22 fig|6666666.571729.peg.994 Hypothetical protein DUF454 
2.21 fig|6666666.571729.peg.1647 
Cystathionine gamma-synthase (EC 
2.5.1.48);Ontology_term 
2.20 fig|6666666.571729.peg.2013 hypothetical protein 
2.20 fig|6666666.571729.peg.539 
Lipid carrier : UDP-N-acetylgalac-
tosaminyltransferase (EC 2.4.1.-) / 
Alpha-1%2C3-N-acetylgalactosa-
mine transferase PglA (EC 
2.4.1.-)%3B Putative glycosyltrans-
ferase;Ontology_term 
2.20 fig|6666666.571729.peg.1876 Putative inner membrane protein 
2.20 fig|6666666.571729.peg.1712 
Phospholipid ABC transporter shut-
tle protein MlaC 
2.18 fig|6666666.571729.peg.781 
Formamidopyrimidine-DNA glyco-





2.18 fig|6666666.571729.peg.463 hypothetical protein 
2.18 fig|6666666.571729.peg.1317 Stringent starvation protein A 









ABC transporter%2C permease pro-
tein 2 (cluster 5%2C nickel/pep-
tides/opines) 
2.16 fig|6666666.571729.peg.965 
Permease of the drug/metabolite 
transporter (DMT) superfamily 
2.15 fig|6666666.571729.peg.1221 
Type I restriction-modification sys-
tem%2C specificity subunit S 
2.15 fig|6666666.571729.peg.584 FIG017861: hypothetical protein 
2.15 fig|6666666.571729.peg.1610 Protein PhnA 
2.15 fig|6666666.571729.peg.1827 
3-hydroxyacyl-[acyl-carrier-protein] 
dehydratase%2C FabZ form (EC 
4.2.1.59);Ontology_term 
2.15 fig|6666666.571729.peg.944 
Sulfate adenylyltransferase subunit 2 
(EC 2.7.7.4);Ontology_term 
2.14 fig|6666666.571729.peg.187 
Sigma factor RpoE negative regula-
tory protein RseB precursor 
2.14 fig|6666666.571729.peg.416 
tRNA pseudouridine(13) synthase 
(EC 5.4.99.27);Ontology_term 
2.13 fig|6666666.571729.peg.660 
Membrane-bound lytic murein 
transglycosylase F (EC 4.2.2.n1) 
2.13 fig|6666666.571729.peg.87 
Anaerobic glycerol-3-phosphate de-
hydrogenase subunit B (EC 
1.1.5.3);Ontology_term 
2.13 fig|6666666.571729.peg.1690 
T6SS component TssG 
(ImpH/VasB) 
2.13 fig|6666666.571729.peg.1652 hypothetical protein 
2.13 fig|6666666.571729.peg.62 hypothetical protein 
2.13 fig|6666666.571729.peg.1006 
Riboflavin synthase eubacterial/eu-
karyotic (EC 2.5.1.9);Ontology_term 
2.12 fig|6666666.571729.peg.224 hypothetical protein 
2.11 fig|6666666.571729.peg.389 hypothetical protein 






phohydrolase MazG (EC 
3.6.1.8);Ontology_term 
2.11 fig|6666666.571729.peg.1452 hypothetical protein 
2.10 fig|6666666.571729.peg.595 FIG00847847: hypothetical protein 
2.10 fig|6666666.571729.peg.316 
Pantothenate kinase (EC 
2.7.1.33);Ontology_term 
2.10 fig|6666666.571729.peg.506 






Type I restriction-modification sys-
tem%2C DNA-methyltransferase 
subunit M (EC 2.1.1.72);Ontol-
ogy_term 
2.09 fig|6666666.571729.peg.735 




mine transferase PglH (EC 
2.4.1.-);Ontology_term 
2.09 fig|6666666.571729.peg.1825 
Lipid-A-disaccharide synthase (EC 
2.4.1.182);Ontology_term 
2.08 fig|6666666.571729.peg.375 Protein translocase subunit SecY 
2.08 fig|6666666.571729.peg.1176 Protein ygiW precursor 
2.08 fig|6666666.571729.peg.1393 






2.08 fig|6666666.571729.peg.292 converved hypothetical protein 
2.07 fig|6666666.571729.peg.1807 
Copper sensory histidine kinase 
CpxA 
2.07 fig|6666666.571729.peg.321 RecA protein 
2.06 fig|6666666.571729.peg.95 
Phosphoribosylformylglycinamidine 
synthase%2C synthetase subunit (EC 
6.3.5.3) / Phosphoribosylformyl-
glycinamidine synthase%2C gluta-









Transcriptional regulator%2C LysR 
family 
2.04 fig|6666666.571729.peg.1686 
T6SS outer membrane component 
TssL (ImpK/VasF) 





Dihydropteroate synthase (EC 
2.5.1.15);Ontology_term 
2.03 fig|6666666.571729.peg.1913 LOS biosynthesis enzyme LBGB 
2.02 fig|6666666.571729.peg.750 
Uncharacterized UPF0721 integral 
membrane protein 
2.02 fig|6666666.571729.peg.271 
S-ribosylhomocysteine lyase (EC 
4.4.1.21) @ Autoinducer-2 produc-
tion protein LuxS;Ontology_term 
2.02 fig|6666666.571729.peg.1088 
Conserved protein YcjX with nucle-
oside triphosphate hydrolase domain 
2.02 fig|6666666.571729.peg.1082 






Alkyl hydroperoxide reductase subu-
nit C-like protein 
 
 
Table S4: Genes repressed in H. parainfluenzae following addition of H2O2 com-
pared to no added H2O2 
 
Fold 




-4683.91 fig|6666666.571729.peg.756 FIG00697202: hypothetical protein 
-90.59 fig|6666666.571729.peg.537 hypothetical protein 
-68.30 fig|6666666.571729.peg.458 
Putative Dihydrolipoamide dehydro-
genase (EC 1.8.1.4)%3B Mercuric ion 
reductase (EC 1.16.1.1)%3B PF00070 
family%2C FAD-dependent NAD(P)-
disulphide oxidoreductase;Ontol-
ogy_term -37.22 fig|6666666.571729.peg.646 hypo hetical protein 
-32.75 fig|6666666.571729.peg.1745 
Cytochrome d ubiquinol oxidase sub-




-28.32 fig|6666666.571729.peg.1020 hypothetical protein 
-25.31 fig|6666666.571729.peg.742 DNA gyrase inhibitor YacG 
-17.45 fig|6666666.571729.peg.607 hypothetical protein 




-11.51 fig|6666666.571729.peg.1289 hypothetical protein 
-11.44 fig|6666666.571729.peg.1275 hypothetical protein 
-11.25 fig|6666666.571729.peg.1389 
Substrate-specific component NikM 
of nickel ECF transporter 
-11.19 fig|6666666.571729.peg.1796 YciL protein 
-10.86 fig|6666666.571729.peg.461 
Inner membrane protein%2C 
KefB/KefC family 




-9.73 fig|6666666.571729.peg.1884 Nucleoid-associated protein YaaK 
-9.51 fig|6666666.571729.peg.1299 LSU ribosomal protein L20p 
-9.25 fig|6666666.571729.peg.566 
LSU ribosomal protein L32p @ LSU 
ribosomal protein L32p%2C zinc-in-
dependent 
-8.62 fig|6666666.571729.peg.251 hypothetical protein 
-8.29 fig|6666666.571729.peg.1473 hypothetical protein 
-8.01 fig|6666666.571729.peg.1409 
Outer membrane stress sensor prote-
ase DegQ%2C serine protease 
-7.81 fig|6666666.571729.peg.562 
Carboxymuconolactone decarbox-
ylase family protein 
-7.48 fig|6666666.571729.peg.676 LSU ribosomal protein L27p 
-7.11 fig|6666666.571729.peg.13 
2-iminobutanoate/2-iminopropanoate 
deaminase RidA/TdcF (EC 
3.5.99.10);Ontology_term 
-6.68 fig|6666666.571729.peg.1818 
Heat shock protein 60 kDa family 
chaperone GroEL 
-6.62 fig|6666666.571729.peg.1982 
ABC transporter%2C permease pro-
tein (cluster 10%2C nitrate/sul-
fonate/bicarbonate) 
-6.59 fig|6666666.571729.peg.1360 
Periplasmic protein p19 involved in 
high-affinity Fe2+ transport 
-6.14 fig|6666666.571729.peg.1862 
FKBP-type peptidyl-prolyl cis-trans 




ated lipoprotein PAL 
-6.01 fig|6666666.571729.peg.1908 
SSU ribosomal protein S18p @ SSU 
ribosomal protein S18p%2C zinc-in-
dependent 




-5.96 fig|6666666.571729.peg.433 AagD 
-5.96 fig|6666666.571729.peg.1950 Uncharacterized protein YhdT 
-5.90 fig|6666666.571729.peg.453 
putative phage shock protein E pre-
cursor 
-5.80 fig|6666666.571729.peg.685 Rhomboid family protein 




-5.52 fig|6666666.571729.peg.1013 LSU ribosomal protein L25p 
-5.44 fig|6666666.571729.peg.1552 
ADP-ribose pyrophosphatase (EC 
3.6.1.13);Ontology_term 
-5.39 fig|6666666.571729.peg.1768 hypothetical protein 
-5.28 fig|6666666.571729.peg.903 
O-acetylhomoserine sulfhydrylase 
(EC 2.5.1.49) @ O-succinylhomoser-
ine sulfhydrylase (EC 2.5.1.48);On-
tology_term 
-5.19 fig|6666666.571729.peg.1821 Uncharacterized transporter YfbS 
-5.10 fig|6666666.571729.peg.250 2-oxoglutarate/malate translocator 
-5.08 fig|6666666.571729.peg.69 hypothetical protein 
-5.07 fig|6666666.571729.peg.902 Chaperone protein DnaJ 
-5.04 fig|6666666.571729.peg.1395 Hydrogenase-4 component I 
-4.98 fig|6666666.571729.peg.1809 Copper(I) chaperone CopZ 
-4.96 fig|6666666.571729.peg.524 





-4.82 fig|6666666.571729.peg.508 hypothetical protein 
-4.70 fig|6666666.571729.peg.1284 
N5-carboxyaminoimidazole ribonu-
cleotide mutase (EC 5.4.99.18);Ontol-
ogy_term 
-4.60 fig|6666666.571729.peg.1040 FIG001587: exported protein 
-4.59 fig|6666666.571729.peg.1077 
Adenylosuccinate synthetase (EC 
6.3.4.4);Ontology_term 
-4.55 fig|6666666.571729.peg.1403 Hydrogenase-4 component A 
-4.54 fig|6666666.571729.peg.836 hypothetical protein 
-4.48 fig|6666666.571729.peg.546 
Nucleoside diphosphate kinase (EC 
2.7.4.6);Ontology_term 
-4.41 fig|6666666.571729.peg.446 
PTS system%2C mannose-specific 
IID component 
-4.41 fig|6666666.571729.peg.306 Hydrogenase maturation protease 
-4.39 fig|6666666.571729.peg.1072 
3-oxoacyl-[acyl-carrier-protein] syn-
thase%2C KASI (EC 2.3.1.41);Ontol-
ogy_term 
-4.37 fig|6666666.571729.peg.183 






LSU ribosomal protein L36p @ LSU 
ribosomal protein L36p%2C zinc-in-
dependent 
-4.33 fig|6666666.571729.peg.977 




Heat shock protein 10 kDa family 
chaperone GroES 
-4.28 fig|6666666.571729.peg.447 
PTS system%2C mannose-specific 
IIC component 
-4.27 fig|6666666.571729.peg.310 
Ni/Fe-hydrogenase 2 small subunit 






phocarrier protein HPr 
-4.23 fig|6666666.571729.peg.906 hypothetical protein 
-4.20 fig|6666666.571729.peg.96 Orf2 
-4.19 fig|6666666.571729.peg.1858 
Glutathionylspermidine synthase (EC 
6.3.1.8) / Glutathionylspermidine am-
idohydrolase (EC 3.5.1.78);Ontol-
ogy_term 
-4.15 fig|6666666.571729.peg.789 Cyclic AMP receptor protein 
-4.13 fig|6666666.571729.peg.1588 
Hypothetical protein VC0266 (sugar 
utilization related?) 
-4.05 fig|6666666.571729.peg.1322 Integration host factor alpha subunit 
-4.03 fig|6666666.571729.peg.48 hypothetical protein 
-4.00 fig|6666666.571729.peg.1388 
Additional component NikL of nickel 
ECF transporter 
-3.94 fig|6666666.571729.peg.451 Uncharacterized protein YnbE 




-3.86 fig|6666666.571729.peg.1925 DnaJ-like protein DjlA 
-3.86 fig|6666666.571729.peg.785 
Phosphopantothenoylcysteine decar-
boxylase (EC 4.1.1.36) / Phosphopan-
tothenoylcysteine synthetase (EC 
6.3.2.5);Ontology_term 
-3.81 fig|6666666.571729.peg.1998 
Fructose-bisphosphate aldolase class 
II (EC 4.1.2.13);Ontology_term 
-3.81 fig|6666666.571729.peg.550 TonB-dependent receptor 
-3.80 fig|6666666.571729.peg.686 
IMP cyclohydrolase (EC 3.5.4.10) / 
Phosphoribosylaminoimidazolecar-





-3.71 fig|6666666.571729.peg.1436 Uncharacterized protein YraP 
-3.70 fig|6666666.571729.peg.1089 
Superoxide dismutase [Cu-Zn] pre-
cursor (EC 1.15.1.1);Ontology_term 
-3.65 fig|6666666.571729.peg.1563 hypothetical protein 
-3.63 fig|6666666.571729.peg.496 
2-haloalkanoic acid dehalogenase (EC 
3.8.1.2);Ontology_term 
-3.61 fig|6666666.571729.peg.801 
Ribonuclease P protein component 
(EC 3.1.26.5);Ontology_term 
-3.61 fig|6666666.571729.peg.2016 VgrG protein 
-3.60 fig|6666666.571729.peg.716 
Lactoylglutathione lyase (EC 
4.4.1.5);Ontology_term 
-3.58 fig|6666666.571729.peg.278 
D-aminoacyl-tRNA deacylase (EC 
3.1.1.96);Ontology_term 
-3.58 fig|6666666.571729.peg.787 
Transcriptional regulator SlmA%2C 
TetR family 





Copper-translocating P-type ATPase 
(EC 3.6.3.4);Ontology_term 
-3.50 fig|6666666.571729.peg.210 UPF0438 protein YifE 
-3.49 fig|6666666.571729.peg.1907 LSU ribosomal protein L9p 
-3.49 fig|6666666.571729.peg.1883 Recombination protein RecR 
-3.48 fig|6666666.571729.peg.1835 Ribosome recycling factor 
-3.46 fig|6666666.571729.peg.2001 






N-acetylmuramic acid 6-phosphate 
etherase (EC 4.2.1.126);Ontol-
ogy_term 
-3.44 fig|6666666.571729.peg.457 hypothetical protein 
-3.40 fig|6666666.571729.peg.226 
Threonine dehydratase biosynthetic 
(EC 4.3.1.19);Ontology_term 
-3.38 fig|6666666.571729.peg.1937 Alternative ribosome-rescue factor A 
-3.37 fig|6666666.571729.peg.1081 
Putative NAD(P)H nitroreductase 
YdjA 
-3.35 fig|6666666.571729.peg.1512 Phospholipid-binding protein 
-3.34 fig|6666666.571729.peg.1722 
Galactose-1-phosphate uridylyltrans-
ferase (EC 2.7.7.10);Ontology_term 
-3.34 fig|6666666.571729.peg.1485 Transcriptional activator MetR 
-3.33 fig|6666666.571729.peg.1516 
Thiol peroxidase%2C Tpx-type (EC 
1.11.1.15);Ontology_term 
-3.31 fig|6666666.571729.peg.1542 
HesA/MoeB/ThiF family protein > 
sulfur transfer pathway protein CsdL 
-3.29 fig|6666666.571729.peg.11 
LSU ribosomal protein L7p/L12p 
(P1/P2) 
-3.27 fig|6666666.571729.peg.411 
ATP-dependent protease subunit 
HslV (EC 3.4.25.2);Ontology_term 
-3.27 fig|6666666.571729.peg.1264 
Bacterial non-heme ferritin (EC 
1.16.3.2);Ontology_term 
-3.25 fig|6666666.571729.peg.1261 







Transcription termination protein 
NusB 
-3.20 fig|6666666.571729.peg.334 
Cell division protein DivIC 








-3.17 fig|6666666.571729.peg.1660 VgrG protein 
-3.16 fig|6666666.571729.peg.1143 
LSU rRNA pseudouridine(2605) syn-
thase (EC 5.4.99.22);Ontology_term 
-3.14 fig|6666666.571729.peg.1074 
Acetolactate synthase small subunit 
(EC 2.2.1.6);Ontology_term 
-3.14 fig|6666666.571729.peg.700 
Putative pre-16S rRNA nuclease 
YqgF 
-3.13 fig|6666666.571729.peg.336 
Unsaturated fatty acid biosythesis re-
pressor FabR%2C TetR family 
-3.09 fig|6666666.571729.peg.180 Uncharacterized oxidoreductase YjhC 
-3.07 fig|6666666.571729.peg.495 
Large exoproteins involved in heme 
utilization or adhesion 
-3.05 fig|6666666.571729.peg.68 hypothetical protein 
-3.05 fig|6666666.571729.peg.1954 
Biotin carboxyl carrier protein of ace-
tyl-CoA carboxylase 
-3.03 fig|6666666.571729.peg.1427 UPF0033 protein YedF 
-2.97 fig|6666666.571729.peg.73 




ine methyltransferase (EC 
2.1.1.13);Ontology_term 
-2.96 fig|6666666.571729.peg.1873 
3-isopropylmalate dehydratase large 
subunit (EC 4.2.1.33);Ontology_term 
-2.96 fig|6666666.571729.peg.1509 




phosphate synthase (flavodoxin) (EC 
1.17.7.3);Ontology_term 




-2.90 fig|6666666.571729.peg.179 probable oxidoreductase protein 
-2.89 fig|6666666.571729.peg.705 
Chaperone protein ClpB (ATP-de-
pendent unfoldase) 
-2.87 fig|6666666.571729.peg.841 
Nitric-oxide reductase (EC 
1.7.99.7)%2C quinol-dependent;On-
tology_term 
-2.86 fig|6666666.571729.peg.608 Protein translocase subunit SecA 
-2.83 fig|6666666.571729.peg.1067 probable membrane protein YPO3565 
-2.83 fig|6666666.571729.peg.1404 
[NiFe] hydrogenase metallocenter as-
sembly protein HypC 
-2.82 fig|6666666.571729.peg.699 UPF0301 protein YqgE 
-2.82 fig|6666666.571729.peg.1211 
Cold shock protein of CSP family > 
CspD (naming convention as in 
E.coli) 
-2.80 fig|6666666.571729.peg.430 33 kDa chaperonin HslO 
-2.78 fig|6666666.571729.peg.422 





ase (EC 2.1.1.14);Ontology_term 
-2.77 fig|6666666.571729.peg.497 hypothetical protein 
-2.77 fig|6666666.571729.peg.1382 
[NiFe] hydrogenase metallocenter as-























FKBP-type peptidyl-prolyl cis-trans 
isomerase SlyD (EC 5.2.1.8);Ontol-
ogy_term 
-2.74 fig|6666666.571729.peg.439 
Iron(III) dicitrate transport system 
permease protein FecC (TC 
3.A.1.14.1) 
-2.74 fig|6666666.571729.peg.717 Uncharacterized protease YegQ 
-2.72 fig|6666666.571729.peg.1506 
Formate dehydrogenase O gamma 
subunit (EC 1.2.1.2);Ontology_term 
-2.71 fig|6666666.571729.peg.526 
Glycerate kinase (EC 2.7.1.31);Ontol-
ogy_term 
-2.70 fig|6666666.571729.peg.1387 
Additional periplasmic component 






minopyrimidine deaminase (EC 
3.5.4.26) / 5-amino-6-(5-phosphoribo-






DNA recombination and repair pro-
tein RecO 
-2.68 fig|6666666.571729.peg.61 
Glycerol kinase (EC 2.7.1.30);Ontol-
ogy_term 
-2.68 fig|6666666.571729.peg.2005 









-2.67 fig|6666666.571729.peg.1076 Protein of unknown function DUF484 
-2.66 fig|6666666.571729.peg.129 
Triosephosphate isomerase (EC 
5.3.1.1);Ontology_term 
-2.65 fig|6666666.571729.peg.1316 Stringent starvation protein B 
-2.63 fig|6666666.571729.peg.301 
ATP-dependent protease La (EC 
3.4.21.53) Type I;Ontology_term 
-2.63 fig|6666666.571729.peg.1903 
Fumarate reductase flavoprotein sub-
unit (EC 1.3.5.4);Ontology_term 
-2.62 fig|6666666.571729.peg.821 
Histidyl-tRNA synthetase (EC 
6.1.1.21);Ontology_term 
-2.61 fig|6666666.571729.peg.1365 Putative thioredoxin precursor 
-2.61 fig|6666666.571729.peg.1206 UPF0319 protein YccT precursor 











thase (EC 2.2.1.9);Ontology_term 
-2.54 fig|6666666.571729.peg.412 
ATP-dependent hsl protease ATP-
binding subunit HslU 
-2.54 fig|6666666.571729.peg.417 





-2.52 fig|6666666.571729.peg.682 tmRNA-binding protein SmpB 





Thiosulfate sulfurtransferase GlpE 
(EC 2.8.1.1);Ontology_term 
-2.48 fig|6666666.571729.peg.1850 
FIG002060: uncharacterized protein 
YggL 
-2.48 fig|6666666.571729.peg.1402 Hydrogenase-4 component B 
-2.47 fig|6666666.571729.peg.1782 
Zinc ABC transporter%2C ATP-bind-
ing protein ZnuC 
-2.46 fig|6666666.571729.peg.1751 
Crossover junction endodeoxyribonu-
clease RuvC (EC 3.1.22.4);Ontol-
ogy_term 
-2.46 fig|6666666.571729.peg.1144 
Cys regulon transcriptional activator 
CysB 
-2.46 fig|6666666.571729.peg.1541 
Zinc ABC transporter%2C substrate-
binding protein ZnuA 
-2.46 fig|6666666.571729.peg.667 UPF0597 protein YhaM 
-2.45 fig|6666666.571729.peg.472 
Multidrug efflux system EmrAB-
OMF%2C inner-membrane pro-
ton/drug antiporter EmrB (MFS type) 
-2.44 fig|6666666.571729.peg.1968 UPF0701 protein YicC 
-2.44 fig|6666666.571729.peg.1405 
[NiFe] hydrogenase metallocenter as-
sembly protein HypF 
-2.44 fig|6666666.571729.peg.838 




tional regulator NrdR 
-2.43 fig|6666666.571729.peg.886 













-2.42 fig|6666666.571729.peg.734 Putative transport protein YidE 
-2.42 fig|6666666.571729.peg.532 
Glutamine synthetase type I (EC 
6.3.1.2);Ontology_term 
-2.42 fig|6666666.571729.peg.527 
Site-specific tyrosine recombinase 
XerD 





Uridylate kinase (EC 2.7.4.22);Ontol-
ogy_term 
-2.38 fig|6666666.571729.peg.1073 
Acetolactate synthase large subunit 
(EC 2.2.1.6);Ontology_term 
-2.38 fig|6666666.571729.peg.1919 FIG00696423: hypothetical protein 
-2.38 fig|6666666.571729.peg.1346 
BioD-like N-terminal domain / Phos-
phate acetyltransferase (EC 
2.3.1.8);Ontology_term 
-2.36 fig|6666666.571729.peg.692 




genase A (EC 1.1.1.-);Ontology_term 
-2.35 fig|6666666.571729.peg.466 Single-stranded DNA-binding protein 
-2.33 fig|6666666.571729.peg.1286 




phosphate phosphatase (EC 
3.1.3.45);Ontology_term 
-2.32 fig|6666666.571729.peg.1101 
Cytidylate kinase (EC 2.7.4.25);On-
tology_term 
-2.31 fig|6666666.571729.peg.1719 





-2.31 fig|6666666.571729.peg.280 UPF0225 protein YchJ 
-2.30 fig|6666666.571729.peg.1304 Aldose 1-epimerase 
-2.30 fig|6666666.571729.peg.752 










UDP-glucose 4-epimerase (EC 
5.1.3.2);Ontology_term 
-2.28 fig|6666666.571729.peg.492 LSU ribosomal protein L1p (L10Ae) 
-2.28 fig|6666666.571729.peg.1695 T6SS PAAR-repeat protein 
-2.27 fig|6666666.571729.peg.193 
PTS system%2C fructose-specific IIA 
component (EC 2.7.1.202) / Fructose-
specific phosphocarrier protein 
HPr;Ontology_term 







phosphate dehydrogenase (EC 
1.2.1.12);Ontology_term 
-2.26 fig|6666666.571729.peg.1787 
DNA mismatch repair endonuclease 
MutH 
-2.24 fig|6666666.571729.peg.1151 Outer membrane lipoprotein 
-2.24 fig|6666666.571729.peg.1810 
Transcriptional regulator%2C MerR 
family 
-2.23 fig|6666666.571729.peg.1783 






ABC transporter involved in cyto-







Multidrug efflux transporter 
MdtK/NorM (MATE family) 
-2.22 fig|6666666.571729.peg.1104 probable membrane protein YPO2224 
-2.21 fig|6666666.571729.peg.138 Flavin-utilizing monoxygenase 
-2.21 fig|6666666.571729.peg.1777 
ABC transporter%2C substrate-bind-
ing protein (cluster 8%2C B12/iron 
complex) 
-2.21 fig|6666666.571729.peg.1642 
Arginine ABC transporter%2C sub-
strate-binding protein ArtI 
-2.21 fig|6666666.571729.peg.1800 




[NADH] (EC 1.3.1.9);Ontology_term 
-2.20 fig|6666666.571729.peg.783 
LSU ribosomal protein L28p @ LSU 










PTS system%2C sucrose-specific IIB 
component (EC 2.7.1.211) / PTS sys-
tem%2C sucrose-specific IIC compo-
nent;Ontology_term 
-2.19 fig|6666666.571729.peg.674 
Octaprenyl diphosphate synthase (EC 
2.5.1.90);Ontology_term 
-2.19 fig|6666666.571729.peg.574 
3-oxoacyl-[ACP] reductase (EC 
1.1.1.100) FadG2%2C NOT involved 




-2.18 fig|6666666.571729.peg.71 Transcription elongation factor GreB 
-2.18 fig|6666666.571729.peg.1314 
Tryptophan synthase alpha chain (EC 
4.2.1.20);Ontology_term 
-2.18 fig|6666666.571729.peg.2003 
Frataxin homolog CyaY%2C facili-
tates Fe-S cluster assembly%2C inter-
acts with IscS 
-2.18 fig|6666666.571729.peg.822 UPF0070 protein YfgM 
-2.17 fig|6666666.571729.peg.1766 hypothetical protein 
-2.17 fig|6666666.571729.peg.1623 
UDP-N-acetylmuramoyl-tripeptide--
D-alanyl-D-alanine ligase (EC 
6.3.2.10);Ontology_term 
-2.17 fig|6666666.571729.peg.1236 
Oligopeptide ABC transporter%2C 
ATP-binding protein OppF (TC 
3.A.1.5.1) 
-2.16 fig|6666666.571729.peg.89 Glycerol-3-phosphate transporter 
-2.16 fig|6666666.571729.peg.199 




ing protein (cluster 5%2C nickel/pep-
tides/opines) 
-2.15 fig|6666666.571729.peg.1726 
Galactose/methyl galactoside ABC 
transporter%2C permease protein 
MglC (EC 3.6.3.17);Ontology_term 
-2.15 fig|6666666.571729.peg.266 
thiamine-phosphate pyrophosphory-
lase( EC:2.5.1.3 );Ontology_term 
-2.14 fig|6666666.571729.peg.1199 
Electron transport complex protein 
RnfE 
-2.13 fig|6666666.571729.peg.153 
Uncharacterized protein EC-HemY in 
Proteobacteria (unrelated to HemY-
type PPO in GramPositives) 





Cytochrome c-type heme lyase subu-
nit nrfE%2C nitrite reductase com-
plex assembly 
-2.13 fig|6666666.571729.peg.81 
Spermidine/putrescine import ABC 
transporter substrate-binding protein 
PotD (TC 3.A.1.11.1) 
-2.12 fig|6666666.571729.peg.1997 
Phosphoglycerate kinase (EC 
2.7.2.3);Ontology_term 
-2.12 fig|6666666.571729.peg.319 Fluoride ion transporter CrcB 
-2.12 fig|6666666.571729.peg.27 
Competence protein F homolog%2C 
phosphoribosyltransferase do-
main%3B protein YhgH required for 
utilization of DNA as sole source of 






D-alanine--D-alanine ligase (EC 
6.3.2.4);Ontology_term 
-2.10 fig|6666666.571729.peg.1771 
Ribonuclease E (EC 3.1.26.12);Ontol-
ogy_term 
-2.10 fig|6666666.571729.peg.70 
Transcription accessory protein (S1 
RNA-binding domain) 
-2.10 fig|6666666.571729.peg.1239 
Cytidine deaminase (EC 3.5.4.5);On-
tology_term 





Methionine ABC transporter sub-
strate-binding protein 
-2.09 fig|6666666.571729.peg.658 Ribosome-associated inhibitor A 
-2.08 fig|6666666.571729.peg.1075 






Threonyl-tRNA synthetase (EC 
6.1.1.3);Ontology_term 
-2.08 fig|6666666.571729.peg.221 
Acetolactate synthase large subunit 
(EC 2.2.1.6);Ontology_term 
-2.07 fig|6666666.571729.peg.420 Murein hydrolase activator NlpD 
-2.07 fig|6666666.571729.peg.1225 Glutaredoxin 2 
-2.06 fig|6666666.571729.peg.227 
ATP synthase epsilon chain (EC 
3.6.3.14);Ontology_term 
-2.06 fig|6666666.571729.peg.937 
Argininosuccinate synthase (EC 
6.3.4.5);Ontology_term 
-2.06 fig|6666666.571729.peg.1333 hypothetical protein 
-2.05 fig|6666666.571729.peg.1923 




nase (EC 3.5.4.13);Ontology_term 
-2.05 fig|6666666.571729.peg.145 
Phosphoglycerate mutase (EC 
5.4.2.11);Ontology_term 
-2.04 fig|6666666.571729.peg.467 Excinuclease ABC subunit A 
-2.03 fig|6666666.571729.peg.1640 
Arginine ABC transporter%2C per-




ase (EC 2.7.8.20);Ontology_term 
-2.02 fig|6666666.571729.peg.76 UPF0381 protein HI_0636 
-2.02 fig|6666666.571729.peg.1397 Hydrogenase-4 component G 
-2.02 fig|6666666.571729.peg.1614 Cell division protein FtsZ 






ase%2C decarboxylating (EC 
1.1.1.44);Ontology_term 
-2.00 fig|6666666.571729.peg.1953 
Biotin carboxylase of acetyl-CoA car-
boxylase (EC 6.3.4.14);Ontol-
ogy_term 
 
 
 
 
 
 
 
